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Abstract 
 
Humans display a 90% population level bias towards right-handedness, implying the 
vast majority of people have a left-hemisphere dominant for motor control. Although 
handedness presents a weak, but very consistent heritability across the literature 
(estimated to be approximately 25%), to date few genetic loci associated with this 
complex trait have been identified and replicated in subsequent studies. One such gene 
which has been found to be associated with handedness and subsequently replicated is 
PCSK6, most recently through a quantitative GWAS (P < 0.5*10-8, Brandler et al. 
(2013)). Interestingly, PCSK6 is known to activate Nodal, a morphogen involved in a 
highly conserved bilaterian pathway known to regulate left-right body axis 
determination.  
 
Here I present the first molecular characterisation of a handedness-associated region by 
conducting a detailed functional analysis of the PCSK6 locus, combining genetic 
analysis, in silico prediction and molecular assays to investigate how common genetic 
variants influence handedness-related phenotypes. Specifically, I defined the associated 
locus to be 12.7 kb in size, spanning a predicted 1.8 kb bidirectional promoter which 
controls the expression of both an antisense long non-coding RNA (lncRNA), and a 
novel short PCSK6 isoform. A series of luciferase-expressing constructs were generated 
to characterise the promoter, identifying a minimal sequence capable of driving 
transcription in a sense strand direction. I have demonstrated experimentally that one of 
the top associated markers in previous GWA studies, rs11855145, directly 
creates/disrupts a suspected transcription factor bind site in the vicinity of this 
bidirectional promoter.   
 
Further functional studies of the genetic variation within PCSK6 may help explain the 
molecular regulatory mechanisms affecting gene expression. This project provides a 
model for assays to study other GWAS-nominated candidate genes, and in particular for 
establishing the role of noncoding variants. The findings from this study support the 
role of common variants in influencing complex phenotypes, such as handedness. 
Thesis word count: 40,000 words 
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1 Introduction 
1.1 Handedness 
1.1.1 What is handedness? 
 
Handedness is a behavioural asymmetry in which dominant use is lateralised to one 
hand or the other. In humans this laterality of function is displayed in approximately 
90% of the population who show a right hand dominant for skilled manipulation and 
motor functionality (Corballis, 2003). Functional lateralisation exists in multiple paired 
organs across the sagittal plane of the human body; our liver and our guts coil in 
opposite directions, the left kidney is slightly higher and larger than the right, the 
pancreas and spleen are asymmetrically placed right and left of the midline respectively 
and even the organs themselves can be asymmetrical; our heart must be larger on one 
side if that side is to passage blood around the entire body. The brain is no exception, 
exhibiting both functional asymmetries and anatomical asymmetries, e.g. the right 
hemisphere is wider in the anterior region while the left hemisphere is wider in the 
posterior region.  
 
Handedness is a heritable continuum ranging from extreme right to extreme left-
handedness and although substantial evidence exists to support a consistent right hand 
bias for multiple tasks in different societies (Raymond et al., 1996, Perelle and Ehrman, 
1994), the bias has been shown to fluctuate across both time and space. Stock et al. 
(2013), demonstrated this change in a study in which skeletal analysis was used to 
report an 80% right-lateralisation bias in a British medieval population. Additionally, 
Faurie and Raymond (2005) investigated functional specialisation in traditional 
societies and concluded that the prevalence of left-handers reported fluctuates between 
3 and 27%, a figure which varies in Western societies between 2 and 13%. Gender has 
also been shown to influence the incidence of handedness. In a meta-analysis of 144 
studies (N = 1,787,629) Papadatou-Pastou et al. (2008) demonstrated that the sex 
difference is both significant and robust with males 23% more likely to be left-handed 
than females. In short, it remains unclear whether the preference for one hand over the 
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other is learned and influenced by environment, experience and enforcement (Provins, 
1997) or if handedness is innate and genetically controlled (Corballis, 1997), or a 
combination of the above. Furthermore, why a stable, albeit fluctuating, 10% of the 
population is non-right-handed has yet to be fully explained. Yahagi and Kasai (1999) 
demonstrated in a study involving visual skills not subject to social control that left-
handers show less functional asymmetry than right-handers (N = 24), that is, the degree 
to which left handers use their preferred hand is less than that of right-handers.  
Therefore, differences in performance between the two hands are significantly smaller 
for left-handers, resulting in an advantage in the use of the non-preferred hand. Such an 
advantage could maintain a stable ratio of non-right-handers in a population as a result 
of an evolutionarily stable strategy (ESS) (Ghirlanda and Vallortigara, 2004). 
 
1.1.2 Limb preference in the Animal Kingdom 
 
If handedness does represent an ESS then one might expect to see its repeated evolution 
in multiple lineages. Until quite recently humans were considered to be the only species 
that exhibited such a population-level bias in limb preference direction (Hopkins et al., 
2011)  however mounting empirical evidence from a variety of vertebrate and 
invertebrate species has begun to challenge this assumption (Rogers et al., 2013).  
 
Ströckens et al. (2013) recently reviewed the lateralised behaviours of non-human 
vertebrates and found 68% of the 119 species reviewed show lateral bias, 51% of which 
are at a population-level (Table 1.1). One of the most well-known examples of forelimb 
asymmetry in non-human vertebrates are parrots which show a left foot bias of almost 
90% in picking up objects (Rogers, 2008).  As with humans however, this distribution 
might be context specific; parrots, like chicks, use their feet to manipulate or scratch for 
food whereas pigeons do not. In a study which involved scratching off adhesive tape 
placed on a bill, Güntürkün (1988) found no foot preference in pigeons for removing the 
tape while Rogers and Workman (1993) found 82% of chicks favoured the right foot, a 
result supported by Andrew et al. (2000) who demonstrated chicks have a right bias for 
discriminating food from non-food in a foraging task. Together these results suggest 
limb preference in birds could arise in species that use their forelimbs for manipulation. 
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Other vertebrate species also exhibit a dominant forelimb preference, though in both 
cats and mice this does not seem biased to either the right or left paw at a population 
level (Fabre-Thorpe et al., 1993, Bulman-Fleming et al., 1997). Interestingly, different 
mouse strains exhibit differences in the direction and strength of paw preference, 
indicating that genetic background has a contributory effect on this behaviour (Waters 
and Denenberg, 1994). 
 
Non-human vertebrates have also been observed to display asymmetric behaviours, 
overt or otherwise; for example several species of fish display population-level biases, 
that is, the majority of a population will consistently turn to the left or the right to avoid 
predation (Bisazza et al., 2000), an analogous trait reflected in humans where the right 
hemisphere is specialised for avoidance and the left tends to be specialised for approach 
(Davidson, 2004). A left-hemisphere dominance for vocal production appears in both 
canaries (Halle et al., 2003) and frogs (Bauer, 1993) while mice have shown a left-
hemispheric advantage for the recognition of ultrasonic communication calls (Ehret, 
1987). As noted by Corballis (2009), this left hemisphere control of vocalisation 
production and perception might be a precursor to left hemisphere dominance for 
language processing in humans.  
 
 
 
 
 
 
 
 
 
 
 
 
 
4 
 
Table 1.1 Selection of animal species showing population-level asymmetry where limb preference has 
been investigated 
 
 Preferred side %  
species Measure N left right none citation 
spitting spiders limb loss 36 75 25 - (Ades and Ramires, 2002) 
Eurasian curlew roosting on one foot 310 45 55 - (Randler, 2007) 
red kangaroo bipedal feeding 21 86 4 10 (Giljov et al., 2015) 
ostrich forward foot resting posture 65 22 68 10 (Baciadonna et al., 2010) 
chicks foot preference  50 6 84 10 (Casey and Martino, 2000) 
buzzard foot to grasp prey 34 32 53 15 (Csermely, 2004) 
cane toads righting behaviour 42 10 90 - (Robins and Rogers, 2002)  
leatherback turtles Flipperedness 361 46 54 - (Sieg et al., 2010) 
tortoises righting behaviour 34 18 53 29 (Stancher et al., 2006) 
wallabies bipedal feeding 27 74 7 19 (Giljov et al., 2013)  
bottlenose dolphins flipper rubbing 111 45 - 55 (Sakai et al., 2006) 
bats Climbing 25 24 76 - (Zucca et al., 2010)  
lions forelimb stand preference  24 21 75 4 (Zucca et al., 2011) 
rats paw preference 198 20 73 7 (Guven et al., 2003) 
whales rolling feeding behaviour 11 10 90 - (Canning et al., 2011) 
gorilla hand preference (various) 76 22 54 24 (Hopkins et al., 2011) 
lemurs food reaching 194 47 33 20 (Ward et al., 1990) 
spider monkey food reaching 13 79 21 - (Laska, 1996)  
olive baboon communicative gestures 60 17 58 25 (Meguerditchian and Vauclair, 2006) 
chimpanzees hand preference (various) 536 29 50 21 (Hopkins et al., 2011) 
Japanese macaques hand preference (various) 394 38 30 32 (Itani et al., 1963) 
 - dash indicates where no value was recorded or appropriate   
 
 
Asymmetry at the population-level can also occur among invertebrates, supporting 
growing evidence that the specialisation of the brain's hemispheres was already in place 
prior to the arrival of the vertebrates half a billion years ago (MacNeilage et al., 2009). 
The Bombus terrestris honeybee favours the right antenna in responding to learned 
odours (Anfora et al., 2011), a similar population-level lateralisation to the recall of 
olfactory memory found in honeybees and several species of Australian stingless bees 
(Frasnelli et al., 2012). The study of invertebrate asymmetry is also important if we are 
to understand the role of environment on how limb asymmetries develop (Palmer, 
2012). Both the water bug Belostoma flumineum (Kight et al., 2008) and Temnothorax 
albipennis ant (Hunt et al., 2014) display a population-level left turn bias, a possible 
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result of a lateralised central nervous system (CNS), while the spectacularly asymmetric 
forelimbs of some crustaceans such as the fiddler crab (Backwell et al., 2007) show 
how significant behaviour can be in prompting and orienting morphological, and 
consequently functional, asymmetries (Versace and Vallortigara, 2015). 
    
Collectively, these studies provide important insights into the functional and anatomical 
asymmetries that exist across a wide range of taxa and species. However due to the 
phylogenetic distances involved and the considerable number of studies that report a 
lack of functional asymmetry at a population level (Hook, 2004), it is difficult to say 
which if any of these asymmetries could be precursors to handedness in humans. To do 
so requires a more detailed look at our closest relatives. 
 
1.1.3 Handedness in non-human primates  
 
If the laterality of hand function can be shown to exist in non-human primates 
(chimpanzees in particular) it could make them a useful model in offering insights into 
the emergence of human handedness. However, the expression of manual laterality in 
non-human primates at a population level and their potential continuities with Homo 
sapiens remains less than conclusive. Drawing on an extensive range of sources, 
Meguerditchian et al., (2013) reviewed the collective findings and concluded that for 
bimanual behaviours, that is, the engagement of two hands in a coordinated and 
asymmetrical manner, right hand dominance for manipulation seems to extend to all 
terrestrial primates, but not to arboreal species. The frequency of right-hand bias is 
consistently lower than that found in humans and in a meta-analysis of 1,524 wild and 
captive great apes Hopkins (2006) did find right-hand bias at the population level, 
though never exceeding 55% bias for all samples.  
 
Though some studies report no population-level asymmetries in the nonhuman primates 
(McGrew and Marchant, 1997, Papademetriou et al., 2005, Cashmore et al., 2008), 
behavioural observations for forelimb asymmetries have been shown with a similar 
right-hand bias for bimanual behaviours in baboons (Vauclair et al., 2005), 
chimpanzees and gorillas (Llorente et al., 2011), and in adult bonobos (Chapelain et al., 
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2011). To confound matters, most data are derived from great apes kept in captivity, 
with only two studies investigating bimanual coordinated behaviours in wild groups 
(chimpanzees: Corp and Byrne (2004) and gorillas: Byrne and Byrne (1991)). This 
poses a problem since evidence of population-level hand bias in wild primates is rare 
(Parnell, 2001, Byrne and Byrne, 1991). The discrepancy in findings between captive 
and wild apes, has prompted some to argue that captive apes may have been influenced 
by human handlers in a predominantly right-handed environment (Palmer, 2002) or that 
the limited sample sizes of wild-population studies are denied the statistical power 
larger captive cohorts do not lack (Hopkins and Cantalupo, 2005). 
 
In conclusion, where the literature shows a hand preference in great apes, it does so at a 
reduced ratio and not the consistent 9:1 we see at the population level in humans. The 
high level of right-hand dominance displayed by humans should therefore be considered 
a unique, derived trait (Gibson, 1993). By implication, the inconsistent population-level 
handedness seen in our nearest relative, the chimpanzee, suggests that the trait is 
derived in Homo sapiens and that population-level right-handedness must have emerged 
sometime after the divergence from our last common ancestor approximately 5.4 
million years ago (Patterson et al., 2006). The search for the emergence of handedness 
must therefore focus on hominin species prior to Homo sapiens. 
 
1.1.4 Right-hand dominance in the hominin lineage  
 
Paleoanthropological research in to the handedness of ancient humans employs a range 
of excavated data including skeletal elements, prehistoric art, tool-manufacturing 
techniques and directional cut marks on faunal material for inferring hand preference 
(Frayer et al., 2012). For example, by comparing Upper Palaeolithic (ca. 50,000-10,000 
years ago) hand stencils found on the walls of French caves to modern students’ 
technique for producing similar representations, Faurie and Raymond (2004) found an 
identical ratio of at least 77% right-handedness in both groups. Further back in the 
hominin lineage, an analysis of skeletal asymmetry (e.g. rigidity of the second 
metacarpal) by Stock et al. (2013) was used to reflect habitual mechanical loading and 
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infer hand dominance among thirteen hunter-gatherers populations as far back as the 
late Pleistocene age (ca. 126,000 years ago), confirming a 62.5% right bias.  
 
Electron microscopy provides a means of detecting enamel scratches that occur on 
fossilised teeth as a result of tool manipulation performed at the front of the mouth 
(Lozano-Ruiz et al., 2004). Using this technique, Frayer et al. (2012) were able to infer 
a left hand preference of 12% for a group of 17 Homo neanderthalensis specimens 
30,000-130,000 years old. This conclusion is supported by Uomini (2011) whose 
comprehensive analysis of the fossil and archaeological records suggested 8–
20% of Homo neanderthalensis to be left-handed. Ancestral to Homo neanderthalensis, 
the same study indicated that by the Middle Pleistocene age (ca. 781,000 to 126,000 
years ago) there was already a strong bias towards right hand dominance. Finally, by 
analysing the wear and tear of cleavers and hand axes dating from roughly one million 
years ago, Phillipson (1997) was able to make inferences on ancient human 
handedness by reconstructing grip types, observing a majority of right hand users in the 
process. Taken together, these studies help establish that by half a million years ago 
significant lateralisation had occurred in the hominin lineage (McGrew and Marchant, 
1997), though most behavioural scientists are in general agreement that right-
handedness could have evolved even earlier, approximately 2.5 million years ago.  
 
1.1.5 How did handedness evolve? 
 
Several theories exist to explain how handedness may have evolved in humans since the 
divergence from our last common ancestor. Though now largely discounted, Corballis 
(1997) proposed a genetic mutation unique to the evolution of Homo 
sapiens approximately 150,000 - 200,000 years ago prompted a stable right hand bias. 
This theory fits the genetic data and offered a reasonable explanation for the stable 9:1 
bias ratio found in humans but doesn’t explain the mounting evidence for population-
level asymmetries in other species. One theory posited by Rogers and Andrew (2002) 
does take this in to account and proposes that 500 million years ago lateralisation for 
perceptual and motor control of feeding emerged in the earliest vertebrates, organisms 
whose mouth was located on the head’s left side. In support of this theory, motor 
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control by the left hemisphere of right side organs/forelimbs has been identified in all 
classes of vertebrate from fish (Bisazza et al., 1998) to non-human primates (Hopkins, 
2006). 
 
The task complexity hypothesis (Fagot and Vauclair, 1991, Bradshaw and Rogers, 
1993) proposes that demanding bimanual behaviours enhance a stronger degree of 
handedness than simple unimanual tasks, as observed in Australian parrots that show a 
left foot bias of up to 90% (Brown and Magat, 2011) when using coordinated foot-beak 
actions, a bias not recorded in birds that eat seeds with beak alone. In addition, Forrester 
et al. (2013) found that chimpanzees, gorillas and children all show a stronger right bias 
in response to inanimate objects but not to animate objects, suggesting any right hand 
bias in primates is a result of a left-hemisphere that originally specialised for tool use.   
 
Another theory that looks beyond the order of primates suggests that a species posture 
can influence forelimb bias. The postural origin theory (MacNeilage et al., 1987) 
proposes bipedalism facilitates bimanual object manipulation and thereafter manual 
laterality, with a positive correlation between the degree of upright posture and forelimb 
laterality as seen in non-human primates as well as marsupials (Hopkins et al., 2011); 
with the more quadrupedal species less likely to express manual lateralisation than their 
bipedal counterparts (Giljov et al., 2015). 
 
Ultimately, handedness is a behavioural laterality whose control is dominated by one 
hemisphere, a feature shared by another functional lateralisation, and a uniquely human 
one, language.    
   
1.1.6 Handedness and Language 
 
The majority of both left and right-handed individuals possess a left-hemisphere 
dominant for language comprehension and production (Rasmussen and Milner, 1977), 
though right-handers (88%) are more likely to demonstrate a left hemisphere dominance 
than left-handers (78%) (Mazoyer et al., 2014). For the remainder of the population, 
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language lateralisation is specific to the right-hemisphere, or is distributed 
symmetrically across both hemispheres (Knecht et al., 2000).   
 
This left hemisphere dominance for both language and handedness in the majority of the 
population previously led some to suggest handedness and language coevolved as 
uniquely human traits (Corballis, 2003) however the ever-increasing evidence for 
population-level forelimb asymmetries in phylogenetically distant species has since led 
to a general dismissal of this hypothesis. Instead, a more widely held theory posits that a 
human left-hemisphere dominance for both language and handedness is an outcome of 
the lateralisation of motor functionality that arose earlier in human evolution 
(Meguerditchian et al., 2013). If a gestural language was the precursor to speech 
then the circuits controlling this gesturing hand may have developed over time so as to 
take control of the neuronal circuits involved in language (Thomas, 2006, Pollick and de 
Waal, 2007). Such an integration between spoken language and communicative gestures 
has been recorded in the activation of different brain areas (Willems et al., 2007, Andric 
et al., 2013) with gestures, such as gestural hand movement, found to be asymmetrical 
in children (Trevarthen, 1996) as well as nonhuman primates (Meunier et al., 2013, 
Hopkins et al., 2003). To this effect, a well-known region in the frontal lobe of the 
human brain associated with speech production, Broca’s area (Figure 1.1), is in essence 
a premotor module which coordinates muscle contraction patterns that are related to 
other functions besides language (Rorden et al., 2008). Interestingly, Broca’s area has a 
distinctive degree of anatomical asymmetry, a lateralisation also found in the analogous 
region of the chimpanzee brain, even though it does not yet correspond to language 
capability (Cantalupo and Hopkins, 2001). 
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Figure 1.1 Broca’s area marked in red is a region in the human frontal lobe of the dominant hemisphere 
with functions linked to speech production  
 
 
1.1.7 Why study handedness? 
 
Understanding how right-hand dominance evolved and is sustained at a population level 
is still a complex challenge, though hand bias may have offered an evolutionary 
advantage by allowing for non-redundant cerebral functionality and enlarged brain 
capacity through the increased speed of unihemispheric processing (Ocklenburg and 
Gunturkun, 2012).  
 
The shared left hemisphere dominance for both motor control and language in the 
majority of the population has led some researchers over the years (Eglinton and 
Annett, 1994, Hynd et al., 1990, Tonnessen et al., 1993) to posit a possible link between 
hand preference and disorders that affect language development such as dyslexia, a 
relatively common disorder with approximately 5-10% of children affected (Pennington 
and Bishop, 2009). Although no consistent association has been found between hand 
preference and dyslexia (Francks et al., 2003c, Brandler et al., 2013) evidence exists to 
suggest there may be atypical cerebral asymmetry in dyslexic individuals (for a review 
see Richlan et al. (2009) and Friederici (2006)). In a series of eight consecutive post-
mortem studies Galaburda et al. reported individuals with dyslexia displayed reduced 
planum temporale asymmetry (Galaburda et al., 1985, Galaburda, 1989). Several in vivo 
structural magnetic resonance imaging (MRI) studies initially supported this finding 
11 
 
(Hynd et al., 1990, Duara et al., 1991) although most controlled studies have not found 
such an association (Best and Demb, 1999, Eckert et al., 2003, Leonard et al., 2002). 
One finding which has been replicated is based on an independent post-mortem study 
by Witelson (1985) which indicated the corpus callosum (CC), the main fibre tract 
connecting the two cerebral hemispheres, to be larger in lefthanders in the general 
population. This suggestion that the CC plays a role in the expression of handedness is 
supported by genetic evidence in a study by Brandler et al. (2013) (see section 1.2.3). 
Additionally, a functional MRI meta-analysis of six studies confirmed general activity 
appears greater in the right hemisphere of dyslexic individuals (Maisog et al., 2008) 
with subsequent functional transcranial Doppler ultrasound confirming this finding 
(Illingworth and Bishop, 2009). In short, the exact relationship between dyslexia, 
handedness and cerebral asymmetry remains elusive.  
 
Several other studies have observed a link between a reduced frequency of right-
handedness and neuropsychiatric disorders. In a meta-analysis of 16 studies (N = 3,175 
patients with 65,284 control subjects) Dragovic and Hammond (2005) indicated that 
schizophrenia patients are significantly more left-handed than controls  (odds ratio of 
1.81, 95% confidence interval 1.6-2.1). Multiple meta-review articles incorporating 
dozens of studies have confirmed this consistent leftward shift (e.g. Hirnstein and 
Hugdahl (2014), Satz and Green (1999), Sommer et al. (2001)). Although null findings 
(Wahl, 1976, Oddy and Lobstein, 1972) and even reports of fewer non-right-handers in 
schizophrenia samples (Taylor et al., 1980) have been found in earlier individual 
studies, in all, the vast weight of empirical evidence supports the establishment of a 
significant, reproducible link between schizophrenia and left-handedness. 
 
Thus, studying the aetiology of handedness may provide us with important insights in to 
the development and trajectories of other forms of functional laterality and aspects of 
psychological functioning that are more difficult to study, particularly during infancy 
and childhood. 
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1.1.8 The development of handedness 
 
Long before language function has developed, anatomical bias is observed even at the 
early fetal stages, with the right hand more developed than the left by 7 post fertilisation 
weeks (PFWs) (O'Rahilly and Muller, 2010) and the temporal gyri to be asymmetrical 
in fetal brains from 10–44 PFWs (Galaburda et al., 1978). Additionally it has been 
shown that the development of the right hemisphere precedes that of the left in the 
brains of infants between 12 and 36 months of age, though this pattern is reversed 
towards the left hemisphere during language development at approximately 3 years of 
age (Chiron et al., 1997). 
 
In an oft-cited study Hepper et al. (1991) used ultrasound to observe that most foetuses 
at 15 PFWs prefer to suck their right thumb, following up this study 14 years later with 
the finding that  67% of left-handed foetuses remained left-handed while 100% of right-
handed foetuses remained right-handed (Hepper et al., 2005). Tan and Tan (1999) have 
also suggested that lateralised motor behaviour in early gestation is predictive of hand 
preference in adulthood, comparing neonate palmar grasp reflex strength to adult hand 
preference. Whether this early hand bias is controlled by spontaneous movement 
regulation in the spinal cord or by high-level regulation in the left hemisphere (Sun and 
Walsh, 2006), is still unknown however if valid, then such results demonstrate that 
foetuses early in the gestation period are manifesting lateralisation bias for handedness 
similar to those displayed later in childhood. 
 
As a result of the infant’s position in utero, most infants prefer to lay their heads to one 
side when supine for the first 12-24 weeks of life (Michel and Goodwin, 1979). Though 
hand preference during infancy is highly flexible (Corbetta et al., 2006), it has been 
posited that infant postural preferences can influence the development of hand bias 
(Michel, 1981); recordings of hand preference for grasping objects (Michel et al., 2006) 
and reaching (Marschik et al., 2008) have been observed to mirror hand preference 
distributions firmly established by 7 years of age. 
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The studies presented thus far provide evidence that both functional and anatomical 
brain asymmetry precede the absorption of information from environment and cognitive 
development; some indeterminate intrinsic controls regulate human handedness very 
early in foetal development, a manifestation most likely derived from both 
environmental and genetic factors. 
 
1.1.9 Genetic models of handedness  
 
Although historically there have been non-genetic theories proposed for the 
determinism of hand preference (Provins, 1997, Morgan and Corballis, 1978), empirical 
support for the genetic contribution to handedness first came from twin studies which 
showed that monozygotic twins are more likely to be concordant for handedness than 
dizygotic twin pairs (Bryden et al., 1997, Sicotte et al., 1999). A study conducted by 
Medland et al. (2009b) of almost 25,000 twins subsequently concluded that hand 
preference is a weak genetic trait with a heritability of almost 25%, thereby ruling out 
exclusively non-genetic arguments in the process.  
 
After several attempts to accommodate all the data (for a review see Harris (1992)) two 
competing but similar genetic causal models by McManus (1985a) and Annet (1998) 
proposed that hand preference is controlled by a single hypothesised gene with two 
alleles. Other simple genetic models were also proposed including the random-recessive 
model (Klar, 2003) and the X-linked three alleles model (McKeever, 2004), however all 
simple models, though they accommodate the heritability estimates (Klar, 1996),  have 
been largely discarded. Traditional molecular approaches such as linkage analysis have 
failed to identify a single-gene locus that can be replicated across studies while evidence 
from the large cohorts of modern genome-wide association studies (GWASs) conclude 
in a rejection of the simple genetic models. One such GWAS meta-analysis of 10 
studies (Armour et al., 2014) had 99% power to detect a single locus for the simple 
models of McManus and Annett but found no significant associations. Thus, how 
handedness is determined genetically is not straightforward and must involve multiple 
genes or other unknown factors (Mackay, 2014). 
 
14 
 
1.1.10 Previous studies and candidate genes 
 
The handedness trait in humans appears to have been under the selective pressures of 
multiple factors; bipedal posture, communicative gesturing and task complexity may be 
manifested in a complex genetic architecture and influenced by the possibility of 
multiple evolutionary origins (Table 1.1). Furthermore, in a meta-analysis of GWASs  
McManus et al. (2013) concluded that handedness is not determined by a single genetic 
locus but instead estimate a minimum of 40 loci to be involved in determining this 
complex trait. Genetic linkage studies have not identified a single locus, instead 
proposing multiple regions connected with handedness (Figure 1.2). This may be due to 
differences in how handedness was measured between studies or, alternatively, provides 
further evidence to support the notion that handedness is a polygenic trait.  
 
Handedness has typically been measured using a questionnaire approach (e.g. (Annett, 
1970, Oldfield, 1971)) in which participants are asked to provide a simple binary ‘left’ 
or ‘right’ answer. Due to language bias restrictions and the subjective nature of this 
methodology many researchers have also employed a quantitate-centric approach, 
instead utilising hand performance measures to infer relative hand skill by deriving a 
score which indicates the difference in performance between the two hands.  One such 
measure of hand performance is PegQ, a peg-board task which measures the time taken 
by individuals to move a row of pegs from one location to another with the left hand 
and right hand separately, after which a laterality quotient score is derived (see section 
2.2 for a full discussion). 
 
The first genome-wide linkage screen was conducted by Francks et al. (2002) on 195 
dyslexic sibling pairs, identifying two quantitative trait loci (QTLs) for the PegQ 
measure on chromosome regions 17p11–q23 and 2p11.2–12. The latter QTL was 
subsequently confirmed in a study of left-handed brothers (Francks et al., 2003a) and 
revealed a parent-of-origin effect (Francks et al., 2003b). Assessed by questionnaire, 
Warren et al. (2006) identified  in 584 Mexican–Americans  a linkage signal for writing 
hand preference within chromosome region 12q21–23. Using a similar questionnaire-
centred approach to derive a laterality quotient, Van Agtmael (2002) found genetic 
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linkage for handedness on chromosome region 10q26 in a study of 25 Australian 
nuclear families. Finally, in a cohort of 180 pairs of left-handed brothers, Laval et 
al. (1998) proposed linkage between relative hand skill as measured by questionnaire 
and the Annett Peg board test (Annett, 1994) and a marker on the X chromosome 
(Xq21). For a summary of previous genetics studies investigating hand preference see 
Table 1.2  
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Table 1.2 Previous genetics studies investigating hand preference and relative hand skill and the candidate loci implicated 
 
 
 
 
Linkage Analysis Studies 
Reference 
Sample set characteristics  
Country Composition Phenotype Findings summary 
Laval et al. (1998) UK 
N = 180 pairs of 
left-handed 
brothers 
Measure of relative 
hand skill 
A weak linkage finding for handedness close to the Xq21.3 region was observed 
(maximum LOD score of 2.8). No evidence for a locus linked to increased likelihood of 
left-handedness.   
Van Agtmael et al. (2002) Australia N = 173 Hand preference Segregation analysis in an extended pedigree identified allele sharing in the NODAL 
candidate region on chromosome 10 for left handers 
Francks et al. (2002) UK N = 195 reading-
disabled sibling 
pairs 
Measure of relative 
hand skill 
Locus on chromosome 2p11.2-12 yielded strong evidence for linkage to a measure of 
relative hand skill, PegQ (empirical P=.00007), and another locus on 17p11-q23 was 
also identified (empirical P=.002) 
Francks et al. (2003a) UK N = 105 pairs of 
left handed adult 
brothers 
Measure of relative 
hand skill 
Further evidence for linkage of the 2p12-q11 locus to a measure of relative hand skill 
(P=.00035), which exceeded the critical value of P=0.01 
Warren et al. (2006) US N = 584 Hand preference for 
writing 
Using genome-wide multipoint linkage screens using 382 highly informative autosomal 
STR markers, suggestive linkage signals for drawing (LOD 2.10) and writing (LOD 
2.00) hand preference were identified on chromosome 12q21–23 
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Association Studies 
Gene Reference 
Sample set characteristics  
Findings summary Country Composition Phenotype 
AR Medland et al. 
(2005) 
Australia/Holland N = 783 adults Hand preference for 
writing 
A greater number of CAG repeats in the androgen receptor gene AR was 
correlated with a lower incidence of left-handedness 
LRRTM1 Francks et al. 
(2007) 
UK N = 222 dyslexic 
siblings 
Quantitative 
measure for 
handedness 
LRRTM1 (Leucine-rich repeat transmembrane neuronal 1) is a maternally 
suppressed gene that is associated paternally with handedness  
COMT Savitz et al. (2007) South Africa N = 240 (55 bipolar 
disease patients and 
relatives) 
Hand preference/ 
Relative hand skill 
Significant association between the catechol-O-methyltransferase gene 
COMT Val158Met polymorphism and relative hand skill but not hand 
preference, with the Met allele of this polymorphism being associated with 
greater right-handed skill 
APOE Bloss et al. (2010) US N = 147 children Hand preference for 
writing 
Apolipoprotein E gene APOE epsilon 2 allele carriers showed a 
significantly higher prevalence of left-handedness compared to other allele 
carriers 
PCSK6 Scerri et al. 
(2011a)/Brandler et 
al. (2013) 
UK N = 192/728 
dyslexic individuals 
Quantitative 
measure for 
handedness 
Proprotein convertase subtilisin/kexin type 6 PCSK6 gene  is associated 
with handedness in individuals with dyslexia 
AR Hampson and 
Sankar (2012) 
Canada N = 180 adult males Hand preference Mixed-handers carry a significantly longer CAG repeat in the AR gene 
than either strong left- or strong right-handers who did not differ 
significantly from each other in terms of CAG repeat length 
PCSK6 Arning et al. 
(2013) 
Germany N = 1113 adults Hand preference PCSK6 is associated with degree of handedness (consistent vs. inconsistent 
handedness), but not direction (left-handedness vs. right-handedness) 
 
N/A 
 
 
 
Medland et al. 
(2009a) 
 
Australia/UK 
 
N = 23,433 
 
Hand preference for 
writing 
 
No significant associations found. Promising results were found on 
chromosome 5 (P=2.455 x 10-7) and 13 (P=6.149 x 10-7), in regions that 
encompass SLIT3, MAB21L1  and NBEA 
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Figure 1.2 Graphical summary of candidate loci for hand skill or hand preference from previous studies. Each coloured line represents the approximate location on 
each numbered chromosome of a locus implicated either through previous linkage analysis or association studies. See Table 1.2 for further details on individual 
studies. 
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Linkage analysis, though suitable for detecting single gene defects in families with a 
clear cut pattern of inheritance, is impractical when analysing complex traits where it is 
hypothesised many loci make small contributions to the trait aetiology (Bush and 
Moore, 2012). Instead, GWAS is a hypothesis-free approach that typically compares the 
allele frequency of genetic variants across the genome to check which variants are 
associated with a trait or disease. For quantitative traits, correlation between alleles of 
each variant and the trait is measured in population or clinical-based cohorts. Genetic 
variants are usually referred to as common (Minor Allele Frequency or MAF > 1% in a 
human population) or rare (MAF < 1%) and divided broadly in to several classes: 
Single Nucleotide Polymorphisms (SNPs), indels and structural variants (e.g., Variable 
Number Tandem Repeats (VNTRs) and Copy Number Variations (CNVs) among others 
(Eichler et al., 2007)). SNPs are the most prevalent class of genetic variation among 
individuals; as of September 2015 dbSNP build 144 contains 97,535,033 validated 
SNPs (http://www.ncbi.nlm.nih.gov/projects/SNP/snp_summary.cgi). Whether common 
complex traits are primarily due to common variants with small effect size (Reich and 
Lander, 2001) or are the result of rare, high-penetrance variants (Bodmer and Bonilla, 
2008) is still being debated (Gibson, 2012, Saint Pierre and Génin, 2014). In any case, 
the importance of common and rare variants in common complex phenotypic traits has 
been firmly established with each variant type contributing to various degrees 
depending on the heritability and epidemiology of the particular trait under 
consideration (Wellcome Trust Case Control, 2007, Sanna et al., 2008, Visscher et al., 
2012, Rivas et al., 2011).   
 
An earlier study which investigated the fine mapping of linkage regions was conducted 
by Francks et al. (2007) who reported the significant association of a quantitative 
measure of human handedness with a haplotype upstream of the Leucine rich repeat 
transmembrane neuronal 1 (LRRTM1) gene in a set of 222 dyslexic siblings when the 
haplotype was inherited paternally (though this finding could not be replicated in the 
same study). In a study involving a similar quantative measure, Savitz et al. (2007) 
conducted a family-based genetic association analysis of a bipolar cohort with family 
members (N = 240) and found relative hand skill was significantly associated with a 
functional variant in the catechol-O-methyltransferase (COMT) gene.  
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It has been hypothesised that prenatal exposure to testosterone may affect lateralisation 
by influencing cell death in the foetal brain (Bauer et al., 2013, Haudry et al., 2013). 
Testosterone binds to the X chromosome-linked androgen receptor (AR), which 
contains a polymorphic CAG repeat, the length of which positively correlates with 
testosterone levels in males, and negatively correlates in females. In a candidate gene 
approach involving 783 twin pairs Medland et al. (2005) found that the length of the 
repeating CAG sequence has reverse effects on the probability of left-handedness in 
females and males. The same genetic marker was subsequently found to be associated 
with mixed-handedness in a smaller cohort of 180 adult males (Hampson and Sankar, 
2012).  For a visual summary of previous findings see Figure 1.2.  
 
One of the most significant, intriguing and recurring associations discovered to date has 
been between various measures of handedness and a chromosome region (15q26) within 
the gene proprotein convertase subtilisin/kexin type 6 (PCSK6). In the first GWAS for a 
quantitative measure of human handedness (as assessed by the peg-board task, PegQ), 
(Scerri et al., 2011a) found the first SNP for handedness to be identified at a genome-
wide significant level (P < 5 x 10-8). Although no SNPs gave P-values below 5 × 10−8 in 
an initial RD cohort (N = 192), a meta-analysis of this and a subsequent two RD cohorts 
(N = 744) showed rs11855415, a SNP located within an intron of PCSK6, to 
be significantly associated with the PegQ measure (P = 2 x 10−8). The minor ‘A’ allele 
of rs11855415 was shown to confer increased relative right-hand skill in the dyslexic 
cohort and showed a nominally significant trend towards reduced laterality of hand skill 
in the general population (P=0.002, N = 2,666). The observation that the increase in 
relative right-hand skill associated with rs11855415 was specific to the dyslexic cohort 
led the authors to suggest there may be epistatic interaction between PCSK6 and 
dyslexia candidate genes thought to be involved in axon guidance and neuronal 
migration such as KIAA0319 (Dennis et al., 2009), DCDC2 (Schumacher et al., 
2006) and DYX1C1 (Wang et al., 2006). A GWAS for the same quantitative measure of 
relative hand skill (PegQ) was conducted by Brandler et al. (2013) though this time 
combining the previous 3 RD cohorts of Scerri et al. (N = 728) and found the most 
strongly associated variant, rs7182874 (P = 8.68 × 10−9), to be located within the 
same PCSK6 locus, further supporting the previous rs11855415 association reported by 
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Scerri et al. (2011a). The rs7182874 association was specific to a dyslexic cohort (N = 
728) and was not associated with handedness in a general population cohort (N = 
2,666); the most highly associated SNP in the general population cohort was rs7883190 
(P = 2.08 × 10−6) which is located 6 kb upstream of the gene GPC3, a gene that causes 
visceral organ asymmetry defects when disrupted in mice. In an independent study of a 
German general population (N = 1,113) Arning et al. (2013) showed a 33 bp variable-
number tandem repeat (VNTR) within the same PCSK6 15q26 locus to be significantly 
associated (P < 0.0025) with the degree of handedness rather than the direction, as 
assessed by a hand preference questionnaire (Oldfield, 1971). The authors also 
investigated for the effect of rs1185415 SNP and found it failed to reach nominally 
significant levels of association (P = 0.14) though a failure to replicate can occur for 
numerous reasons including inadequate sample size or variability in phenotype 
definitions across independent samples (Greene et al., 2009), as was the case here. 
However like Scerri et al. they concluded that carriers of the minor ‘A’ allele show 
reduced variability in relative hand skill in the general population, though they did not 
indicate how significant this association to be. Since no significant association was 
found to exist between the VNTR and handedness direction, it may be that handedness 
consistency (or strength of preference) and direction represent distinct phenotypes. 
Support for this is provided in multiple studies which show handedness consistency, as 
opposed to handedness direction, is a reliable predictor of hand performance in several 
cognitive domains, e.g. risk perception (Westfall et al., 2012) and episodic memory 
retrieval (Propper et al., 2005) (for review see Prichard et al. (2013)).  
Curiously, the notion that strength and direction of preference is represented by two 
discrete phenotypes is also supported by studies in zebrafish. In this species (Danio 
rerio), behavioural lateralisation is modulated by structural asymmetries in the 
epithalamus, a part of the dorsal forebrain, which includes the pineal gland (Bianco and 
Wilson, 2009). The occurrence of these anatomical asymmetries is regulated during 
embryonic development by several genes within the Nodal pathway, a highly conserved 
pathway across the Bilateria phyla, which determines left-right asymmetry and 
anteroposterior body asymmetries early in development (Levin, 2005, Grande and Patel, 
2009). Disruption of this pathway does not affect the structural asymmetry itself, but 
leads to a randomised direction of the asymmetry and not leftward as in the wild-type 
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(Concha et al., 2000). Therefore, it seems reasonable to suggest that the strength and 
direction of these hemispheric asymmetries in zebrafish might be controlled by two 
different genetic pathways. 
Significant evidence from multiple large-scale studies suggests PCSK6 is important in 
the development of handedness, but its exact contribution to phenotype expression 
remains unknown. One possible mechanism by which PCSK6 could influence in the 
ontogenesis of handedness is its primary role in the LR-determining Nodal pathway 
(Shen, 2007). To understand this role it is necessary to take a look at this intriguing 
handedness candidate in greater detail. 
 
1.2 PCSK6 
1.2.1 The PCSK6 gene  
 
Secretory proteins such as receptors, hormones, neuropeptides, adhesion molecules, 
growth factors and enzymes are essential for cellular function and are biologically 
activated through post-translational processing in the form of endoproteolytic cleavage 
(Artenstein and Opal, 2011). Such a mechanism has allowed evolutionarily complex 
species to maintain homeostasis, responding to challenges where and when required. 
PCSK6, previously known as PACE4, is one such cleavage enzyme and belongs to a 
family of furin-like proprotein convertases which proteolytically activate substrates 
through the recognition of specific single or paired basic amino acids found within the 
substrates proregion (Layne, 2013). PCSK6 is constitutively secreted from the trans-
Golgi network into the extracellular matrix and primarily expressed in the liver, brain, 
testis and colon (Figure 1.3). There are 8 recognised spliced transcript variants (Pruitt et 
al., 2014), some of which are assumed to be inactive in cleavage due to missing protein 
domains, and others which are expressed only in certain tissues (Tsuji et al., 1997).  
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Figure 1.3 PCSK6 gene expression in adult human tissue. The plot was generated by the Gtex portal 
www.gtexportal.org and represents relative gene expression for PCSK6 in reads per kilobase per million 
(RPKM) across a range of adult tissue types. See (Lonsdale et al., 2013) for details on data generation.  
 
 
1.2.2 PCSK6 role in complex traits and disease  
 
PCSK6 is thought to influence glioblastoma (GBM) tumour progression (Delic et al., 
2012) and the development of prostate (D'Anjou et al., 2011), breast (Cheng et al., 
1997) and skin (Bassi et al., 2010) cancers. Interestingly, the gene has also been found 
to be a direct target of the transcription factor forkhead box protein p2 (FOXP2). Vernes 
et al. (2007) demonstrated a reduction of FOXP2 negatively affects the development 
and function of a variety of neural circuits, including those involved in speech and 
language acquisition. This finding supported previous research by (Lai et al., 2001) who 
demonstrated disruption of the FOXP2 in a three-generation pedigree with severe 
speech and language disorders, proposing FOXP2 assumes a primary role in the 
developmental process that culminates in speech and language. 
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 PCSK6 is known to have several downstream substrates, one of which is ADAMTS4, 
whose own substrate BCAN is localised to the surface of neurons in the brain, 
suggesting a primary role for this enzyme in the central nervous system (CNS) 
(Frischknecht and Seidenbecher, 2012). However, one of the more interesting findings 
related to PCSK6 is its role in embryogenesis and development. Knockout mice studies 
show the absence of PCSK6 leads to substantial anatomical defects in axis 
development, visceral orientation and craniofacial abnormalities (Constam and 
Robertson, 2000). Intriguingly, these defects in the left and right axis are preceded at 
embryonic day 8.5 by abnormal mRNA levels of another PCSK6 substrate; the axis 
determining TGF beta-like growth factor Nodal (Constam and Robertson, 2000).  
 
1.2.3 Nodal signalling pathway and cilia 
 
PCSK6 is known to cleave the axis-determining protein Nodal which plays a vital role 
in determining LR and anteroposterior body asymmetries early in development (Levin, 
2005, Grande and Patel, 2009). Specifically, Nodal mRNA produces an immature 
protein form of Nodal that is subsequently cleaved by PCSK6 in order to generate a 
mature morphogen; in effect PCSK6 is regulating Nodal conversion from an inactive to 
an active form (Figure 1.4). 
 
Nodal expression is largely restricted to embryonic tissues and is a critical factor in 
normal embryonic development for a range of species across the entire bilaterian phyla 
(Schier and Shen, 2000). For each of the vertebrate species in which Nodal signalling 
has been studied, Nodal must be activated on the left side to specify the left–right axis 
of the developing body plan. In the absence of Nodal signalling, visceral organs are 
distributed in a random (heterotaxia) or reversed (situs inversus) manner and not the 
default distribution (situs solitus), demonstrating that the Nodal pathway determines the 
direction of asymmetries but not their early establishment (Concha et al., 2000). To 
illustrate the role of PCSK6 in the Nodal pathway Constam and Robertson (2000) were 
able to induce PCSK6 knockdown mouse embryos to bilaterally express the normally 
asymmetrically expressed Nodal morphogen.  
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Figure 1.4 The prominent role of PCSK6 in the developing embryo NODAL pathway (A) The nodal 
precursor is expressed as a homodimeric proprotein, and is cleaved extracellularly to generate the 
carboxy-terminal ligand by Furin (also known as PCSK3) and PCSK6. (B) Mature Nodal ligands bind to an 
EGF-CFC co-receptor which is anchored to the membrane by a glycolipid tether and activates the type I 
(ACVR1B/ACVR1C) and type II receptors (ACVR2A or ACVR2B dimers), which phosphorylates the 
downstream effectors SMAD2/3. (C) Activated receptor SMADs associate with SMAD4 and translocate 
to the nucleus to regulate target gene expression (Arnold and Robertson, 2009). Meanwhile, the 
receptor complex undergoes internalization into endosomes and can be targeted for lysosomal 
degradation (D). (E) Within the nucleus transcription cofactors, including the winged helix factors FOXA2 
and FOXH1, function cooperatively to target promoters leading to transcription that activates expression 
of Nodal target genes, thereby specifying the cell is on the left side of the embryo (Wrana et al., 1994). 
Nodal up-regulates its own expression through a SMAD–FOXH1-dependent auto-regulatory enhancer, 
but also triggers a negative-feedback circuit by prompting the expression of soluble antagonists left–
right determination factor 1 (LEFTY1) or LEFTY2, which reduce Nodal signalling by interacting with EGF-
CFC co-receptors to inhibit their function. The Smad phosphatase PPM1A, promotes efficient SMAD2 
and SMAD3 turnover by promoting the nuclear export of SMAD2 and possibly targeting it for 
proteasomal degradation  
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One of the most interesting questions arising from this research was whether 
asymmetrical patterning of the visceral organs and the phenomenon of brain 
lateralisation are controlled by the same biological mechanisms or pathways. A 
significant analysis and discussion on the subject was presented by Hirokawa et al. 
(2006) who investigated LR asymmetry and the role played by motile cilia; clockwise 
rotating whip-like structures that project from the cell body and create a leftward flow at 
the ventral node thereby inducing asymmetrical expression of genes such as NODAL. 
To demonstrate if visceral and brain lateralisation were controlled by the same pathway, 
McManus et al. (2004) performed an analysis of patients with Primary Ciliary 
Dyskinesia (PCD), a rare genetic disorder that causes a defect in the action of the motile 
cilia lining the respiratory tract. Results showed 50% of people with PCD have 
situs inversus; an expected phenotype, if the motile cilia fail to asymmetrically express 
the Nodal morphogen. However out of 88 individuals with PCD, only 15% of 46 
individuals with situs inversus, and 14% of 42 individuals with situs solitus, were left 
handed. If visceral and brain lateralisation were controlled by the same pathway then 
one would expect an equal ratio of handedness in situs inversus patients though clearly 
cerebral lateralisation is still present, and at a ratio approximate to the general 
population. 
 
It would seem reasonable therefore to suggest that the regulatory mechanisms involved 
in establishing brain asymmetries appear to be distinct from those that establish visceral 
organ asymmetry (Sun and Walsh, 2006). The evidence is mixed however and some 
studies suggest a shared model where handedness is under the control of many variants, 
some of which are in genes that also contribute to the determination of body LR 
asymmetry. For example, using gene-set enrichment analysis (GSEA) of GWAS data 
Brandler et al. (2013) showed polymorphisms within particular LR asymmetry genes to 
be associated with relative hand skill (e.g. PCSK6 P = 3.9 x 10-8, PKD2 P = 3.4 x 10-4 
and MNS1 P = 8.7 x 10-4). The mice homologues of these same genes, when knocked 
out, result in an absent corpus callosum and the LR asymmetry phenotypes heterotaxia 
and situs inversus. 
 
27 
 
1.2.4 RD candidate genes and cilia 
 
Previous research has suggested a potential role for dyslexia candidate genes in the 
function and structure of cilia. A study conducted by Massinen et al. (2011) 
demonstrated the protein of the dyslexia candidate gene DCDC2 localises to the 
primary cilium in rat hippocampal neurons while an overexpression of the same gene 
was shown to increase ciliary length. Using a zebrafish model null for DYX1C1, 
Chandrasekar et al. (2013), produced pleiotropic phenotypes characteristically 
associated with cilia defects such as situs inversus and kidney cysts. These findings, 
suggesting a role for DYX1C1 and DCDC2 in ciliogenesis, were replicated in a large-
scale meta-analysis of gene co-expression networks by Ivliev et al. (2012) who also 
proposed the dyslexia candidate gene KIAA0319 to influence the development of cilia.  
 
Ciliopathies influence not only LR body asymmetry phenotypes (Fliegauf et al., 2007), 
but also a broad spectrum of disorders affecting multiple organs including brain midline 
phenotypes such as absent cerebellar vermis and missing corpus callosum (Badano et 
al., 2006). Furthermore, some ciliary disorders affect the development of the CNS and 
thus can have an effect on cognitive functions. One such disorder is Bardet-Biedl 
syndrome where patients are characterised by situs inversus and language and learning 
deficits, an interesting phenotype in the context of dyslexia (Allendorf and Luikart, 
2007). Indeed, the specificity of the Scerri et al., 2011a) and Brandler et al. (2013) 
findings; that PCSK6 is associated with a measure for relative hand skill in a dyslexic 
cohort, is suggestive of a possible epistatic interaction between PCSK6 and dyslexia 
candidate genes. In conclusion, it would seem that handedness is determined in part by 
the mechanisms that establish LR asymmetry early in development, such as ciliogenesis 
and the PCSK6-dependant Nodal signalling pathway (Brandler and Paracchini, 2014).  
 
 
1.2.5 Role of regulatory elements during neuronal development 
 
The evolution of human-specific anatomical and functional asymmetries has occurred 
without a significant change in the number of protein coding genes, suggesting the 
regulation of gene expression during the development of the CNS plays an important 
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role (Wray, 2007). Specific to this project, the role of non-coding regulatory elements 
are of particular interest since neither of the previous relevant GWA handedness studies 
(Scerri et al., 2011a, Brandler et al., 2013) implicated a coding variant, but instead 
reported the strongest association close to a predicted intronic regulatory region of 
PCSK6 thought to contain non-coding RNA (1.2.5.1), Variable Number Tandem 
Repeats (1.2.5.2) and bidirectional promoters (1.2.5.3).  
  
1.2.5.1 Non-coding RNA  
 
The complexity of the human brain arises from the capacity to produce functional 
diversity through mechanisms such as RNA editing and alternative splicing; processes 
more widespread in the CNS than in any other tissue (Ramskold et al., 2009). The role 
of RNA as the relay of genetic information for protein synthesis has long been known.  
However multiple studies have also demonstrated the functional ability of non-coding 
RNAs (ncRNAs) and their substantial role in regulating gene expression (for review see 
Iyengar et al. (2014)).  
 
ncRNA are often spliced, polyadenylated and roughly classified into two groups: long ( 
> 400 nucleotides) and short ( < 400 nucleotides) though many ncRNAs have mixed 
characteristics and do not clearly fall into any one category (Salta and De Strooper, 
2012). Long ncRNAs (lncRNAs) play key roles in many important biological processes 
such as mammalian X-inactivation (Tian et al., 2010), cell differentiation, 
immunological responses and complex human disease (Ponting et al., 2009). One class 
of lncRNA that is of particular relevance to this project are the Natural Antisense 
Transcripts (NATs). 
 
NATs are RNA polymerase II transcripts that originate from the antisense strand of 
protein-coding sense mRNAs and almost 70% of human and mouse genes have been 
reported to undergo antisense transcription (Werner and Sayer, 2009). Interestingly 
PCSK6 is known to have at least one corresponding NAT. How exactly NATs affect 
their sense counterpart’s RNA level is complex but may occur at multiple levels to 
produce inhibition of the protein product (Katayama et al., 2005). Several studies 
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suggest they are important in the fine-tuning of gene expression and NATs are known to 
play a role in neurological disorders such as Parkinson’s (Morais et al., 2009), 
Huntington’s (Johnson et al., 2010), and Alzheimer’s disease (Seitz et al., 2005). NAT 
involvement in important neuronal processes such as oligodendrocyte differentiation 
(Pollard et al., 2006), cortical neuron specification and migration (Ling et al., 2011, 
Ramos et al., 2013), plasticity and long-term memory formation (Pruunsild et al., 2007) 
has also been shown.   
 
Human lncRNA genes tend to be less well-conserved than protein-coding genes (Pang 
et al., 2006) and can give rise to unique transcripts not found in other species (Lipovich 
et al., 2012). This evolved specificity characteristic of lncRNA is shared by another 
mechanism for gene regulation; VNTRs (Variable Number of Tandem Repeats).   
 
1.2.5.2 VNTRs 
 
The VNTR genetic variation is of particular interest to this project. As discussed 
previously, Arning et al. (2013) demonstrated that a VNTR (rs10523972) at the 
same PCSK6 locus identified in the previous GWA studies (Scerri et al., 2011a, 
Brandler et al., 2013) was significantly associated with handedness consistency but not 
with handedness direction in a general population cohort (P < 0.0025, N = 1,113). 
VNTRs are repetitive copies of the same DNA sequence lying in tandem with one 
another and often occur within regulatory and coding regions (Li et al., 2002). VNTRs 
are not uniformly represented in all classes of genes and a study by Legendre et al. 
(2007) demonstrated that genes in particular categories of biological function are 
enriched for VNTRs (Table 1.3). Two ontological classes emerge from the categories 
presented in Table 1.3: transcriptional regulation and development.  
 
For a long time these repeating DNA sequences were thought to have no biological 
function (Doolittle and Sapienza, 1980). However due to their highly unstable and 
dynamic nature (mutation rates up to 100,000 times higher than in other areas of the 
genome (Vogler et al., 2007)), VNTRs are increasingly seen as being linked to variation 
in function with particular emphasis on transcription regulation. For example, 10% - 
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20% of eukaryotic promoters and genes are estimated to contain a repeating DNA motif 
(Gemayel et al., 2010). VNTRs in regulatory sequences can affect gene expression 
since a variation in the number of repeats can have a significant physical impact on the 
organisation of the DNA structure, thus introducing changes in spacing between critical 
promoter elements and altering the number of transcription factor binding sites (TFBSs) 
(Gemayel et al., 2012).  
 
Table 1.3 Enrichment of function among human genes containing VNTRs. Genes in the human genome 
containing VNTRs are enriched for particular functions and processes. Shown are the most enriched 
categories and the corresponding value of statistical significance. Adapted from Legendre et al. (2007). 
RNA Polymerase II (RNAPII).  
 
 
 
 
An interesting perspective on the involvement of VNTRs in development is presented in 
the work of Allendorf et al. (2013), who provide evidence that VNTRs in key regulators 
of morphological development can drive diversity in dog breeds. Genetic variation in 
VNTRs often located within or next to human genes can lead to neurodegenerative 
diseases such as Fragile-X syndrome (Usdin, 2008) and Huntington’s disease, where the 
presence of glutamine repeats corresponds with the gaining of a regulatory activity 
regulating neural adhesion in the complex mammalian CNS (Gemayel et al., 2012). 
VNTRs have also been found to influence neurodevelopmental disorders such as 
Attention deficit/hyperactivity disorder (ADHD). Hedrick (2005) performed a meta-
Biological Process Adjusted P-value 
Regulation of transcription from RNAPII promoter 8.05 × 10−9 
Positive regulation of transcription; DNA dependent 6.09 × 10−4 
Forebrain development 4.15 × 10−3 
Negative regulation of metabolic processes 3.35 × 10−3 
Embryonic morphogenesis 7.90 × 10−3 
mRNA metabolic processes 9.28 × 10−3 
Sensory organ development 1.11 × 10−2 
Cell fate commitment 1.96 × 10−2 
Base-excision repair; DNA ligation 1.96 × 10−2 
Chromatin remodelling 2.26 × 10−2 
Organ morphogenesis 2.45 × 10−2 
Neurogenesis 2.55 × 10−2 
Anterior/posterior pattern formation 3.01 × 10−2 
Ribosome assembly 3.51 × 10−2 
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analysis of the association between the SLC6A3/DAT1 gene with persistent ADHD in 
1,440 patients and 1,769 controls. A 9/9 genotype of the VNTR in the 3′-untranslated 
region (UTR) of the gene was found to be associated with persistent ADHD (OR 1.34, 
95% CI 1.03–1.76, P = 0.03). However associations between the DAT1 VNTR 
and ADHD have been mostly inconsistent (Hedrick, 2011, Ammerman and Cavalli-
Sforza, 1984). Alternatively VNTRs can also confer beneficial phenotypic variability, 
including plasticity in skeletal morphology (Jin et al., 2009) and cell surface variability 
(Fidalgo et al., 2006). 
 
In short, the abundance of VNTRs in both coding and regulatory regions, across a range 
of organisms, suggests that VNTR genetic variation might be a common mechanism in 
influencing phenotypes, with a large number of studies reporting correlations between 
VNTRs and changes in gene expression (Fuke et al., 2001, Hranilovic et al., 2004, 
Fiskerstrand et al., 1999). 
 
1.2.5.3 Bidirectional promoters 
 
Research suggests most promoters display residual bidirectional transcription; more 
than 10% of protein-coding genes in humans are transcribed from bidirectional 
promoters, that is, a genomic region of DNA that initiates transcription in both 
orientations (Piontkivska et al., 2009). Such bidirectional promoters are the origin of 
pervasive lncRNAs and lead to the transcription of unique, lineage-specific transcripts 
(Piontkivska et al., 2009). Furthermore, in human embryonic stem cells (ESCs), half of 
all expressed lncRNAs represent transcription from bidirectional promoters of known 
protein-coding genes (Sigova et al., 2013), with a significant portion transcribed 
intragenically (Yang et al., 2007). 
 
Interestingly, rs11855415, the first SNP for handedness to be identified at a genome-
wide significant level (Scerri et al. (2011a), P < 5 x 10-8), is located within an intron 
of PCSK6 that is suspected to contain an intragenic bidirectional promoter; possibly 
driving the transcription of a shortened PCSK6 isoform and a lncRNA gene PCSK6-
AS1. Ponjavic et al. (2009) found brain-expressed lncRNAs in mice originating from 
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such promoters are significantly enriched for predicted RNA secondary structures and 
are more frequently conserved. Additionally, these lncRNAs are usually located 
adjacent to protein-coding genes that are (1) also found to be expressed in the brain and 
(2) contribute to nervous system development or in transcriptional regulation. 
 
The outcome of ncRNA transcription from a bidirectional promoter depends on the 
subsequent transcript sequence, length and stability (Wei et al., 2011). ncRNAs 
generated from bidirectional promoters have demonstrated several functional roles 
including gene expression regulation acting at multiple levels; from modifying local 
chromatin (Hirota et al., 2008) to enabling regional signal spreading and more distal 
regulation (Xu et al., 2011).  
 
To conclude, such complex regulatory architecture means that when mapping a 
phenotype to a locus, it is essential to consider bidirectional promoters and ncRNAs as 
sources of phenotypic variability (Wei et al., 2011). In the case of lncRNAs, Gong et al. 
(2015) recently developed a database which identified a total of 495,729 SNPs in more 
than 30,000 human lncRNA transcripts. Furthermore, by mapping SNPs to GWAS 
results from the NHGRI GWAS Catalogue (~10,000 SNPs linked to human 
traits/disease as of July 2015), they found 40% of the lncRNA SNPs were within ±500 
kilo base pairs of 142 GWAS-identified SNPs at a genome-wide significant level.  
 
1.3 Conclusion 
1.3.1 Overall aim of this thesis 
 
Previous findings by Scerri et al. (2011a) and Brandler et al. (2013) have identified 
PCSK6 as the first gene associated with a quantitative measure for relative hand skill 
(PegQ) at a statistically significant level (P < 0.5 x 10-8). The overall aim of the research 
presented in this thesis is to identify and characterise the causal variant(s) which may be 
affecting PCSK6 expression and to define what role regulatory mechanisms (e.g. 
lncRNA, VNTRs) might have to this effect. 
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1.3.2 Overview of the study methodology 
 
The work described in the following chapters attempts to identify the mechanisms 
behind functional genetic change in PCSK6 in order to better understand the biology of 
the handedness trait, and more broadly, to further our understanding of the role of non-
coding genetic variants in complex genetic diseases. 
 
To do this, I performed association analysis for PCSK6 genetic variation with various 
measures for laterality and handedness (Chapter 2), employed bioinformatics analysis to 
refine the region of interest within PCSK6 (Chapter 3), performed sequencing and 
isoform profiling to characterise the refined locus of interest (Chapter 4) before 
considering a functional analysis on the effects of allelic variation on gene expression 
(Chapter 5). A flow chart of the work done in this project is summarised in Figure 1.5. 
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Figure 1.5 Scheme indicating experimental design flow of the research project. Different coloured boxes 
indicate the primary methodology shared by experiments in that section – red indicates gel-based 
electrophoresis analysis, orange includes all luciferase-based experiments, green represents expression 
assays which ultimately use polymerase chain reaction (PCR) and quantitative PCR (qPCR) for 
quantification while gold indicates software-based association analysis. Acronyms used are 
Electrophoresis Mobility Shift Assay (EMSA), transcription factor (TF), transcription factor bind site 
(TFBS), Single Nucleotide Polymorphism (SNP), long non-coding RNA (lncRNA), Variable Number Tandem 
Repeat (VNTR), Proprotein Convertase Serine Kinase 6 (PCSK6).  
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2 ALSPAC Cohort Association Analysis 
 
2.1 Abstract 
 
Scerri et al. (2011a) conducted a  genome wide association study (GWAS) for a 
quantitative measure of relative hand skill (PegQ) in a dyslexic cohort and found the 
most highly associated marker, the Single Nucleotide Polymorphism (SNP) rs11855415 
(P < 0.5 x 10-8), within a locus of PCSK6. The minor allele ‘A’ of rs11855415 was 
found to confer greater relative right-hand skill in a dyslexic cohort while in the general 
population (N = 2,666), the same minor allele showed a trend towards reduced laterality 
of hand skill (P = 0.002). This initial finding was supported by Brandler et al. (2013) in 
a subsequent GWAS who found multiple markers from the same PCSK6 locus to be 
associated with handedness in the same dyslexic cohort (N = 728), the most significant 
of which was rs7182874 (P = 8.68 x 10−9). 
 
I have followed up these GWAS findings by conducting an association analysis 
between rs11855415 and various measures of relative hand skill and laterality in both 
neurodevelopmental and general population subgroups using the same cohorts as 
previously (Scerri et al., 2011a, Brandler et al., 2013). I report a nominally significant 
association between rs11855415 and both a quantitative measure of relative hand skill 
(PegQ7) and a categorical measure of hand preference (Hand11) in a dyslexic subgroup, 
but not in the general population cohort.   
 
Finally, I derived a predictive model of handedness, with the hand performance measure 
MarkQ (r = 0.66), rather than PegQ7 (r = 0.35), contributing most to the variance of the 
handedness phenotype as measured by a categorical measure for hand preference at age 
7 (Hand7). 
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2.2 Introduction 
 
A recurrent finding from previous studies investigating handedness was the significant 
association with a PCSK6 locus in both the general population (Arning et al., 2013) and 
dyslexic cohorts (Scerri et al., 2011a, Brandler et al., 2013). The specificity of the latter 
findings is interesting in the context of a meta-analysis of 25 studies by Eglinton and 
Annett (1994) who found a small but consistent increase in the prevalence of non-right 
handers among dyslexics. An updated meta-analysis of 44 studies by Koufaki (2010) 
supported the earlier findings of Eglinton & Annett and confirmed a statistically 
significant increase in non-right-handedness among dyslexics compared with non-
dyslexics (N = 16,561 OR = 1.57, 95% confidence interval = 1.24 – 1.99). The 
reporting by both Scerri et al. (2011a) and Brandler et al. (2013) of a significant 
association between PegQ and PCSK6 in a dyslexic cohort (though not the general 
population) raises several interesting questions I aim to address in this chapter, namely: 
 
1. Does PCSK6 associate with alternative measures which assess for relative hand 
skill? If not, then what are the properties (gripping, dexterity etc.) of the PegQ 
measure that support such a significant association? 
2. Why is the reported significant association between PCSK6 and PegQ specific 
to a dyslexic cohort and, by extension, does such an association exist in other 
clinical cohorts? 
 
To begin answering these questions it is useful to define what exactly the term dyslexia 
refers to and how we distinguish cohorts for future analysis. Derived from the Greek 
language meaning 'difficulty in reading', dyslexia (or reading disability, RD) can be 
defined as a specific difficulty in learning to read that cannot be attributed to age, 
intellectual deficiency, sensory disorders, or inadequate schooling (Ramus, 2014). RD 
affects approximately 6 - 10% of the population (DeFries, 1989) and although twin 
studies clearly show a genetic basis with a heritability of 0.53 - 0.82 (Wadsworth et al., 
2010, Olson et al., 1989, Petrill et al., 2007), the inheritance mode remains unclear. RD 
shows substantial overlapping predisposition with other neurodevelopmental disorders; 
approximately 33 - 45% of individuals with attention deficit hyperactivity disorder 
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(ADHD) show comorbidity for RD (Field et al., 2013) while it is estimated that 43% of 
children with Specific Language Impairment (SLI) are later diagnosed with RD 
(Snowling et al., 2000). When considering individuals for inclusion in association 
analysis studies it is important to recognise such comorbidities and filter where 
necessary. As such, I have included, with the help of my colleague Dr Kerry Pettigrew, 
both general population and neurodevelopmental disorder subgroups in my association 
analysis of the Avon Longitudinal Study of Parents and Children (ALSPAC) dataset 
(Figure 2.1). 
 
The ALSPAC Children of the 90s project is a long-term birth cohort study that began in 
the early 1990s when it recruited more than 14,000 pregnant women who were due to 
give birth between April 1991 and December 1992. Further information on the 
ALSPAC cohort and the available data can be accessed via the study website 
(http://www.bris.ac.uk/alspac/researchers/data-access/data-dictionary/) and in the 
literature (Boyd et al., 2013, Team, 2001). Briefly, children from 4 weeks to 18 years of 
age are assessed across a wide range of behavioural, physical and neuropsychological 
phenotypes, including reading and laterality-related measures, such as handedness.   
 
The assessment of handedness has traditionally been measured through the use of 
various questionnaires including the Waterloo Handedness Questionnaire (WHQ, 
Steenhuis et al. (1990)), the Edinburgh Handedness Inventory (Oldfield, 1971) and 
Annett’s handedness questionnaire (Annett, 1970) however these suffer inherent 
limitations and do not recognise the multifactorial nature of handedness when they fail 
to assess for fine motor tasks or dexterity. To complement this approach researchers 
have employed performance-based measures such as grip strength, manual sorting, dot 
filling etc. as a cost-effective and accessible method to evaluate handedness. The 
advantages of using performance-based measures are their objectivity and quantitative 
nature, as opposed to the subjectivity and binary (or ‘categorical’) nature of a self-
reporting handedness questionnaire. Indeed, since the strength of hand preference can 
vary by task (Willems et al., 2014), any assessment of one’s handedness based on a 
combination of tasks is preferable to those based on a single task (e.g. asking which 
hand a person writes with) or to assessments that are made without reference to any 
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specific task (e.g. such as a questionnaire’s ‘are you right or left handed?’). 
Furthermore, analysis by Corey et al. (2001) using unimanual motor tasks (moving pegs 
on a board and finger tapping) concluded that handedness is not a one-dimensional 
behaviour and must be defined using multiple measures that assess different aspects of 
hand preference and performance. As such, it is important to determine which 
performance measures accurately predict hand preference scores to facilitate research 
based on distinct handedness groups. In conclusion and in addition to the two primary 
objectives previously stated, this chapter also seeks to establish: 
 
3. What is the correlation between quantitative measures of relative hand skill and 
if such measures can be used as predictors in assessing handedness and its 
stability over time? 
4. Whether the SNP rs1185545, previously identified to be associated with a 
complex trait (relative hand skill), also contributes to other measures of laterality 
such as footedness or eyedness and whether these categorical measures 
themselves correlate with handedness? 
 
2.3 Methods 
 
Below is a detailed methodology which has been used to arrange individuals from the 
ALSPAC dataset in to RD, ADHD, SLI and general population subgroups and how 
these subgroups were subsequently phenotyped for multiple measures of laterality. 
  
2.3.1 Ascertainment criteria for subgroups 
 
From the entire ALSPAC children dataset (N = 15,443 as of July 2014) we identified a 
cohort using criteria defined by Scerri et al. (Scerri et al., 2011b) that included only 
individuals with a near complete data set on all the measures used for sample 
assignment, Intelligence Quotient (IQ) and ethnicity. The same criteria were also used 
for the two previous GWA studies of relevance (Scerri et al., 2011a, Brandler et al., 
2013). To avoid effects of population stratification, we excluded individuals that did not 
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have a white European ethnicity based on a self-reported ethnicity of ’non-white’. Any 
individuals who had a performance IQ ≤ 85 at the age of 8.5 years or a score ≤ -3 
standard deviation (SD) for a composite score of 7 measures from the Children’s 
Communication Checklist (CCC) were removed; this second filter was to rule out 
individuals with autistic features at 7.5 years. These exclusion criteria removed 
individuals that may have performed badly on the psychometric tests for reasons other 
than specific reading or language impairment. Finally, we only included one child from 
any twin pairs for further analysis. 
 
After filtering we were left with a sample baseline of N = 3,747 (F1, Figure 2.1) from 
which to ascertain subgroups. It is worth noting that this sample baseline differs slightly 
to Scerri et al. (2011a) and Brandler et al. (2013) (N = 3,725) since additional samples 
were added to the ALSPAC cohort in the most recent data release (July 2014). For 
subgroup filtering, individuals were assigned by an unaffected status or by 
neurodevelopmental disorder (RD, SLI, ADHD or any of the four comorbid 
combinations of these three disorders) giving eight subgroups in total (Table 2.1).  
 
RD was identified based on an age-adjusted single-word reading score 1 SD below the 
mean for both a 40-word reading test at 7.5 years and a 12-word reading test at 9.5 
years. Two time points were used to correct for random error on each individual 
measure. Individuals missing any data points were excluded. An assignment of ADHD 
was based on a DAWBA DSM-IV clinical diagnosis at 7.5 years of age. To record the 
different components of language impairment, an assignment of SLI was given if an 
individual scored positive for at least two of the following four criteria: 
 
• an age adjusted non-word repetition score ≤ -1 SD at 8.5 years 
• a composite score of 7 measures from the CCC pragmatic aspects of 
communication ≥ -3 SD and ≤ -1 SD at age 7.5 years 
• an age adjusted WOLD comprehension score ≤ -1 SD given at 8.5 years 
• a questionnaire given at 9.5 years asking if the individual has ever had 
language/speech therapy 
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These four criteria target different aspects of language problems and while each of them 
might over-identify impairment, two concomitant low scores have been shown to be a 
valid strategy to predict clinical diagnosis (Catts et al., 2005). In total, there were 442 
affected individuals who met any of the assignment criteria detailed above for RD, SLI 
or ADHD (Affected Subgroup, Figure 2.1). 
 
 
 
Figure 2.1 Diagram illustrating how phenotypic subgroups were identified from the ALSPAC dataset. 
Dashed line represents non-mutually exclusive subgrouping (comorbidity). The subgroups used 
throughout this chapter are highlighted in blue: All, Unaffected, RD and Affected. See Table 2.1 for full 
breakdown. CCC_SUM7 is the sum of first seven scales from the Children’s Communication Checklist, 
Intelligence Quotient (IQ), Reading Disability (RD), Specific Language Impairment (SLI), and Attention-
Deficit/Hyperactivity Disorder (ADHD).  
 
 
The three derived subgroups relevant to this chapter are as follows (blue boxes, Figure 
2.1): 
  
(1) Unaffected Subgroup (N = 3,305): This subgroup was the remainder of the 
ALSPAC cohort after filtering for IQ, ethnicity, missing data and disorder 
 
(2) RD Subgroup (N = 227): This subgroup consists of individuals with either pure 
RD or those with RD and a comorbidity for SLI and/or ADHD 
 
(3) Affected Subgroup (N = 442): This subgroup contains all RD, SLI and ADHD 
individuals  
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Table 2.1 The final subgroup sizes following filtering of individuals from the ALSPAC cohort according to 
disorder 
 
 
 
Subgroup N 
Pure SLI 184 
Pure RD 173 
Pure ADHD 26 
RD + SLI 46 
ADHD + SLI 5 
ADHD + RD 5 
ADHD + RD + SLI 3 
Unaffected 3305 
Excluded from subgroup filtering 11696 
 
 
 
2.3.2 Laterality measures 
 
Phenotype data for the following quantative and categorical measures for handedness 
were made available from the ALSPAC dataset for use in association analysis. 
 
2.3.2.1 Quantitative measures of hand performance  
 
PegQ 
The pegboard task (Annett, 1985) is a quantitative measure for relative hand skill 
that involves the measurement of time taken by an individual to move a row of ten 
pegs from one side of a board to the other using one hand. A relative hand skill 
measure (PegQ) for each subject is derived by calculating the difference between the 
average times for the left hand (L) and the right hand (R), divided by the average 
time for both hands combined: 
 
𝑃𝑃𝑃𝑃 = L− R(𝐿 + 𝑅)/2 
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A pegboard task similar to the Annet pegboard was performed in the ALSPAC 
sample as part of a battery of manual dexterity tests known as Movement ABC 
(Henderson et al., 2007). In this case there were 12 pegs on the table that the child 
picked up one-at-a-time and placed in a pegboard. After a trial practice, children 
performed the test once with each hand. The pegboard task was performed at 37 
months and at 7 years of age (only 10 pegs used in the 37 months task) with a 
laterality quotient score derived for each as above (PegQ37 and PegQ7 
respectively). One outlier (PegQ7 = 6.99) was removed from further analyses. 
 
Handedness is a multifactorial trait and as such, in addition to the pegboard task, the 
ALSPAC dataset allows the measuring of fine motor performance and manual dexterity 
by assessing grip strength, the sorting of matches and marking squares. For the purpose 
of consistency, I derived a similar laterality quotient score for each quantitative measure 
using the equation above.   
  
GripQ 
Grip strength was assessed at 11 years of age using the Jamar hand dynamometer, 
which measures isometric strength in kilograms. The child was given a practice 
squeeze of the dynamometer (not recorded) and then encouraged to squeeze as long 
and as tightly as possible; the higher the reading, the stronger the grip. The child 
repeated the measurement with the left hand and two further measurements were 
taken with each hand, alternating sides to give three readings in total for each side. 
An average for all 3 readings was used to derive the GripQ score. Three outliers 
were removed from the Unaffected subgroup (GripQ = 7.36, 7.83, 8.2).  
 
MarkQ 
At 10 years of age the child was asked to make a short dash on a piece of paper 
which has a grid marked on it consisting of rows of 20 squares. They were asked to 
start at the top left hand side of the squared paper, working across it. When the first 
line is completed the child should start on the left side of the next row with the 
objective to see how many squares can be marked in 60 seconds. When the child has 
completed the test with the preferred hand, they change hands and turn the paper 
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around and repeat. Unlike the other quantative measures, MarkQ has a negative 
mean since the majority are expected to score higher with their right hand than their 
left (i.e. Mean = -0.28, SD = ±0.27, N = 7,351 for all individuals with MarkQ data 
available). For ease of interpretation I transformed MarkQ to a positive mean by 
simply applying a factor of -1 to each phenotypic score. 
 
SortQ 
Both MarkQ and SortQ tests are a repetition of those used in the National Child 
Development Study, 1958 Cohort (Leask and Crow, 2001). At 10 years of age the 
child was asked to take matches one at a time out of a full match box (on their right) 
and transfer them directly to an empty match box (on their left) using one hand only, 
starting with the preferred hand. The children were allowed one practice go (not 
recorded) before they started the task. The tester timed how long it took for the child 
to transfer all the matches from one box to the other. The test was then repeated with 
the non-preferred hand. One outlier was removed from further analyses (SortQ = 
5.46). 
 
For further analyses, all quantitative measures were normalised to a mean of 0 and SD 
of 1. Thus, a positive score indicates superior relative right-hand skill while a negative 
score indicates superior relative left-hand skill.  
 
2.3.2.2 Categorical measures of handedness and laterality 
 
There were also several categorical measures of laterality available from the ALSPAC 
dataset, that is, measures that only provide a binary ‘left’ or ‘right’ result: 
 
Hand7: The child was asked at 7 years of age which hand they wrote with 
 
Hand10: At 10 years of age the child was asked prior to a computer session which 
was their dominant hand 
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Hand11: Prior to the GripQ session at 11 years of age the child was asked to specify 
which their dominant hand was 
 
FOOT: At 37 months the child was invited to kick a ball at a set of skittles, with the 
foot used to kick noted. The ball was placed in front of the child at a midline 
position between the two feet. This task was repeated three times and an average 
taken. 
 
EYE: Three coloured boxes were stood on a table at the child’s eye height. When 
the child was first brought into the room they were asked to look through a hole in 
each box and asked a simple question about the contents in order to maintain 
interest. The examiner noted which eye was used on each occasion. The sample was 
only considered for further analyses if the child used the same eye 3 times.   
 
All correlative analysis was conducted using SPSS v21. Association analysis was 
performed for an allelic model using Plink v1.9 (Purcell et al., 2007). 
   
2.4 Results 
 
2.4.1 ALSPAC quantative measures 
 
The PegQ7, PegQ37, SortQ and GripQ measures show a unimodal distribution in the 
Unaffected subgroup and are continuous and approximately normal, thus making them 
suitable quantitative phenotypes (Figures 2.2 - 2.6). There is no evidence for significant 
skewness or kurtosis (Tables 2.2 - 2.6). The MarkQ distribution displays a slight 
bimodal distribution and higher skewness (0.71, see Discussion section 2.5). 
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PegQ37 
 
Figure 2.2 PegQ37 laterality measure distribution according to subgroup. Q-Q plots were generated with 
SPSS v21. RD subgroup includes those individuals showing comorbidity with ADHD and SLI. Affected 
subgroup includes all individuals with a neurodevelopmental disorder (ADHD, SLI or RD). Scores are 
normalised to a mean of 0 and a standard deviation of 1 
 
Table 2.2 A summary of the skewness and kurtosis of the PegQ37 scores 
 
Subgroup N Skewness Kurtosis 
Unaffected 402 -0.19 0.44 
RD 16 -1.28 2.68 
Affected 36 -0.46 -0.63 
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PegQ7 
 
Figure 2.3 PegQ7 laterality measure distribution according to subgroup. Q-Q plots were generated with 
SPSS v21. RD subgroup includes those individuals showing comorbidity with ADHD and SLI. Affected 
subgroup includes all individuals with a neurodevelopmental disorder (ADHD, SLI or RD). Scores are 
normalised to a mean of 0 and a standard deviation of 1.  
 
Table 2.3 A summary of the skewness and kurtosis of the PegQ7 scores 
 
Subgroup N Skewness Kurtosis 
Unaffected 2825 -0.04 0.94 
RD 197 -0.28 0.88 
Affected 380 -0.25 0.45 
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SortQ 
 
 
Figure 2.4 SortQ laterality measure distribution according to subgroup. Q-Q plots were generated with 
SPSS v21. RD subgroup includes those individuals showing comorbidity with ADHD and SLI. Affected 
subgroup includes all individuals with a neurodevelopmental disorder (ADHD, SLI or RD). Scores are 
normalised to a mean of 0 and a standard deviation of 1 
  
Table 2.4 A summary of the skewness and kurtosis of the SortQ scores 
 
 Subgroup N Skewness Kurtosis 
Unaffected 3147 -0.01 0.42 
RD 209 0.02 0.12 
Affected 412 -0.2 0.17 
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MarkQ 
 
 
Figure 2.5 MarkQ laterality measure distribution according to subgroup. Note the secondary peak in 
Affected and Unaffected subgroups represents a subpopulation of left-handers. See  
Figure 2.7 for separated distributions. Q-Q plots were generated with SPSS v21. RD subgroup includes 
those individuals showing comorbidity with ADHD and SLI. Affected subgroup includes all individuals 
with a neurodevelopmental disorder (ADHD, SLI or RD). Scores are normalised to a mean of 0 and a 
standard deviation of 1. 
  
Table 2.5 A summary of the skewness and kurtosis of the MarkQ scores 
 
Subgroup N Skewness Kurtosis 
Unaffected 3115 0.71 1.03 
RD 211 0.29 0.55 
Affected 410 0.47 0.71 
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GripQ 
 
Figure 2.6 GripQ laterality measure distribution according to subgroup. Q-Q plots were generated with 
SPSS v21. RD subgroup includes those individuals showing comorbidity with ADHD and SLI. Affected 
subgroup includes all individuals with a neurodevelopmental disorder (ADHD, SLI or RD). Scores are 
normalised to a mean of 0 and a standard deviation of 1. 
  
Table 2.6 A summary of the skewness and kurtosis of the GripQ scores  
 
Subgroup N Skewness Kurtosis 
Unaffected 2859 0.54 4.82 
RD 177 0.54 0.65 
Affected 382 0.69 3.03 
50 
 
2.4.2 Categorical measures for handedness 
 
The ALSPAC dataset provides several measures of categorical hand preference 
recorded over a four year period (age 7-11 years). Three categorical measures for self-
reported handedness (Hand7, Hand10 and Hand11) were tested for correlation within 
three subgroups; Unaffected, RD and Affected. Table 2.7 indicates all three measures to 
be highly correlated with self-reported handedness a stable measure over the time 
period, irrespective of subgroup status. As the measure with the most phenotype data 
available, Hand7 (N = 8,084) was selected as a stable self-reported measure of hand 
preference for subsequent analyses. Any individuals (N = 46) that displayed variation in 
self-reported hand preference were removed from further analyses. 
 
 
Table 2.7 Pearson’s correlation between categorical measures for self-reported handedness at 7 
(Hand7), 10 (Hand10) and 11 (Hand11) years of age in the Unaffected (italics), RD (underlined) and 
Affected (bold) subgroups. All correlations are significant at the 0.01 level (2-tailed).  
 
 
 Hand10 Hand7 Hand11 
Hand10 1 .95, (N = 2807) .95 (N = 2807) 
  .93 (N = 189) .95 (N = 189) 
  .91 (N = 365) .95 (N = 365) 
Hand7  1 .96 (N = 2807) 
   .98 (N = 189) 
   .96 (N = 365) 
Hand11   1 
 
 
2.4.3 Correlation between quantative measures 
 
To reduce confounding variables such as the subjective nature inherent in self-reporting 
measures, researchers use performance-based measures which assess the differences 
between the two hands on a given task. An analysis of five such quantitative measures 
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of relative hand skill in the ALSPAC dataset (GripQ, SortQ, MarkQ, PegQ37 and 
PegQ7, Table 2.8) indicates a weak correlation between each measure across all 
subgroups. There is a slight increase in correlation between the measures in the Affected 
subgroup (r = 0.07 - 0.25) compared to the Unaffected subgroup (r = 0.06 - 0.2). The 
highest correlated pair of measures in all 3 subgroups was between PegQ37 and PegQ7 
(Unaffected, RD and Affected subgroups were r = 0.15, r = 0.58 and r = 0.22 
respectively). 
The current analysis serves to determine which of the five performance-based measures 
produces the strongest prediction of hand preference as measured by the self-reporting 
Hand7 categorical measure. To this effect, I developed a predictive model of 
handedness using stepwise multiple linear regression analysis (MLRA) using Hand7 as 
the dependent variable and four hand performance measures as independent variables. 
Note the PegQ37 measure was removed from the analysis due to the reduced number of 
data points available (N = 402) since models which impute missing data have been 
shown to cause subsequent relationships to be over-identified (Allison, 2002). 
 
An examination of the subsequent correlation matrix (grey bars, Table 2.8) reveals 
MarkQ to have the highest correlation with the Hand7 measure for hand preference 
across all subgroups. The Pearson coefficient indicates a consistent inverse correlation 
since all performance measures have a positive mean score while the Hand7 hand 
preference variable is categorical (1= right-handed 2= left-handed); as the Hand7 
dependent variable increases to ‘2’ (signifying left-handedness) then the relevant 
predictor will undergo an equivalent shift to the left on the normalised distribution 
curve. All performance measures, except the SortQ task in the Unaffected cohort, 
contributed to the prediction of hand preference. In the Unaffected cohort the MLRA 
model (Hand7= 1.11 - 0.19(MarkQ) -0.05(PegQ7) -0.03(GripQ)) produced an explained 
variance of 48% (adjusted R2= 0.48). In the RD cohort the model (Hand7= 1.12 - 
0.148(MarkQ) - 0.052(PegQ7) + 0.007(GripQ) -.022(SortQ)) produced an adjusted R2= 
0.22 while in the Affected cohort a model (Hand7= 1.13 - 0.168(MarkQ) – 
0.057(PegQ7) -0.017(GripQ) – 0.019(SortQ)) produced an adjusted R2= 0.35.  
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Table 2.8 Pearson’s correlation between quantitative measures of relative hand skill and dexterity in the 
ALSPAC dataset subgroups Unaffected (A), RD (B) and Affected (C). The grey box in each table indicates 
the Pearson’s correlation between the dependent variable Hand7 (hand preference) and multiple 
measures of hand performance (independent variables) when using MLRA. Note PegQ37 was not 
included due to missing data.  
 
  
(A) Unaffected Subgroup (N = 2,353) 
 GripQ SortQ MarkQ PegQ37 PegQ7 
GripQ 1 .06** .2** .043 .14** 
SortQ  1 .15** .12* .13** 
MarkQ   1 .13* .3** 
PegQ37    1 .15** 
PegQ7     1 
Hand7 -.22** -.12** -.66** - -.35** 
 
 
(B) RD Subgroup (N = 144) 
 GripQ SortQ MarkQ PegQ37 PegQ7 
GripQ 1 -.04 .16* .07 .16 
SortQ  1 .04 .29 .03 
MarkQ   1 .09 .19** 
PegQ37    1 .58* 
PegQ7     1 
Hand7 -.072 -.06 -.47** - -.264** 
 
 
(C) Affected Subgroup (N = 307)  
 GripQ SortQ MarkQ PegQ37 PegQ7 
GripQ 1 .07 .1 .25 .2** 
SortQ  1 .08 .07 -.01 
MarkQ   1 -.22 .2** 
PegQ37    1 .22 
PegQ7     1 
Hand7 -.16* -.1 -.57** - -.3** 
 
                      Correlation is significant at the **0.01 level (2-tailed) and *0.05 level (2-tailed). 
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2.4.4 Ambidexterity 
 
Deriving a laterality quotient for the five quantitative measures also enabled the 
recording of which individuals displayed ambidexterity, that is, the state of being 
equally adept in the use of both hands at a particular task. A phenotypic association 
between ambidexterity and neurodevelopmental disorders has been reported previously 
in RD (Tonnessen et al., 1993), developmental disorder (Goez and Zelnik, 2008) and 
schizophrenia (Barrantes-Vidal et al., 2013, Tran et al., 2015), though several earlier 
studies did not observe this association (Pennington et al., 1987, Gilger et al., 1992). 
My data do not support a straightforward relationship between relative hand skill and 
neurodevelopmental subgroups (Table 2.9). 
 
Table 2.9 Ambidexterity recorded in the quantitative measures for hand performance. Sample sizes (N) 
included in brackets. PegQ37 is not included due to low sample sizes (RD, N=16). Ambidexterity was 
recorded as an individual with a normalised performance score within the range ± 0.05  
  
Measure All (N) Unaffected (N) RD (N) Affected (N) 
GripQ 4.3% (288/6,686) 4.3% (123/2,862) 1.7% (3/178) 4.2% (16/383) 
SortQ 4.7% (349/7,383) 5.1% (143/2,793) 2.9% (6/209) 4.4% (18/412) 
MarkQ 4.7% (345/7,360) 4.8% (151/3,117) 5.2% (11/211) 3.6% (15/411) 
PegQ7 3.2% (221/7,002) 3.6% (102/2,827) 3.0% (6/197) 3.4% (13/380) 
 
 
 
2.4.5 Hand, Foot and Eye Correlation 
 
Questionnaires such as the Waterloo Handedness Questionnaire (WHQ, Steenhuis et al. 
(1990)) and the Edinburgh Handedness Inventory (Oldfield, 1971) typically focus on 
hand preference and fail to explore dominance for foot or eye, even though footedness 
has been reported as a more robust predictor of language lateralisation than handedness. 
In a limited study, Elias and Bryden (1998) demonstrated footedness to be a far better 
predictor of language lateralisation than handedness (N = 32, P < .001). Similarly, in a 
cohort of 37 epileptic candidates for temporal lobe resection, Watson et al. (1998) found 
in Wada testing neither handedness alone nor the interaction of handedness and 
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footedness contributed substantially more than footedness alone to the prediction of 
language laterality. Other research also suggests that non-right-footedness plays a role 
in schizophrenia (Tran et al., 2015, Schiffman et al., 2005), though these findings have 
been inconsistent (Nicholls et al., 2005, Asai et al., 2011). Analysis of the Hand7, Foot 
and Eye categorical measures of laterality across all three subgroups (Table 2.10) shows 
hand preference is only weakly correlated with foot preference (Unaffected r = 0.28) 
however both RD and Affected subgroups were too underpowered to reliably perform 
MLRA on due to low sample size (N = 18 and 33). In total, just 10.4% of the variance 
as measured by Hand7 can be explained when using Foot and Eye variables as 
predictors in the Unaffected subgroup (MLRA model Hand7 = 0.71 + 0.22(Foot) + 
0.11(Eye)). My data support previous findings (Teng et al., 1976, Hoosain, 1990), 
showing the correlation between handedness and eyedness (r = 0.22) to be weaker than 
the correlation between handedness and footedness (r = 0.28, Table 2.10). 
 
Table 2.10 Pearson’s correlation between categorical measures for self-reported handedness, 
footedness and eyedness in the Unaffected (italics), RD (underlined) and Affected (bold) subgroups. ** 
Correlation is significant at the 0.01 level (2-tailed).  
 
 
 Hand7 Foot Eye 
Hand7 1 .28** (N = 375) .22** (N = 375) 
  -.09 (N = 18) -.19 (N = 18) 
  -.09 (N = 33) .21 (N = 33) 
Foot  1 .2** (N = 375) 
   .081 (N = 18) 
   -.11 (N = 33) 
Eye   1 
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2.4.6 Association analysis of rs11855415 
 
Finally, I investigated if the significant association between SNP rs11855415 and 
handedness recorded previously (P = 4.7 × 10−7, Scerri et al. (2011a); P= 6.96 × 10−8, 
Brandler et al. (2013)) was exclusive to a pegboard measure in an RD subgroup or 
whether this finding could be extended to other measures of relative hand skill across 
multiple subgroups. The only measure showing nominally significant association with 
rs11855415 was PegQ7 in the RD (P= 0.002) and Affected (P= 0.02) subgroups as 
reported in Table 2.11. These results act as a benchmark in confirming this analysis was 
performed on a very similar subset to previous GWA studies i.e. Scerri et al. (2011a) in 
their analysis of an RD cohort (N = 368, P= 0.033, β= 0.19). Furthermore, individuals 
with the minor (derived) ‘A’ allele of rs11855415 were shown to have significantly 
greater relative right-hand skill compared with those carrying the major ‘T’ (ancestral) 
allele. The mean effect size of each copy of the minor allele is 0.28 standard deviations 
(SD) to the positive (right-handed) end of the PegQ7 distribution (see ‘β’ in Table 2.11) 
in the Affected subgroup and β= 0.29 in the RD subgroup. In the Unaffected subgroup 
(N = 2,597), I did not detect significant association between rs11855415 and relative 
hand skill (P = 0.32, β = −0.034).  
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Table 2.11 Association analysis results for the PCSK6 genetic variant rs11855415 and hand performance 
measures for relative hand skill and dexterity in multiple subgroups. Each result represents a P-value 
and subgroup size. Further details of the nominally significant PegQ7 associations are included below 
the main table. β is the mean effect size of each copy of the minor allele measured in standard 
deviations. SE is the standard error. R2, the regression r-squared, estimates the proportion of the 
phenotypic variation that is explained by the rs11855415 marker. Highlighted in bold are the nominally 
significant associations between rs11855415 and PegQ7 in the RD and Affected subgroups. 
   
                                                  Group 
Measure         All   Unaffected         RD   Affected  
GripQ 0.31 (N=5,956) 0.46 (N=2,636) 0.17 (N=167) 0.11 (N=346) 
PegQ37 0.33 (N=568) 0.91 (N=378) 0.88 (N=15) 0.38 (N=33) 
PegQ7 0.36 (N=6,101) 0.32 (N=2,597) 0.02 (N=183) 0.002 (N=341) 
MarkQ 0.87 (N=6,498) 0.69 (N=2,860) 0.15 (N=195) 0.13 (N=369) 
SortQ 0.52 (N=1,955) 0.37 (N=2,890) 0.35 (N=193) 0.94 (N=370) 
 
Measure Subgroup (N) P-value β SE R2 
PegQ7 RD (183) 0.02 0.29 0.12 0.02 
PegQ7 Affected (326) 0.002 0.28 0.28 0.09 
 
 
As defined in the Methods section, the RD subgroup in Table 2.11consists of 
individuals with either pure RD or those with RD and comorbidity for SLI and/or 
ADHD while the Affected subgroup contains all RD, SLI and ADHD individuals (and 
combinations of comorbidities). The significant level of association found between 
PegQ7 and rs11855415 in the Affected subgroup (P = 0.002, N = 341, Table 2.11) 
might therefore be as a result of the RD cohort within the Affected subgroup driving 
this association. However, the further division of the Affected subgroup (N = 341) in to 
its constituent cohorts of pure SLI (N = 154), RD (N = 148) and ADHD (N = 24) 
resulted in no one single clinical cohort displaying significant association between 
rs11855415 and the PegQ7 measure (Table 2.12). When combining both RD and 
ADHD cohorts from the Affected subgroup there is a significant association (P = 0.02, 
N = 161) between rs11855415 and the PegQ7 measure (Table 2.12). 
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Table 2.12 Association analysis results for the PCSK6 genetic variant rs11855415 and the PegQ7hand 
performance measure for relative hand skill in the Affected subgroup. The Affected subgroup was 
divided in to its constituent cohorts according to disorder. Each result represents a P-value and 
subgroup size. β is the mean effect size of each copy of the minor allele measured in standard 
deviations. SE is the standard error. R2, the regression r-squared, estimates the proportion of the 
phenotypic variation that is explained by the rs11855415 marker. 
 
 
Measure Subgroup (N) P-value β SE R2 
PegQ7 ADHD (20) 0.08 0.61 0.33 0.16 
PegQ7 RD (141) 0.15 0.19 0.13 0.01 
PegQ7 SLI (135) 0.32 0.16 0.16 0.01 
PegQ7 SLI & RD (37)* 0.08 0.6 0.32 0.08 
PegQ7 SLI + ADHD (155)† 0.06 0.27 0.15 0.02 
PegQ7 RD + ADHD (161) † 0.02 0.29 0.12 0.03 
PegQ7 SLI + RD (276) † 0.10 0.17 0.10 0.01 
 
* Indicates individuals displaying comorbidity for both disorders rather than combined subgroups   
† Indicates the sum of combining subgroups and not co-morbidity  
 
 
In conclusion, a test for association between rs11855415 and the categorical measures 
for laterality was also conducted using the Hand7, Hand10, Hand11, Foot and Eye 
measures (Table 2.13). Although Hand7 does not display nominal significance, Hand7 
and Hand11 are highly correlated in the RD and Affected subgroups (r = 0.975 and 
0.964 respectively, see Table 2.7 previously) where Hand11 does show nominal 
significance (P ≤ 0.02). In this basic allelic model the minor A allele of rs11855415 has 
a low-mid effect size in both RD and Affected subgroups (OR = 0.29 and 0.47 
respectively). Hand11 carries an effect in the same direction as the previous association 
analysis between rs11855415 and PegQ7 (β = 0.28 - 0.29, Table 2.13). That is, a shift 
towards right-handedness for each additional minor A allele. 
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Table 2.13 Association analysis results for the PCSK6 genetic variant rs11855415 and categorical 
measures for handedness, footedness and eyedness in multiple subgroups. Each result represents a P-
value and subgroup size for that association tested. Further details of the nominally significant Hand11 
associations are included below the main table. OR is the odds ratio, Chi is the chi-square basic allelic 
test and F is the frequency of the minor A allele for rs11855415.  
 
                                                  Group 
Measure         All   Unaffected        RD   Affected 
Hand7 0.17 (N=8,084) 0.27 (N=3,284) 0.08 (N=224) 0.12 (N=441) 
Hand10 0.70 (N=7,498) 0.52 (N=3,177) 0.09 (N=213) 0.11 (N=418) 
Hand11 0.89 (N=6,688) 0.52 (N=2,870) 0.01 (N=201) 0.02 (N=382) 
Foot 0.80 (N=1,028) 0.36 (N=417) 0.7 (N=19) 0.36 (N=38) 
Eye 0.72 (N=7,438) 0.07 (N=2,982) 0.2 (N=206) 0.35 (N=408) 
 
Measure Subgroup (N) P-value Chi OR F 
Hand11 RD (201) 0.01 5.97 0.29 0.24 
Hand11 Affected (382) 0.02 5.27 0.47 0.23 
 
 
2.5 Discussion 
 
Quantative measures offer several advantages over self-reporting hand preference 
questionnaires (e.g. elimination of both language reliance and the subjective nature of 
self-reporting), though such hand performance measures display their own inherent 
limitations. An analysis of five quantitative measures of relative hand skill in the 
ALSPAC dataset (GripQ, SortQ, MarkQ, PegQ37 and PegQ7) demonstrated poor intra-
correlation (Table 2.8), suggesting each unimanual task likely records only one aspect 
of manual performance abilities (e.g., speed, accuracy or dexterity). As such, motor 
behaviour is not a unitary trait and should be defined using multiple measures of both 
hand performance and hand preference.  
 
Through the use of MLRA modelling I examined which of the five hand performance 
measures might best predict hand preference as measured by Hand7. The use of MLRA 
allowed the decomposing of each predictor of hand preference such that each Pearson 
correlation represented the unique predictive capacity of each individual variable (Table 
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2.8). MarkQ is the majority contributor to the regression equation followed by PegQ7 
and GripQ with an adjusted R2 = 0.48, or in other words, 48% of the variability in 
Hand7 can be accounted for by just three of the measures of relative hand skill in the 
Unaffected subgroup (P < 0.001, N = 2,353). Removal of the GripQ independent 
variable only reduced the predicted variance by 1% to 47%. Such a minor contribution 
to the variance is to be expected since grip strength has been consistently reported to be 
weakly lateralised (Borod et al., 1984, Steenhuis et al., 1990). The SortQ measure was 
an excluded predictor from the model. Though the adjusted R2 value may not appear 
high (0.48), since all predictors are statistically significant (P < 0.001), one can still 
draw important conclusions about how changes in the predictor values are associated 
with changes in the response value. 
 
The correlation between hand performance and hand preference (Hand7) also depends 
strongly on the task being measured. Correlation ranges from r = 0.12 (SortQ) to r = 
0.66 (MarkQ) in the Unaffected subgroup (Table 2.8). This suggests a positive 
relationship between complexity of task and correlation score since both MarkQ and 
PegQ require skilled and learned manipulation of pen and peg respectively in 
comparison to the unimodal nature of the SortQ measure.  
 
Interestingly, significantly different distributions exist for hand performance and hand 
preference (Nicholls et al., 2010). Hand preference yields a bimodal (or J-shaped) 
distribution with a large number of strongly right-handed individuals, a smaller number 
of strongly left-handed individuals, and few individuals in between (Ocklenburg et al., 
2014). That MarkQ is the best predictor of hand preference in this data likely arises 
from the fact that the distribution of scores appears bimodal (Figure 2.5); tasks 
producing bimodal distributions provide clear support for distinct handedness groups 
(left vs right) whereas unimodal distributions suggest a continuum or a series of groups 
(strong , weak and mixed) might best describe handedness. A demonstration of this can 
be seen in Table 2.5 which indicates the distribution of MarkQ scores to be markedly 
skewed in the Unaffected subgroup (skewness = 0.71). When the subjects are 
subdivided into left- and right-handers, the skewness is significantly reduced (right hand 
skew= 0.1, N = 2,082; left hand skew = -0.3, N = 267). In fact, data from both right and 
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left-handers can be adequately described by normal distributions of differing means but 
having the same variance (Figure 2.7: right mean = 0.24, SD = ±0.74; left mean = -1.8, 
SD = ±0.75). A similar trend exists when repeating this left-right division in the other 
subgroups. This would support the notion that left and right-handers represent two 
distinct subsamples in a population as proposed by McManus (2002). 
 
 
 
Figure 2.7 MarkQ distribution in the Unaffected subgroup. This quantative measure of relative hand skill 
has been subdivided in to left (top) and right (bottom) handers according to the self-reporting hand 
preference measure Hand7. Scores are normalised to a mean of 0 and a standard deviation of 1. Q-Q 
plots were generated with SPSS v21. For the original combined distribution of left and right handers in 
the Unaffected subgroup see Figure 2.5 
 
The distribution of hand performance data seems to be task-dependent to a large extent, 
with some tasks clearly showing more bimodal distributions (e.g. handwriting (Provins 
et al., 1982); dots (Tapley and Bryden, 1985) and punching holes (Annett, 1992). In 
contrast, hand performance measured with  the peg board task typically shows a 
unimodal distribution (Annett and Kilshaw, 1984), though the argument exists that the 
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peg board data are also bimodal since a smaller distribution of left-handers might be 
concealed within the tail of the larger distribution of the right-handers (McManus, 
1985b). Unlike the MarkQ data which appears to represent two distinct subsamples in a 
population, my pegboard task data for the Unaffected subgroup (N = 2,825, skewness = 
-0.04, kurtosis = 0.94) demonstrate an unskewed platykurtic distribution with a wider 
spread of values around the mean indicative of a classic unimodal distribution as a 
visual inspection confirms (Figure 2.3). 
 
One limitation of my interpretation of the hand performance data in this chapter was the 
use of laterality quotients (Oldfield, 1971). Such laterality quotients are only sensitive to 
the direction of handedness whereas alternative methodologies such as a laterality score 
(LS) have been shown to be sensitive to both the degree and direction of handedness (p. 
169, Mandal et al. (2000)). 
 
As discussed in the chapter introduction, it is of interest to see whether the PCSK6 SNP 
rs11855415 which Brandler et al. (2013) and Scerri et al. (2011a) found to be 
significantly associated with PegQ also shows association with other laterality measures 
in both clinical and general population cohorts. When testing for association between 
the SNP rs11855415 and multiple quantative measures of relative hand skill (see Table 
2.11), only PegQ7 showed nominal significance in the Affected (P = 0.002, N = 341) 
and RD subgroups (P = 0.02, N = 183). This finding results in several points worthy of 
discussion, namely:  
(1) The specificity of this finding - that only PegQ is significantly associated with 
rs11855415 - may relate to the notion that handedness is a multivariable trait which can 
be viewed as a multiple of separate phenotypes each representing hand strength, speed, 
dexterity etc. Since each of the performance measures record different aspects of 
handedness, this association might just represent a relationship between a genetic 
variation and one specific phenotype of handedness. Alternatively, the peg-board task 
might simply provide a measure (PegQ) which represents a broader aggregate of 
handedness aspects (grip, manual dexterity, spatial awareness etc.) than the other hand-
performance measures. For example, the highest correlation in all 3 subgroups between 
a PegQ measure and a non-peg measure for relative hand skill was between GripQ and 
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PegQ7 (RD and Affected subgroups were r = 0.16 and r = 0.2 respectively), while the 
equivalent values between GripQ and MarkQ show an overall weaker correlation (r = 
0.16 and r = 0.1 for the RD and Affected subgroups respectively).  
(2) Why a significant association between rs11855415 and PegQ was observed in only 
the RD and Affected subgroups and not the general population remains to be clarified. 
One possible reason why both Brandler et al. (2013) and Scerri et al. (2011a) report 
significant association specific to the RD subgroup might be that such a finding 
represents a false positive; an artefact as a result of the slight variation in how the peg-
board task was conducted between the RD and general population cohorts (see Brandler 
et al. (2013) for peg-board task details). An analysis of Table 2.3 shows a discrepancy 
in skewness between the Unaffected (-0.04, N = 2825), RD (-0.28, N = 197) and 
Affected (-0.25, N = 380) subgroups though none record a skewness score which 
indicates the data is significantly skewed (≤-1 or ≥1). As such, all subgroups are 
considered to have a normal distribution. A visual inspection of Figure 2.3 also fails to 
report any substantial difference in the tails of the Unaffected, RD and Affected 
subgroup distributions, indicating a similar spread of extreme lateralised individuals 
regardless of the subgroup. In any case, the observation that the increase in relative 
right-hand skill associated with rs11855415 in PSCK6 is specific to the RD and 
Affected subgroups may represent epistatic interaction between PCSK6 and RD 
susceptibility genes.  
(3) A further division of the Affected subgroup in to its constituent disorder cohorts of 
pure SLI, ADHD and RD (Table 2.12) showed no one disorder cohort to display 
significant association between rs11855415 and PegQ7. Therefore from these data at 
least, SLI individuals can be discounted from driving the signal we see for significant 
association between rs11855415 and PegQ7 in the Affected subgroup. Since the RD 
Subgroup in Table 2.11 displayed significant association between rs11855415 and 
PegQ7 (P=0.02), it would therefore appear the signal in the Affected subgroup is driven 
by the pure RD cohort with the possible addition of pure ADHD individuals and 
individuals co-morbid for both disorders (ADHD+RD, N = 5, Table 2.1). Although the 
sample sizes are small (e.g. ADHD, N = 20), the association in Table 2.12 is in the same 
allelic trend i.e. individuals with the minor ‘A’ allele of rs11855415 have significantly 
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greater relative right-hand skill compared with those carrying the major ‘T’ (ancestral) 
allele. This differs to the allelic trend of the general population which displays a trend 
towards reduced laterality of hand skill for the minor allele (β = −0.03, N = 2,597).  
 
If the ADHD cohort is influencing the significant association in the Affected subgroup, 
as the trend in Table 2.12 suggests, then the argument exists that PegQ data should be 
collected in children across a range of neurodevelopmental disorders rather than just in 
dyslexic individuals. It would be of great interest to see what effect an increase in 
clinical sample numbers might have on such trends and what ramifications this has in 
defining the link between handedness, language and brain asymmetries. 
 
In conclusion, this chapter supports previous GWAS findings that the SNP rs11855415 
shows nominally significant association with a performance measure for relative hand 
skill in dyslexic (RD) and affected (RD, SLI, ADHD) subgroups. The remainder of this 
thesis will investigate this association by first defining the extent of the PCSK6 locus in 
which the SNP is found (Chapter 3 & 4) and thereafter performing a functional analysis 
of the genetic variants within this region of association (Chapter 5). 
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3 In silico analysis of the PCSK6 locus 
 
3.1 Abstract 
 
Chapter 1 introduced two genome wide association (GWA) studies which have reported 
significant genetic association implicating a PCSK6 locus with handedness (Brandler et 
al., 2013, Scerri et al., 2011a). Due to the nature of their design, GWA studies typically 
return candidate Single Nucleotide Polymorphisms (SNPs) which may or may not be 
the causal genetic variant driving the reported association. We are thus required to 
define the PCSK6 locus of interest and determine the list of genetic variants within it for 
further study via functional genomic analyses. These analyses are performed using a 
combination of linkage disequilibrium (LD) mapping, evolutionary conserved sequence 
identification and the prioritisation of putative functional SNPs and regulatory elements 
by the integration of bioinformatics methods including interrogation of the 
Encyclopaedia of DNA Elements (ENCODE) project datasets and promoter database 
prediction software. The data presented in this chapter provide evidence that the 
functional variant(s) contributing to previous GWAS signals at the PCSK6 locus reside 
within a 12.7 kb sequence which is predicted to contain a 1.8 kb secondary promoter. 
 
3.2 Introduction 
 
GWA studies indicate associations between specific genomic loci and normal or 
pathological traits via a set of genetic marker SNPs designed to tag all known common 
variants in the genome in a hypothesis-neutral framework (Hirschhorn and Daly, 2005). 
However, pinpointing the strongest candidate causal variants from GWAS-associated 
loci and revealing the biological relevance of these associations remains a significant 
challenge. So far, there has only been limited scope for functional investigation in to the 
many biological hypotheses turned up by GWA studies (for example studies see Vernes 
et al. (2008) and Massinen et al. (2009)). This is the first study to perform a functional 
analysis of a locus previously detected to be significantly associated with a measure of 
handedness. 
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Post-GWAS functional follow-up studies typically involve the selection of variants that 
are the most likely to be the causal SNP underlying GWAS results. Several approaches 
have evolved over time – from a simple selection of markers to follow up based on their 
ranked marginal association test statistics to a more elegant approximate Bayesian 
procedure, based on posterior probabilities that each marker is the causal marker 
(Thompson et al., 2013). This chapter uses an approach that involves linkage 
disequilibrium (LD), the notion that alleles at neighbouring loci tend to be co-inherited, 
or in other words, a non-random association of alleles that is influenced by selection, 
the rate of recombination and population structure among other factors (Ardlie et al., 
2002). As a starting point, a complete catalogue of all variants at the associated locus 
that are in LD is required. 
 
The public availability of the HapMap project data (http://hapmap.ncbi.nlm.nih.gov/) 
allows access to sufficiently comprehensive genotyping data from which to compile 
such a list of genetic variants; 108,502 quality controlled SNPs are available alone for 
chromosome 15 on which PCSK6 is positioned. All previous association studies 
relevant to this project (Arning et al., 2013, Brandler et al., 2013, Scerri et al., 2011a) 
were conducted on cohorts of white European ethnicity and as such all further analysis 
and discussion is consigned to this population.   
 
The challenge of identifying functional variants from GWAS-identified loci is further 
complicated by variant types; while coding variants are easier to detect and annotate 
since they have a direct effect on protein structure and subsequent function, a common 
feature of GWAS findings is the vast majority of reported markers lie in intergenic or 
intronic regions (~88%, Welter et al. (2014)). Noncoding variants usually reside in 
regions whose annotations are characteristic of regulatory sites, such as sequence 
conservation, transcription factor binding sites (TFBSs), epigenetic markings etc. and 
are thought to influence gene expression through either transcriptional, post-
transcriptional or post-translational mechanisms (Ward and Kellis, 2012). The process 
of transcription is a complex one which begins when RNA polymerase II assembles at a 
gene promoter with the basal transcription machinery and begins to catalyse production 
of the complementary RNA (Alberts et al., 2008). Polymerases are large enzymes 
composed of almost a dozen subunits, typically complexed with numerous transcription 
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factors (TFs) by associating with regulatory sequences. The accessibility of such TFs is 
largely dependent upon chromatin structural changes which are controlled by epigenetic 
histone modifications, such as acetylation and methylation (Strahl and Allis, 2000).  
 
The advent of large-scale studies designed to identify regulatory elements in humans 
such as the ENCODE project (Consortium et al., 2007) has vastly improved our ability 
to annotate putative cis-regulatory variants, thereby facilitating the design of 
downstream functional analyses and testable hypotheses. For example, the ENCODE 
project includes chromatin immunoprecipitation with sequencing (ChIP-SEQ) data, a 
method used to analyse protein interactions with DNA. ENCODE tracks are useful in 
displaying ChIP-SEQ epigenetic data, since any non-coding variants found within 
regions marked with histone modifications are useful in reliably marking regulatory 
regions (Visel et al., 2009). 
 
If regulatory elements are shown to contain non-coding variants, then one can use 
comparative genomics to infer conserved noncoding sequences (CNSs) perform 
functions, which places varying degrees of constraint on their evolution (Jegga and 
Aronow, 2001). In other words, such CNSs can be informative since functional 
sequences are more likely to be retained through evolution, compared with non-
functional sequences (Haudry et al., 2013, Burgess and Freeling, 2014), as 
demonstrated by Thomas et al. (2003) who used conservation of bases across a region 
to successfully identify functional elements. In keeping with a definition used 
previously (Duret et al., 1993, Loots et al., 2000, Dermitzakis et al., 2002), in my 
analysis conserved sequences are defined as having 70% identity over at least 100 bp of 
ungapped alignment (which is above the average rate of neutral conservation) between 
human and orthologous sequences from other species.   
 
In conclusion, in this chapter I define the extent of a PCSK6 locus previously identified 
to be associated with handedness. Additionally I provide a catalogue of candidate 
variants that fall within this region and use comparative genomics and ENCODE project 
data to identify CNSs and regulatory elements which contain genetic variants that may 
ultimately affect PCSK6 expression.  
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3.3 Methods 
3.3.1 Defining the region of Linkage Disequilibrium 
 
Haploview v4.2 (Barrett et al., 2005) was used to visually inspect the haplotype 
structure and frequency of the downloaded genotype data for the canonical PCSK6 gene 
(NM_002570.4) in the HapMap CEPH population (Rel28 PhaseII+III Aug10 NCBI36, 
dbSNP126). SNP genotype data for the forward (fwd) strand was used for this purpose. 
Note that although the more expansive 1000 Genomes Project data (Genomes Project et 
al., 2012) was publicly available at the time of querying, the HapMap dataset was used 
for consistency purposes since this was the dataset originally used by Scerri et al. 
(2011a) for their imputation of SNPs. Haploview enables the analysis of LD patterning 
through the use of colour coding which indicates the pairwise correlation D’ or 
r2 coefficients (measures of LD) between SNPs. Pairwise comparisons of markers 
greater than 500 kb apart and individuals with more than 50% missing genotypes were 
ignored.  
 
3.3.2 Interrogation of the TFBS databases 
 
All 22 SNPs of the defined 12.7 kb HapMap block were queried for TFBSs in 20-base 
pair sequences centred on each SNP allele using the TRANSFAC v2014.4 (Matys et al., 
2006) and Genomatix MatInspector v8.0.6 (Cartharius et al., 2005) databases. Only 
those SNPs that displayed significant TFBS gain/loss on allelic variation were 
considered for further functional analysis (Table 3.1). TRANSFAC used a minFP 
profile to minimise false positives reported by the interrogated vertebrate taxonomic 
group. 1000 Genome Pilot project data offers superior SNP resolution to the HapMap 
Rel28 PhaseII+III dataset and as such was used with SNAP v2.2  (Johnson et al., 2008) 
to create a list of SNPs (see Appendix B) that were in LD (> 0.4 r2) with rs11855415, 
the highest associated PCSK6 marker from a previous handedness GWA study (Scerri 
et al., 2011a).  
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3.3.3 Software prediction of the secondary promoter region 
 
Beginning with an initial spread of 1 kb either side (chr15:101873604-101875513, 
hg19) of the H3K27Ac acetylation markings (indicative of an active promoter) at the 
PCSK6 locus (track C, Figure 3.2), several software packages were used to create a 
consensus prediction for the extent of a suspected secondary promoter in both strand 
directions. Promoter2.0 (Knudsen, 1999) predicts transcription start sites (TSSs) of 
vertebrate RNA Polymerase II promoters in DNA sequences while Proscan v1.7 
predicts promoter regions based on scoring homologies with putative eukaryotic RNA 
Polymerase II promoter sequences. The Mammalian Promoter Database (MPromDb) 
(Gupta et al., 2011) and the DataBase of Transcriptional Start Sites (DBTSS, Suzuki et 
al., 2015) are both curated databases that provide exact positions of TSSs identified 
from ChIP-Seq experiment  and TSS-seq results respectively. 
 
3.3.4 Identifying evolutionarily conserved sequences 
 
To identify conserved sequences across the previously defined region of LD 
(chr15:101863220-101875949, hg19, see Results section 3.4.3), the comparative 
genomics tool of the Ensembl genome browser (http://www.ensembl.org/) was used to 
obtain a multiple-sequence alignment for the human reference (hg19) and 13 eutherian 
mammals; chimp, gorilla, orang-utan, rhesus, baboon, marmoset, mouse, rat, rabbit, 
cow, dog, cat and horse (genome releases listed in Appendix B).  Note that I have 
restricted analyses to genome assemblies that have been sequenced at relatively high 
coverage (> 6 X) to minimise the impact of sequencing and assembly errors. Sequence 
conservation was analysed by pair-wise alignment using the mVISTA service (default 
parameters, http://genome.lbl.gov/vista/mvista/submit.shtml) and the Vertebrate Multiz 
Alignment & Conservation (100 Species, Element Conservation by phastCons) track 
from the UCSC Genome Browser (Siepel et al., 2005). For the mVista service any 
variant that fell within the 12.7 kb associated region in an interval ≥ 70% conservation 
across a 100bp sliding window in any of the species was considered conserved. 
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3.4 Results 
3.4.1 Region of Linkage Disequilibrium 
 
As discussed previously in the introductory chapter, two GWA studies (Brandler et al., 
2013, Scerri et al., 2011a) have implicated a locus of PCSK6 to be associated with 
handedness at a genome wide significant level (P-values below 5 × 10−8) in a dyslexic 
cohort. These studies were followed up by an independent association study of a general 
population cohort which also reported a genetic variant at that locus, a VNTR 
(rs10523972), to be associated with the degree of handedness (P = 0.001, significance 
threshold: P < 0.0025, adjusted for multiple comparisons). Together these studies 
suggest a PCSK6 locus of unknown size, contains the causal variant(s) driving an 
association signal between PCSK6 and handedness. It is possible to define such a locus 
by taking note of the location of the most significantly-associated genetic variants 
uncovered in previous GWA studies (rs11855415 P = 2.0 × 10-8 and rs7182874 P = 8.68 
×10−9, see track D Figure 3.2) and to annotate all SNPs in LD with these variants at that 
locus. Such a locus would encapsulate not just the tagged genetic variants but also the 
causal variant(s). For this purpose I downloaded data from the International HapMap 
project to map the LD among SNPs in the PCSK6 gene. There are two popular LD 
measures provided in the HapMap data, D′ and r2; higher values of each imply stronger 
LD among the SNPs. I used D′ as the basis for partitioning the PCSK6 gene into regions 
of LD since this measure is normalised for allele frequencies, thereby making it better 
suited than r2 for estimating the overall LD across pairs of multi-allelic loci (Zapata, 
2000). 
 
The blue triangle in Figure 3.1 indicates a 12.7 kb block of LD containing 22 SNPs (for 
a zoomed-in version see track D, Figure 3.2) including the highest associated PCSK6 
markers from previous GWA studies and is defined to be in the region 
chr15:101863220-101875949, hg19. This region spans from rs11630012 (within intron 
13 of PCSK6) to rs1871975 (intron 17), and contains intriguing epigenetic markings 
(track C, Figure 3.2) around the highest associated SNP rs11855415 and the VNTR. 
The high LD amongst the 22 SNPs (Appendix B) in the region precludes identifying the 
precise causal variant(s) through association analysis alone. All 22 SNPs are included 
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on the Illumina Omni Express SNP array (as used in the latest Brandler et al. (2013) 
GWAS) and have a minor allele frequency exceeding 5%.  
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Figure 3.1 LD structure of the HapMap North and Western European population (CEPH) at the PCSK6 gene.SNP genotype data for the PCSK6 gene (accession: 
NM_002570) was downloaded from the HapMap data source for the CEU population (Rel28 PhaseII+III Aug10 NCBI36, dbSNP126) and evaluated with Haploview v4.2 
(Barrett et al., 2005). A red box indicates the absolute D prime (D’) between two loci while an empty blue box represents low LD. The navy triangle indicates the 
genomic region harbouring the genetic variants as represented in Figure 3.2.
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Figure 3.2 PCSK6 locus associated with relative hand skills  
(A) PCSK6 is located on chromosome 15q26.3 indicated by the red box (B) Zoomed-in 
view of the PCSK6  region associated with relative hand skill (Brandler et al., 2013, Scerri 
et al., 2011a). A 1.8kbp region (beige box) is predicted to be a regulatory element 
involved in driving transcription in a sense (black transcript, accession DB023826) and 
antisense (green transcript, RP11-299G20.3) direction (C) Tracks from the UCSC Genome 
Browser (http://genome-euro.ucsc.edu) showing Chip-SEQ ENCODE data indicating 
putative promoter activity in (B). From top, the tracks show H3K27Ac and H3K4Me3 
histone marks as determined in different cell lines. The highest peak (violet) indicates 
epigenetic markings in the K562 cell line. The bottom track displays RNA Polymerase II 
binding for the K562 cell line which shows a higher signal compared to other cell lines. (D) 
The genetic associations cluster within a 12.7 kb linkage disequilibrium (LD) block as 
defined by HapMap CEPH data (chr15:101863220 – 101875949). For the purpose of 
clarity only the highest-associated GWAS-detected markers are included here. The black 
bar indicates the rs10523972 VNTR position within the predicted promoter. rs7182874, 
the highest-associated marker in the most recent GWAS (Brandler et al., 2013) is in high 
LD (black diamond) with rs11855415 (Scerri et al., 2011a). A red box indicates the 
absolute D prime (D’) between two loci while an empty blue box represents low LD 
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3.4.2 Allelic effect on transcription factor binding affinity 
 
All 22 SNPs from the HapMap data within the 12.7 kb LD region were tested for allelic 
effects on the loss/gain of TFBSs using the TRANSFAC (Matys et al., 2006) and 
Genomatix MatInspector (Cartharius et al., 2005) databases (Table 3.1). The marker 
rs11855415 was predicted to affect the largest number of TFBSs and is located in close 
proximity (< 500 bp) to a region predicted to act as a secondary bidirectional promoter 
(track C, Figure 3.2), the annotation of which is discussed in the following section 
(3.4.3). The SNP rs11855415 displays the most significant loss/gain of TFBSs on allelic 
variation. It is also worth noting that the VNTR rs10523972 also lies within the same 
12.7 kb LD region and is predicted to have two TFBSs at the junction of each tandem 
repeat; c-Ets-1 is an enhancer-binding protein that activates transcription (Wasylyk et 
al., 1990) while Tel-2 has been shown to be a transcription repressor (Gu et al., 2001) 
however an extensive search of the literature suggests neither TF to function in 
multiplex, a relevant mechanism of action if each tandem repeat were acting as a bind 
site.     
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Table 3.1 In silico TFBS prediction of the PCSK6 locus associated with handedness. Combined TRANSFAC 
(v2014.4) and Matinspector (MatInspector Release 8.0.6) prediction of allelic effects on TFBSs for SNPs 
at the PCSK6 locus associated with the PegQ measure of handedness. 
 
  
SNP allele transcription factors 
rs3825921 A None 
rs3825921 G None 
rs1871975 C None 
rs1871975 T None 
rs1871976 A None 
rs1871976 G None 
rs1871978 C HSF 1 
NF-E2-related factor 1/Transcription Factor MafG 
heterodimers  binding to subclass of AP1 sites 
rs1871978 T MyT1 
RREB-1 
rs9806218 A None 
rs9806218 G None 
rs9806256 C Cardiotrophin-1 
rs9806256 T Nuclear transcription factor Y 
Binding site for a Pbx1/Meis1 heterodimer 
rs4965830 A Homeobox C10/Hox-3iota 
Muscle TATA box 
rs4965830 T Intestine specific homeodomain factor for Homeobox 
protein CDX-1 
Homeobox protein Hox-B9 
Homeobox protein Hox-C13 
Homeobox protein Hox-D12 
rs2220055 A None 
rs2220055 G None 
rs2277593 C None 
rs2277593 G None 
rs2277593 T None 
rs7182874 C Paired box protein Pax-5 
Protein BANP 
Krueppel-like factor 6 
rs7182874 T T-cell acute lymphocytic leukemia protein 1 
rs12901236 C Inhibitor of growth protein 4 
rs12901236 T Inhibitor of growth protein 4 
rs1471656 C None 
rs1471656 T None 
rs1947942 A Xvent-1 protein 
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rs1947942 G None 
rs752028 C None 
rs752028 T Breast cancer type 1 susceptibility protein: Upstream 
stimulatory factor 2 complex 
rs882422 A Krueppel-like factor 6 
rs882422 G Krueppel-like factor 6 
Transcription intermediary factor 1-beta 
BEN domain-containing protein 
rs752026 A None 
rs752026 G None 
rs755867 A None 
rs755867 G None 
rs2073592 C None 
rs2073592 T None 
rs2239858 A Killer cell lectin-like receptor subfamily G member 1 
rs2239858 G Killer cell lectin-like receptor subfamily G member 1 
rs12916087 A None 
rs12916087 G None 
rs12900794 C None 
rs12900794 T None 
rs11855415 A Sex-determining region Y protein 
POU domain, class 6, transcription factor 1 
Homeobox protein Hox-A5 
POU domain, class 4, transcription factor 3 
Homeobox protein BarH-like 2 
POU domain, class 2, transcription factor 1 
Homeobox protein Hox-B3 
LIM-homeodomain transcription factor 
Homeobox protein Nkx-6.3 
DNA-binding protein SATB1 
GS homeobox 1 
Zinc finger protein 333 
rs11855415 T POU domain, class 3, transcription factor 2 
Intestine specific homeodomain factor for Homeobox 
protein CDX-1 
Homeobox B8 / Hox-2delta 
Spalt-like transcription factor 1 
Special AT-rich sequence-binding protein 1, predominantly 
expressed in thymocytes, binds to matrix attachment 
regions (MARs) 
Homeobox D10 
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Figure 3.3 UCSC genome browser tracks indicating TFBSs as assayed by ChIP-seq at the PCSK6 locus of 
interest (chr15:101863220-101875949) according to the ENCODE project datasets (Gerstein et al., 
2012). PCSK6 canonical (accession: NM_002570) and shorter isoform (accession: LN714797) genes are 
displayed relative to the PCSK6-AS1 lncRNA transcript (A). SNPs within the 12.7 kbp region of LD (see 
Figure 3.2 & Table 3.1) (B) lie in close proximity to epigenetic markings (H3K27Ac and H3K4Me3 histone 
marks, (C)) indicative of a bidirectional promoter. Numbering adjacent to the DNAse clusters (D) indicate 
combined data from the peaks of multiple cell lines (from a total of 125 cell types assayed). Green 
vertical bars within the transcription factor bind sites (E) represent DNA binding motifs. ChIP-seq 
experiments were performed by the ENCODE project on 91 cell types, with transcription factors binding 
at the indicated locations in the following cell types: A549 (A), GM12878 (G), IMR90 (I), HeLa-S3 (H), 
HepG2 (L), K562 (K), U87 (u), HEK293 (h), GM12872 (g) and PANC-1 (p).   
  
A 
B 
C 
D 
E 
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3.4.3 Predicted region of secondary promoter 
 
The location of two previously identified genetic variants found to be associated with 
handedness (SNP rs11855415 and VNTR rs10523972) is within a region that displays 
enrichment for histone modifications (track C, Figure 3.2). Specifically, the ENCODE 
project tracks represent epigenetic markings including trimethylation of Lys4 of histone 
H3 (H3K4Me3, associated with promoters that are active or poised to be activated); 
acetylation of Lys27 of histone H3 (H3K27Ac, often found near active regulatory 
elements since its thought to enhance transcription possibly by blocking the spread of 
the repressive histone mark H3K27Me3) and monomethylation of Lys4 of histone H3 
(H3K4Me1, associated with enhancers and with DNA regions downstream of 
transcription starts). As such, the obvious bimodal distribution of both H3K27Me3 and 
H3K27Ac markings at this location are highly suggestive for the presence of a putative 
bidirectional secondary promoter. 
 
Taking an initial spread of 1 kb either side of the H3K27Ac acetylation markings at the 
PCSK6 locus (chr15:101873604-101875513, hg19) I used several databases and 
software algorithms to predict the minimum sequence required to drive transcription in 
both strand directions. From the analysis indicated (Table 3.2), the consensus is that the 
TSS for a bidirectional promoter is located between chr15:101873808-101874718 
(hg19). After primer design considerations that might be required in downstream assays, 
the sequence of interest was extended to 1,806 bps spanning chr15:101873803-
101875608 (hg19).  
 
This putative secondary promoter (beige box, track B, Figure 3.2) is within the vicinity 
of two expressed sequence tags (ESTs) that are potentially driven by it: 1) The RP11-
299G20.3 EST is a suspected long non-coding RNA (lncRNA) type gene, a regulatory 
element transcribed in an antisense direction and suspected to have an effect on gene 
expression on the sense strand (green transcript, track B, Figure 3.2) and 2) the 
DB023826 EST appears to be a 4-exon shorter isoform of the PCSK6 gene (black 
transcript, track B, Figure 3.2). Further characterisation of this suspected secondary 
promoter region is pursued in the chapters which follow. 
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Table 3.2 PCSK6 secondary promoter prediction. Several software packages were used to form a 
consensus of which sequence within an initial 2 kbp spread (chr15:101873604-101875513, hg19) would 
act as a promoter. Note DBTSS and Promoter 2.0 offer predictions on both strands. DBTSS provides a 
visualisation of the TSSs predicted in both a sense and antisense strand direction in Figure 3.4.  
 
  software   strand          TSS                      Notes 
Promoter 2.0 Sense (-) chr15: 101874713 Highly likely prediction (1.091) 
 Antisense (+) chr15:101873983 Marginal prediction (0.57) 
Proscan v1.7 Sense (-) & 
Antisense (+) 
chr15:101873808 Promoter Score: 56.47 (Cutoff = 53) 
MPromDb Sense (-) & 
Antisense (+) 
chr15:101874396-
101874718 
Annotated as a bidirectional novel 
promoter in lymphoblastoid CD4+T cells 
DBTSS Sense (-) chr15:101874407 Cell/tissue: PC3, testis & HEK293 
 Antisense (+) chr15:101874697 Cell/tissue: RERF-LC-MS, testis & 
HEK293 
 
 
 
 
 
 
Figure 3.4 Visualisation of the TSSs annotated in the DBTSS database on both sense and antisense 
strands within PCSK6 intron 14. The total counts track represents TSS capped analysis of gene 
expression (CAGE) peaks which are identified by DPI (decomposition based peak identification) from 
adult testis samples. See http://fantom.gsc.riken.jp/5/ for further details and data exploration. H3K27Ac 
markings are indicative of a bidirectional promoter driving transcription of a short PCSK6 isoform on the 
sense strand (black) and a lncRNA on the antisense strand (green).  
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3.4.4 Evolutionary conserved sequences 
 
The functional importance of the 22 noncoding SNPs previously identified at the 12.7 
kb PCSK6 locus can be explored in terms of constrained elements. Previous analyses of 
conserved noncoding sequences in the human genome (Pennacchio et al., 2006, 
Bejerano et al., 2004) have defined ultraconserved elements among mammals 
(sequences at least 200bp in length that are 100% identical among human/mouse/rat) as 
useful indicators of sequences with an increased likelihood of demonstrating gene 
regulatory activity. This was demonstrated in a recent study by Forrest et al. (2014) who 
showed regulatory regions such as promoters often overlap evolutionarily conserved 
sites in mammals. Interestingly within the 12.7 kb LD region previously identified 
(track D, Figure 3.2), both the known PCSK6 exons and the region encompassing the 
suspected secondary promoter satisfy this definition of ultraconserved elements (track 
B, Figure 3.5). 
 
Of the 22 SNPs identified, only 5 lie within VISTA pair-wise conserved sequences 
across all 14 mammalian genomes (see Appendix B). None of these variants are exonic 
though three SNPs, the GWAS-detected rs11855415, rs12900794 and rs12916087 lie 
within the predicted bidirectional secondary promoter. Apart from rs11855415, none of 
the SNPs are predicted to affect a TFBS (Table 3.1) and as such were discounted from 
downstream functional analysis. Analysis of the rs11855415 SNP reveals that the major 
T allele is conserved across all species except rabbit, while the rs7182874 SNP C allele 
is conserved across all species except mouse, rat and cat (track C, Figure 3.5).  
 
Both the SNP rs11855415 and the VNTR were previously shown to lie within 
epigenetic markings indicative of promoter activity (track C, Figure 3.2) though the 
later also appears to disrupt an evolutionary conserved sequence (black bar, track A, 
Figure 3.5); if this is the case, rather than a sequencing artefact, it would make the 
VNTR an interesting candidate for functional analysis.  
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GGCCCCGCTGG Human TCATTTTTATT 
GGCCCCGCTGG Chimp TCATTTTTATT 
GGCCCCGCTGG Gorilla TCATTTTTATT 
GGCCCCACTGG Orangutan TCATTTTTATT 
GGCCCCACTGA Rhesus TCATTTTTATT 
GGCCCCACTGA Baboon TCATTTTTATT 
GGCCCCATTGG Marmoset TCATTTTTATT 
- - - - - - - - - - - - Mouse ACACTTTTATT 
- - - - - - - - - - - - Rat TCAATTTTAAT 
GGCCCCAGCGG Rabbit -----------------C 
TCCC-CAAGGG Cow TCATTTTTATT 
TCCC-CAGAGG Dog TCATTTTTACT 
T------------------ Cat TCATTTTTACT 
GCCC-CAGGGG Horse TCATTTTTAAT 
 
Figure 3.5 Sequence conservation across a PCSK6 region associated with handedness. (A) Blue track 
displays exons 14 - 17 of the PCSK6 gene (accession: NM_002570) with a shorter PCSK6 isoform (black) 
and antisense lncRNA PCSK6-AS1 (green) originating from a putative secondary promoter. For purposes 
of clarity only the two highest associated SNPs from previous GWAS, rs11855415 and rs7182874 (Scerri 
et al., 2011a, Brandler et al., 2013), are shown above the 100 vertebrate conservation (phastcons) track 
from the UCSC Genome Browser. The VNTR range is represented by a black horizontal bar. (B) Plot of 
conservation spanning between the PCSK6 LD block (chr15:101863220-101875949, hg19) and the 
reference sequences from 13 eutherian mammals. The mVista service was used to visualise alignment 
for the identification of sequence similarity. Pink coloured regions are > 70% conserved and indicate 
conserved non-coding sequence (CNS) between the human and query sequence using a calculation 
window of 100 bp. (C) Aligned sequence from 14 species for SNPs rs7182874 and rs11855415.   
 
A 
B 
C 
81 
 
3.5 Discussion 
 
This chapter describes an approach to define the extent of a PCSK6 locus previously 
reported to be associated with handedness. LD maps are a useful parameter in guiding 
post-GWA functional studies and have been used by researchers to untangle the 
evolutionary history of humans, including population growth and structure, selection, 
genetic drift, migration, recombination rates and mutations (Hedrick, 2011). In this 
chapter, I visually inspected LD patterning at a PCSK6 locus showing association with 
handedness to determine the extent of the association signal and the position relative to 
the PCSK6 gene. I defined a 12.7 kb block containing 22 SNPs in modest to high LD 
(D’ = 0.55 – 1, Appendix B) spanning introns 13 – 17 (chr15:101863220 – 101875949). 
Patterns of LD have been previously known to be noisy where nearby pairs of sites from 
the same region might be in weak LD and pairs of sites that are many kbps apart might 
be in almost complete LD (Wall and Pritchard, 2003). Analysis of the distribution of 
LD across the PCSK6 gene in the CEU population (Figure 3.1) indicates, to the 
contrary, multiple distinct neighbouring regions of LD (for criteria see 3.3.1) separated 
by inferred recombination events (Gabriel et al., 2002).  
 
All 22 SNPs within the 12.7 kb LD region were tested for allelic effects on the loss/gain 
of TFBSs with the marker rs11855415 predicted to affect the largest number of  TFBSs. 
Interestingly some of the TFs predicted to bind at this location are known to have an 
effect during ‘multicellular organismal development’ (GO:0007275) and 
‘anterior/posterior pattern specification’ (GO:0009952) such as HOXA5, HOXB3, 
HOXB8, HOXD10 and HOXB13 (UniProt, 2015). Another TF predicted to bind to the 
A but not the T allele of rs11855415 is a protein known to play a role in the formation 
of radial glia, the cells that provide a scaffold structure for neuronal migration (Kiyota 
et al., 2008). Results from the TFBS predictions suggest rs11855415 to be a primary 
candidate for functional analysis. Combining the identification of sites containing 
known binding motifs with sequences of evolutionary conservation is a powerful 
approach to identifying SNPs which may have a functional effect. Many studies are 
increasingly integrating knowledge of cross-species conserved regions in to the 
selection process when considering SNPs for functional studies – whether it is to 
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identify evidence of eQTLs (Sillé et al., 2012), potential splice sites (Burgess and 
Freeling, 2014) or insertions/deletions (indels) (Ajawatanawong et al., 2012). Five of 
the 22 SNPs appeared within a CNS (see Appendix B), though of these only 
rs11855415 was predicted to contain a TFBS and as such was retained for further 
analysis.  
 
The defined 12.7 kb LD region appears to contain a suspected regulatory element as 
indicated by sequence conservation (UCSC phastcons track, Figure 3.5). Analysis of the 
histone modification markings at the region (track B, Figure 3.2) provides a 
complementary approach; one of the parameters that controls gene transcription is the 
interplay of regulatory events between gene promoters and gene-distal regulatory 
elements called enhancers (Andersson, 2015). Enhancers are typically short (50 - 1500 
bp) sequences of DNA that bind activator proteins which interact at a promoter to begin 
gene transcription. To aid the functional characterisation of this PCSK6 locus and the 
generation of hypotheses it is essential to define the regulatory element as either an 
enhancer or a promoter. Fortunately, ENCODE project data provides distinct chromatin 
signatures for these different regulatory elements; the substantial bimodal distribution 
for H3K27Me3 markings is highly suggestive for the presence of a secondary promoter 
internal to the PCSK6 gene. In contrast, enhancers typically display low H3K4Me3 
markings relative to H3K4Me1 markings. Further evidence suggesting this element to 
be a promoter rather than a strict enhancer is the H3K27Ac and RNAPII markings 
(track C, Figure 3.2) which are much less pronounced at enhancers. 
 
Inspection of the UCSC genome browser indicated there are two spliced expressed 
sequence tags (ESTs) with exons originating at this locus, one in a sense direction to the 
gene, and the other antisense (track B, Figure 3.2). The transcription of such a 
bidirectional gene pair, coupled with the epigenetic markings previously discussed is 
indicative of a bidirectional promoter, a common feature of mammalian genomes 
(Koyanagi et al., 2005). In silico predictions and promoter databases provide further 
support for a bidirectional promoter (Table 3.2 & Figure 3.4) however de novo 
prediction of regulatory elements has its limitations, for example, not all promoters in 
eukaryotes have the same characteristic elements (e.g. a TATA box). I have attempted 
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to offset this limitation with the addition of two curated database services which 
annotate gene promoters identified from ChIP-Seq experiment results (PromDB) and 
the sequencing of cDNA from humans and mice (DBTSS). It should also be noted that 
many tools rely on ENCODE data, which only has a limited scope of certain TFs and 
cell types so a high probability of false positives exists where SNPs might influence 
signals in irrelevant cell types. Ultimately, these in silico tools represent a useful 
starting point to guide the design of functional assays. 
 
From the 22 SNPs, 5 were identified to lie within a CNS when comparing conserved 
sequences across 14 eutherian mammals (rs2073592, rs2277593, rs12916087, 
rs12900794 and rs11855415). Only rs11855415 indicated substantial predicted effects 
on allelic variation (Table 3.1) which in addition to the VNTR lies in close proximity to 
the suspected bidirectional promoter and as such may have a functional effect by 
affecting the transcriptional machinery that can bind at that location and thereby 
modulating transcriptional output. It is reasonable to posit that SNPs within conserved 
regions may be more likely to have phenotypic effects than SNPs in non-conserved 
sequences. In such a context, conserved sequence can be used as a putative annotation 
for genomic regions that may have functional importance, even when the exact nature of 
their function is unknown. The close proximity of rs11855415 and the VNTR to a 
suspected regulatory sequence in a region of strong conservation (phastCons track, 
Figure 3.5) across 13 orthologous species’ sequences is a possible indication of an 
orthologous functional regulatory element that has been evolutionarily conserved. 
Though this regulatory element might be conserved, evidence supports an association 
between bidirectional promoters and lineage-specific novel transcripts in 
mammals (Piontkivska et al., 2009). Furthermore, Gotea et al. (2013) argue that the 
lineage-specific activation of bidirectional promoters is an important mechanism for the 
emergence of novel transcripts which provide a molecular pool for functional 
diversification and adaptive change. 
 
VNTRs display mutation rates up to 100,000 times higher than in other areas of the 
genome (Vogler et al., 2007). The VNTR at the PCSK6 locus was shown to disrupt the 
sequence alignment between humans and all other aligned mammals (track B, Figure 
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3.5), though this finding most likely represents an artefact of genome assembly rather 
than a genuinely novel sequence that has evolved since the last common ancestor of 
humans and chimpanzees. In conclusion, SNP rs11855415 and the VNTR fall in a 
genomic region with relatively higher sequence conservation in 14 mammals 
investigated compared to neighbouring genomic areas. Of the 22 SNPs systematically 
analysed in silico, rs11855415 is predicted to affect the largest number of TFBSs on 
allelic variation - no other SNP shown to lie within a CNS was predicted to affect the 
binding of TFs. In addition, rs11855415 and the VNTR are both predicted to lie within a 
bidirectional promoter. The SNP rs7182874, identified to be significantly associated 
with handedness by Brandler et al. (2013), is not within a CNS or a suspected 
regulatory element. All things considered, both the SNP rs11855415 and the VNTR 
make interesting functional candidates for future analyses. 
 
For now, building on the findings of this chapter I proceed with a functional approach to 
identifying the etiological variant(s) driving the association between a 12.7 kb region of 
LD and handedness, and the role, if any, a 1.8 kb predicted secondary promoter may 
have.   
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4 Functional elements at the PCSK6 locus associated with 
handedness 
4.1 Abstract 
 
Despite the abundance in availability of genome-scale data, the relationship between 
genome sequence and complex trait phenotype is still neither straightforward nor 
entirely understood. A functional analysis of the genetic variants within the 12.7 kb 
PCSK6 locus is preceded in this chapter by a cataloguing of the expression of all the 
RefSeq-recognised PCSK6 isoforms across a battery of cell lines. In Chapter 3 the 
K562 cell line displayed epigenetic markings indicative of an intronic bidirectional 
promoter which my findings here suggest drives the transcription of several novel long 
non-coding RNA (lncRNA) gene isoforms (PCSK6-AS1/2/3) and a previously 
unknown PCSK6 shorter isoform (SI) complete with signal peptide and 3’UTR 
(accession #LN714797). Conformational DNA sequencing has enabled prediction of the 
SI’s protein function and though thought to be inactive and not secreted by the cell, may 
be exerting some phenotypic effect through its predicted growth factor-like binding and 
PLAC domains. Interrogation of the ENCODE project RNA sequencing (RNA-seq) 
datasets suggest the SI is retained in the nucleus in most cell lines, though the human 
embryonic stem cell line (hESC) differed in its predominant export of the SI to the 
cytosol for presumed further processing. Microarray datasets for both the developing 
and adult brains suggest a relatively high expression of the SI in the corpus callosum 
(CC), a region of the brain thought to exert an influence on functional laterality. The 
results I present in this chapter make the 12.7 kb PCSK6 locus associated with 
handedness more amenable to detailed functional studies which will be required to 
characterise the role, if any, of the PCSK6 gene’s isoforms in the development of the 
handedness trait. 
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4.2 Introduction 
 
Strategies for the prioritisation of SNPs from GWAS signals and thus the progression 
from GWAS-identified tagged SNP to functional SNP to mechanism typically begin 
with a linkage disequilibrium (LD) approach as presented in Chapter 3. While the 
region to be functionally annotated can be guided by LD structure, there are challenges 
to this approach if the strength of the correlation between the tagged SNP and the 
functional genetic variant is low due to noise or otherwise. To understand how genetic 
variants identified within the 12.7 kb LD block might affect function, I characterised 
part of the regulatory landscape by analysing histone modification signalling and 
evolutionary conserved sequences. Such an approach yielded a short DNA stretch of 1.8 
kb which was putatively annotated as a bidirectional promoter predicted to drive the 
transcription of a 3-exon Natural Antisense Transcript (NAT) PCSK6-AS1, a lncRNA 
on the antisense strand, and a shorter version of the canonical PCSK6 gene 
(NM_002570) on the sense strand. This shortened PCSK6 isoform (DB023826.1) is 
thought to be four exons in length, the first of which is not included in any other PCSK6 
isoform according to the NCBI Reference Sequence database, RefSeq 
(http://www.ncbi.nlm.nih.gov/refseq/). Little evidence exists for either lncRNA or SI 
transcript in the literature; Kimura et al. (2006) previously detected a single cDNA 
clone of the PCSK6 SI when investigating alternative promoters in adult testis while the 
existence of the PCSK6-AS1 lncRNA was first posited with the release of the 
GENCODE gene sets arising from the ENCODE project (Harrow et al., 2012).  
 
The transcription of two adjacent genes coded on opposite strands, with their 5' ends 
oriented toward one another are known as bidirectional gene pairs (BGPs) (Yang et al., 
2007). In humans, 10% of protein-coding genes and more than half of all expressed 
lncRNAs represent divergent transcription from such promoters (Sigova et al., 2013, 
Trinklein et al., 2004). BGPs are typically expressed in a highly spatial- and temporally- 
specific manner (Djebali et al., 2012) with previous studies indicating a positive 
correlation between the majority of identified sense/antisense gene pairs expressed, 
though inversely correlated pairs are also known to exist (Katayama et al., 2005, 
Morrissy et al., 2011, Mizuta et al., 2013). It is worth noting in the context of PCSK6-
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AS1 that expression of lncRNAs from bidirectional promoters are generally highly 
enriched in neuronal genes (Hu et al., 2014) and human embryonic stem cells (hESCs) 
where > 60% promoters might be bidirectional and associated with divergent 
lncRNAs (Sigova et al., 2013). Conversely, most human promoters are thought to bind 
polymerase complexes in a bidirectional manner and are therefore capable of initiating 
transcription in both strand directions (Wei et al., 2011). Thus, we cannot exclude that 
the presence of lncRNAs at some bidirectional promoters may represent a passive by-
product of gene transcription. In short,  it is still unclear how exactly NATs affect their 
sense counterpart’s RNA expression level though it is likely that other lncRNAs will be 
identified at loci identified by GWASs as more RNA-seq data and methodologies for 
detecting rare transcripts become available (Han et al., 2015). A primary aim of this 
chapter is therefore to confirm and annotate the existence of such a BGP at the 
previously identified PCSK6 locus. 
 
Analysis of expression pattern is often one of the first steps in understanding a gene’s 
function however the novel first exon of the shorter PCSK6 isoform means a paucity of 
datasets from which we can query expression since no microarray data exist which have 
been probed at this genomic location. Fortunately the public availability of the 
ENCODE project’s RNA-seq data allows the detection of alternative splicing and the 
quantification of expression levels down to the level of individual transcript isoform 
(Feng et al., 2013). In higher eukaryotes, the vast majority of protein-coding genes 
express multiple transcript isoforms (Nagasaki et al., 2005) and PCSK6 is known to 
have at least 8 confirmed and annotated isoforms according to RefSeq (see Table 4.1). 
 
PCSK6 is widely expressed in humans, with particularly high expression in the liver, 
spinal cord (Figure 1.3) and corpus callosum (CC, the broad band of nerve fibres 
joining both hemispheres, Figure 4.1). Callosal involvement has long been suspected in 
neurodevelopmental disorders such as autism (Frazier et al., 2012), ADHD (Paul, 2011) 
and dyslexia; the CC in dyslexic individuals is of different size and shape (von Plessen 
et al., 2002, Hynd et al., 1995) and inter-hemispheric transfer is less efficient compared 
to normal subjects (Sotozaki and Parlow, 2006). The callosal transfer deficit hypothesis 
(Fabbro et al., 2002) suggests dyslexia may be accounted for by an abnormal CC and, 
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consequently, defective transfer and direction of neural impulses in the brain which are 
responsible for anomalous performance e.g. in written language processing. 
Interestingly, the front portion of the CC has been reported to be 11% larger in left-
handed and ambidextrous people than right-handed people (for a meta-analysis see 
Driesen and Raz (1995)). If previous research suggests both dyslexia and handedness 
are influenced by the size and function of the CC, then might there be a pleiotropic gene 
or function of the CC influencing both phenotypes simultaneously?  
 
Although a significant proportion of transcript isoforms are most likely the result of 
noise in the splicing process (Chern et al., 2006, Melamud and Moult, 2009), several 
prominent examples of isoform switching resulting in a large impact on cellular 
phenotypes are known to exist in the mammalian brain (da Cruz e Silva et al., 1995, 
Cheung et al., 2007). For example, Flames et al. (2004) demonstrated different isoforms 
of Neuregulin-1 (NRG1), a schizophrenia candidate gene involved in controlling 
neuronal migration, are expressed in the developing cortex. Intriguingly, NRG1 is 
involved in glycogen synthase kinase 3 (GSK3) signalling, disruption of which affects 
many fundamental processes of brain development (Lovestone et al., 2007). 
Furthermore, Hur and Zhou (2010) showed that only one of the GSK3 isoforms is 
expressed specifically in the nervous system, with the highest levels found during 
development. While the functional relevance of most spliced isoforms localised to the 
brain or otherwise, remains unknown (Tress et al., 2007), these findings demonstrate 
the importance of analysing altered isoform expression rather than considering just the 
canonical gene expression in developmental traits and diseases. As a consequence, this 
chapter will explore PCSK6 isoform expression in both the developing and adult human 
brain, with a particular emphasis on the CC.  
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Figure 4.1 The human corpus callosum. Sagittal and anterior view of the human cerebrum within which 
the corpus callosum marked in red connects both hemispheres via a thick band of nerve fibres   
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Table 4.1 PCSK6 canonical and spliced isoforms according to RefSeq. Length of the isoform is given in base pair (bp) cDNA and translated protein amino acid (AA) 
length. Signal peptide prediction was provided by the SignalP 3.0 service (Bendtsen et al., 2004). Comments supplemented by RefSeq (accessed August 2015). See 
Figure 4.2 for a visual representation of the isoforms.  
 
Accession 
Number 
RefSeq Isoform Length 
(bp,AA) 
Enzymatically active Signal 
Peptide 
Comments 
 NM_002570 PACE4A-I  992,969 Yes, secreted Yes Encoding the predominant canonical isoform, PACE4A-I precursor protein seems to exist in the reticulum 
endoplasmic as both a monomer and a dimer-sized complex whereas mature PACE4A-I exists only as a 
monomer, suggesting that propeptide cleavage affects its tertiary or quaternary structure. Isoform PACE4A-I 
is expressed in heart, brain, placenta, lung, skeletal muscle, kidney, pancreas, but at comparatively higher 
levels in the liver.  
 NM_138319 PACE4A-II  998,956 Yes, secreted Yes PACE4A-II is at least expressed in placenta. 
 NM_138320 PACE4E-II  927,962 Possibly,  Retained 
intracellularly 
Yes 
 
 
Endomembrane system; Peripheral membrane protein. Note=Retained intracellularly probably through a 
hydrophobic cluster in their C-terminus. Isoform PACE4E-II is at least present in cerebellum. 
 NM_138321 PACE4E-I  921,975 Possibly,  Retained 
intracellularly 
Yes 
 
Endomembrane system; Peripheral membrane protein. Note=Retained intracellularly probably through a 
hydrophobic cluster in their C-terminus. Isoform PACE4E-I is expressed in cerebellum, placenta and 
pituitary 
 NM_138324 PACE4C  128,652 Probably not, not 
secreted 
Yes Not secreted, remains probably in zymogen form in endoplasmic reticulum. Placenta. 
 NM_138323 PACE4CS  368,623 Probably not, not 
secreted 
Yes Not secreted, remains probably in zymogen form in endoplasmic reticulum 
 NM_138325 PACE4D  341,497 Probably not, not 
secreted 
No PACE4D is at least expressed in placenta. 
 NM_138322 PACE4B  611,487 Probably not Yes Predicted to be secreted 
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The choice of cell type is important when considering any functional analysis of 
candidate genetic variants since regulatory elements such as bidirectional promoters are 
known to be highly tissue- and cell-type specific (Kippner et al., 2014). For example, a 
recent study detailed very different activities of eleven enhancers across four mammary 
epithelial cell lines, emphasising the necessity of performing these assays in various 
cellular contexts (Rhie et al., 2013). An essentially healthy, non-aberrant tissue is 
perhaps the hardest context to replicate and maintain in a laboratory situation; many of 
the cell lines used throughout this study are cancerous in etiology (e.g. HeLa, SH-
SY5Y), used here not by design but rather for practical purposes; the myeloid cell line 
K562 is a less than ideal model for neurogenesis however the cells are well-documented 
and easy  to culture/transfect and so can be used in experiments in which the macro 
behaviour of the cell itself per se is not of interest. Several curated databases such as the 
Human Protein Atlas (Uhlen et al., 2015)  do exist in which PCSK6 expression in 
individual cell lines is detailed (Figure 4.3) however such databases tend to aggregate 
RNA expression across all transcripts rather than offer specific expression profiles for 
individual isoforms. Therefore an empirical assessment of PCSK6 isoform expression 
across multiple cell lines is required if we are to understand the role, if any, of the 
PCSK6 SI.  
In summary, by using multiple techniques this chapter will annotate in detail a locus of 
the PCSK6 gene associated with handedness which is predicted (see Chapter 3) to 
contain a bidirectional promoter driving expression of a lncRNA (PCSK6-AS1) and a 
shorter PCSK6 isoform (DB023826). To begin analysing the PCSK6 locus in a 
functional capacity requires the compilation of a catalogue of PCSK6 isoforms across 
various cell lines (4.4.1). Confirmation of the existence of the SI and lncRNA involved 
Polymerase Chain Reaction (PCR) assays and Sanger sequencing (4.4.2 and 4.4.6). 
Acquiring the cDNA sequence also enabled estimates of protein structure and therefore 
function (4.4.3), if any, in addition to a querying of RNA-seq and microarray databases 
for gene isoform expression profiling (4.4.4 and 4.4.5). The shorter PCSK6 isoform is 
predicted to express a novel exon and little proof of its existence is evident in the 
literature, however inference from existing gene expression data is possible (4.4.4).   
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4.3 Methods 
 
4.3.1 PCSK6 isoform profiling 
 
Analysis of PCSK6 gene isoform expression was performed by extracting and purifying 
total RNA (tRNA) from the range of cell lines indicated in Figure 4.2 (RNeasy Mini 
Kit, Qiagen) which were all cultured according to ATCC guidelines except for the H9 
hESC-derived cells which were cultured according to the manufacturer’s instructions 
(Life Technologies). Five μg of DNase-treated RNA (Ambion DNA-free Kit, 
Invitrogen) was used for cDNA synthesis using random hexamer primers as part of the 
Superscript III assay (Invitrogen). Each PCSK6 isoform was PCR amplified as follows: 
MyTaq™ DNA Polymerase (Bioline) was used for PCR reactions (4 μl Buffer Master 
Mix, 1 μl cDNA, 400 nM of each primer, 1 Unit Taq polymerase and made up to 20 μl 
with H2O) with the following conditions: 60 s at 95 °C followed by 40 cycles of 10 s at 
95 °C, 20 s at 60 °C, 30 s at 72 °C before finishing with 5 min at 72 °C. 1 μl of 6 X 
Orange-G loading dye was added to 5 μl PCR product and run on a 0.8% TAE agarose 
gel. PCR product clean-up was performed (2 μl of ExoSAP-IT for every 5 μl PCR 
product, 37 °C 15 min then 80 °C 15 min) before confirming all sequences by Sanger 
sequencing (DNA Sequencing and Services, Dundee). To minimise technical variation 
all cell lines were profiled using the same amount of starting tRNA, an equal amount of 
template cDNA in PCR and run on the same thermal cycler together. All primers 
throughout this project were designed using Primer3 (Rozen and Skaletsky, 2000), 
tested for primer specificity with Primer-BLAST (Ye et al., 2012) and are listed in 
Appendix A. 
 
4.3.2 PCSK6-AS annotation 
 
RNA extraction, cDNA synthesis and PCR components were all conducted as above. 
The primer pair 5’-GGTGCAGAAAACAAGCCTG and 5’-
CTTCCCTGCTGGCGTTTTTG was originally used to detect PCSK6-AS1 (spanning 
intron 1 from exon 1 to exon 2 of PCSK6-AS1, see Figure 4.12). When it became 
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apparent there was more than one PCSK6-AS isoform I designed the primer pair 5’-
GGTGCAGAAAACAAGCCTG 5’-AAAGGCAGGAAAACCAAAGT and 5’-
GGTGCAGAAAACAAGCCTG 5’-TGCCAAAAGAGTTATAGGTGATT to 
distinguish between PCSK6-AS1 and PCSK6-AS2/3 lncRNA respectively. Conditions 
for both PCRs were as follows: 60 s at 95 °C followed by 40 cycles of 15 s at 95 °C, 15 
s at 56 °C, 20 s at 72 °C before finishing with 5 min at 72 °C. 1 μl of 6 X Orange-G 
loading dye was added to 5 μl PCR product and run on a 1.8% TAE agarose gel. Bands 
were excised using QIAquick Gel Extraction Kit (Qiagen) according to the 
manufacturer’s instructions, quantified on a Nanodrop 2000 and diluted to 20 ng/μl for 
Sanger sequencing (DNA Sequencing and Services, Dundee).  
  
4.3.3 RNA-seq analysis  
 
For RNA-seq analysis of the PCSK6 SI’s novel exon RNA-seq BAM files from Cold 
Spring Harbor Laboratories and Caltech were downloaded from the ENCODE 
Consortium’s UCSC data source (http://genome.ucsc.edu/ENCODE/downloads.html). 
All RNA reads were more than 200 nucleotides in length and were obtained as short 
reads from the Illumina GAIIx platform. The average depth of sequencing was ~200 
million reads (100 million paired-ends). Biological replicates across multiple cell lines 
were obtained representing Poly-A+ and Poly-A- RNA from whole cells and subcellular 
compartments where available. For more information on ENCODE library preparation 
and sequencing methodology refer to Parkhomchuk et al. (2009). BWA v0.7.12 was 
used for mapping raw sequences against the human genome (hg38), after which 
SAMtools v1.2 was used for post-processing all RNA sequence read alignments in the 
BAM format. SAMtools view facility enabled the alignment of the 5 PCSK6 exons 
listed in Table 4.3. A shell script was developed with the help of Dr Miguel Pinheiro for 
the quantification of RNA-seq reads (Appendix F). For the RNA-seq analysis of 
PCSK6-AS1 I used the Human Body Map data: RNA-seq reads for over 16 tissue types 
were made publicly available by the EMBL-EBI 
(http://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-513/) and visualised via the 
NONCODE database (Xie et al., 2014). Briefly, RNA was prepared for sequencing as 
follows: 1 µg of tRNA was subjected to two rounds of oligo-dT beads binding. Purified 
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mRNA was fragmented and random primed for cDNA synthesis. cDNA fragments were 
end repaired, dATP added, and ligated to the Illumina pair-end sample prep adaptor. 
The ligated material was amplified by PCR for 15 cycles, and used for Illumina 
sequencing on a HiSeq 2000. A full protocol is detailed in Derrien et al. (2012). 
Additional samples submitted by the Rinn lab (Harvard) were also represented in Figure 
4.11. These RNA-seq reads were also paired end but were sequenced on an Illumina 
GA2 rather than a Hiseq 2000, with 50,000 reads per sample. Full details for the Rinn 
lab samples submitted can be found in Cabili et al. (2011). 
 
4.3.4 PCSK6 isoform expression in the developing and adult human brain 
 
PCSK6 gene expression in the developing human embryonic brain was performed by 
querying early-late prenatal (8-38 post-conception weeks, PCWs) developmental 
transcriptome data of the Brainspan project 
(http://www.brainspan.org/rnaseq/search/index.html). Prenatal LMD microarray data 
for a male donor (H376.IIIA.02) aged 15 PCWs was also interrogated 
http://www.brainspan.org/lcm/search/index.html. Expression analysis of the SI in the 
adult human brain (Donor H0351.2001: 24 year old male) was performed using the 
Allen Brain Atlas (http://www.brain-map.org/).Relevant PCSK6 probes from the 
datasets were A_23_P151907, A_23_P390006, A_24_P189997 and 
CUST_9258_PI416261804.  Gene expression was viewed using the Brain Explorer 2 
(v2.3.5). For additional corpus callosum analysis pre-mRNA splicing patterns of 
PCSK6 in various tissues was available from an independent microarray dataset (NCBI 
dataset record GDS832). Oligonucleotide probes 36 nucleotides in length, centrally 
positioned with respect to each exon-exon junction were designed for all human RefSeq 
mRNA sequences having at least one exon-exon junction. For further details on library 
preparation see Johnson et al. (2003). 
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4.4 Results 
 
4.4.1 PCSK6 isoform profiling 
 
To define which cell lines might be suitable for the functional analysis of genetic 
variants at the PCSK6 locus I began by cataloguing alternatively spliced PCSK6 mRNA 
isoforms across a broad range of cells representative of brain and non-brain tissues alike 
(Figure 4.2). Different protein isoforms are generated through alternative splicing of 
pre-mRNA and genes tend to express many isoforms simultaneously (Djebali et al., 
2012). By analysing the different gene isoforms observed within and across cell lines 
we can also discern in which cell/tissue type the novel short PCSK6 isoform may be 
expressed; if a cell line does not express isoforms containing exons downstream of the 
bidirectional promoter (i.e. lanes 2-5, all panels, Figure 4.2) then it is unlikely to express 
the PCSK6 SI either. 
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Figure 4.2 PCSK6 isoforms tested for expression in multiple cell lines. Only the 3’ end of all transcripts 
has been included in the UCSC RefSeq tracks in blue since all recognised RefSeq isoforms share the same 
PCSK6 5’ end. Dashed red line marks the approximate location of the bidirectional promoter and the 
novel exon. The canonical PCSK6 gene is labelled PACE4A-I. cDNA for the following cell lines was used 
for expression analysis: SH-SY5Y (A), RPE-1 (B), K562 (C), hNSC (D), HeLa (E), HEK293 (F) and 1321N1 (G). 
Lanes in each of the agarose gels are (Lane 2)PACE4-AI 998 bp, (3)PACE4-AII 992 bp, (4)PACE4E-II 927 
bp, (5)PACE4E-I 921 bp, (6)PACE4C 128 bp, (7)PACE4CS 368 bp, (8)PACE4B 341 bp, (9)PACE4 611 bp and 
(10) β-Actin positive control 352 bp. The 100bp Gene O’Ruler (Lane 1) is marked by a grey triangle at 
500bp in panel A. The blue arrow indicates exon 13 of the canonical PCSK6 gene. 
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Figure 4.2 shows the neuroblastoma SH-SY5Y (Panel A) and non-neuronal RPE-1 (B), 
K562 (C) and HEK293 (F) cell lines to express to varying degrees all eight PCSK6 
isoforms discussed in Table 4.1. Only 3 isoforms are expressed in all cell lines; 
PACE4CS, PACE4B and PACE4D, and all are upstream of the predicted bidirectional 
promoter (red line, Figure 4.2). The astrocytoma glial 1321N1 is the only cell line not to 
express the canonical PCSK6 isoform at a detectable level (Lane 2, Panel G, Figure 
4.2). However the primary difference between all 7 cell lines appears to be the extent of 
which bands in lanes 5 and 6 (isoforms PACE4E-I, and PACE4C respectively) are 
expressed. For example neither hNSC nor HeLa express these spliced isoforms while 
both K562 and HEK293 display an additional unidentified band in lane 6, possibly a 
hitherto unknown spliced isoform. It is worth noting lane 6 (PACE4C) is the isoform 
immediately upstream of the genetic variants associated with handedness (rs11855415, 
VNTR) and the predicted bidirectional promoter.  
 
The broad range of isoform expression coupled with the histone modification markings 
discussed in Chapter 3 (Figure 3.2) and the comparatively high protein expression as 
indicated by the Human Protein Atlas data in Figure 4.3 makes K562 a suitable 
candidate cell line for the functional testing of genetic variants within PCSK6. 
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Figure 4.3 PCSK6 expression across a range of cell lines according to the Human Protein Atlas (HPA). The 
HPA (Uhlen et al., 2015) displays the RNA-levels in purple bars for each cell line, which represent an 
aggregate expression of multiple isoforms expressed in that cell line. The cell lines are ordered according 
to cellular origin. RNA values are represented as FPKM (Fragments Per Kilobase of transcript per Million 
fragments sequenced) and further described here: 
http://www.proteinatlas.org/about/assays+annotation#rna 
 
4.4.2 Annotating the PCSK6 SI 
 
Analysis of the PCSK6 isoforms also shows the canonical gene’s exon 13 (blue arrow, 
Figure 4.2) to be present in all cell lines and therefore acts as a useful marker; the novel 
exon of the shorter PCSK6 isoform is predicted to be the first of that transcript and a 
PCR using a primer pair (green arrows & Panel C, Figure 4.4) spanning from the novel 
exon to exon 13 demonstrates the novel exon is not part of a longer known isoform but 
belongs to a transcript whose transcriptional start site (TSS) originates within the 
bidirectional promoter. A second primer pair spanning from the novel exon to the 
3’UTR of the canonical PCSK6 gene (yellow line, Figure 4.4) further indicates the 
shorter PCSK6 isoform not to be four exons in length as previously thought (Kimura et 
al., 2006) but fully extends the full length of the PCSK6 gene. Sanger sequencing of the 
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PCR product (accession #LN714797) confirmed the PCSK6 SI isn’t a truncated product 
of random bidirectional promoter activity, but a full-length gene isoform complete with 
3’ UTR and poly-A tail. This PCR analysis provided the first evidence that the predicted 
bidirectional promoter within a locus associated with handedness is driving 
transcription of a novel PCSK6 SI. 
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Figure 4.4 Annotating the shorter PCSK6 isoform.All PCR assays used oligo d(T) cDNA derived from 
multiple cell lines; K562 (Lane 2, HeLa(3), 1321N1(4), hNSC(5) and SH-SY5Y(6). In panels A&B there are 
two ladders; black triangle indicates 1,000 bp on a 1 kb NEB ladder in lane 1, 100 bp Gene O’Ruler ladder 
in lane 8. In panels C&D a white triangle indicates the 200 bp step on a 50 bp NEB ladder. (A) Represents 
the PCR product of the light blue arrows, the primer pair used for gene expression analysis of the novel 
PCSK6 SI (#LN714797). This product (1,247 bp) spans from the first exon of the novel SI to the 3’UTR of 
the canonical PCSK6 gene. The yellow line indicates the full extent of the transcript, exceeding the four 
exon length previously found (Kimura et al., 2006) (B) A β-Actin primer pair (product 353 bp) was used 
as a positive control for cDNA synthesis (C) PCR product of the green arrows which represent the primer 
pair (product approximately 300 bp) used to indicate the shorter PCSK6 isoform does not share the 
upstream exon 13 belonging to the canonical PCSK6 gene (D) PCR product of the dark blue arrows which 
indicate a primer pair used as a positive control to demonstrate a product of 211 bp spanning exon 13 
and 14 was present in all but one of the cell lines tested (1321N1, Lane 3). See Appendix A for all 
labelled primer sequences. Labelled are the PCSK6 isoforms of relevance (see Figure 4.2).  
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4.4.3 PCSK6 SI protein prediction 
 
The function of the PCSK6 SI is still unknown, however sequencing of the SI (blue 
arrows, Figure 4.4) provides a 9-exon 1.2 kb sequence (Chromosome 15: 101305125-
101334254, see Appendix C.3) which can be translated and used as the basis for 
function prediction according to Interproscan (Mitchell et al., 2015), thereby enabling 
the functional analysis of the SI by classifying the sequence into known families, 
predicting domains and cleavage sites in the process (Figure 4.5). 
  
 
 
 
 
Figure 4.5 The predicted protein domains of the PCSK6 isoforms.The top panel displays the canonical 
isoform (A) and the bottom panel displays the shorter PCSK6 isoform (B) as identified by Interproscan. 
The amino acid (aa) length on the x-axis indicates the location of each predicted domain. The active sites 
predicted by the Scanprosite software (de Castro et al., 2006)) at aa 205, 246 and 420 are shown (black 
diamonds): these represent conserved aspartate, histidine and serine – the catalytic triad. Protein 
sequences for both isoforms are included in the Appendix C.4. See Table 4.2 for additional protein 
properties.  
A 
B 
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Several substantial differences are predicted to exist between the canonical PCSK6 
protein (4,409 bp/969 aa) and the SI (1,222 bp/362 aa). As a proprotein convertase 
PCSK6 is synthesised as an inactive precursor (or ‘zymogen’) that is chaperoned 
through the cell by its prodomain, of which the SI lacks. Prodomains are known be 
involved in protein folding and activation (Thomas, 2002), the loss of which results in a 
lack of an autoproteolytic initial cleavage step thereby rendering the protein inactive and 
localised to the endoplasmic reticulum (Leduc et al., 1992). For the full length 
canonical PCSK6 protein this is followed by a pH- and calcium-dependent cleavage 
event in the trans-Golgi network–endosomal compartments that completes its activation 
(Anderson et al., 2002). The SI is also predicted to lack a catalytic domain which 
contains the catalytic triad necessary for cleavage. Both PCSK6 isoforms are predicted 
at a minimum to have a signal peptide/transmembrane domain at the N-terminus (Table 
4.3) which directs translocation in to the endoplasmic-reticulum (ER), an insulin-like 
growth factor domain which confers protein-protein interaction properties and directs 
cell surface tethering and a PLAC (protease and lacunin) domain, a Cys-His-rich 
domain of about 40 residues at the carboxyl-terminus.  
 
In short, analysis of the SI at a predicted protein level suggests its molecular function 
may involve a growth factor receptor domain IV (Figure 4.5 & Table 4.2), the fourth 
extracellular domain common in all receptor tyrosine protein kinases which influences 
the regulation of ligand binding to receptor domains (Cho and Leahy, 2002).  
 
 
 
 
 
 
 
 
 
 
 
103 
 
Table 4.2 Properties of the canonical PCSK6 protein and the predicted shorter PCSK6 isoform 
 
Protein PCSK6 (NP_002561.1) 
PCSK6 SI 
(#LN714797) 
Gene Isoform PACE4A-I To be confirmed 
Length  
(cDNA bp/protein aa) 
4409bp/969 aa 1222bp/362 aa 
Biological Process Release of mature proteins from their 
proproteins by cleavage at the 
RX(K/R)R consensus motif 
None predicted 
PTM (aa) Phosphorylation: 
S291,Y298,S303,Y637,T755,S757, 
T815 
Unknown 
 Ubiquitylation: K136  
 Glycosilation: N259, N914, N932  
Molecular Function Peptidase_S8 (PF00082) 
P_proprotein (PF01483) 
S8_pro-domain (PF16470) 
GF_recep_IV (PF14843) 
PLAC (PF08686)  
GF_recep_IV 
(PF14843) 
PLAC (PF08686) 
Signal peptide Prediction: Yes 
Probability: 0.999 
Prediction: Yes 
Probability: 0.958 
Enzymatically active Yes, secreted Unknown 
 
Note: ExPasy Translate (http://web.expasy.org/translate/) was used to translate DNA to the equivalent 
amino acid sequence. Post translational modification (PTM) identification was via the curated 
Phosphosite service (www.phosphosite.org, Hornbeck et al., 2004) and the molecular function was 
predicted using Pfam (pfam.xfam.org, Finn et al., 2014). Signal peptide 
(http://www.cbs.dtu.dk/services/SignalP-3.0/, reference here) predicted cleavage probability. The 
protein sequences used to predict the properties for both isoforms are included in the Appendix C.4.    
 
 
4.4.4 RNA-seq and microarray analysis of the PCSK6 SI 
 
Given the predicated catalytic inactivity of the SI at the protein level, I focused my 
analysis on whether the SI might have a regulatory effect at the RNA level and the 
cellular subcompartment in which this might occur since an interrogation of different 
subcellular RNA fractions can provide a snapshot of the status of an mRNA transcript 
along the RNA processing pathway. The large dynamic range, public availability of data 
and the ability to detect previously unknown transcripts means RNA-seq is the method 
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of choice for the profiling of the novel first exon, a sequence of mRNA that 
differentiates the SI from all other known PCSK6 isoforms. Five sequences were 
designed for querying the ENCODE Consortium’s RNA-seq data which enabled 
quantification of exons upstream and downstream of the novel exon (Table 4.3 & 
Figure 4.6) in separate cellular fractions (nucleus, cytosol and whole cell). The analysis 
of RNAs isolated from different subcellular fractions also provides data concerning 
compartment-specific relative steady-state abundance and the post transcriptional 
processing state for each of the detected transcripts. For example, the ENCODE RNA-
seq data also divides quantification in to poly(A)+ (enriched with mature mRNA) and 
poly(A)- signals (a variety of other RNA types such as pre-mRNA and ncRNA which 
usually lack a poly(A) tail). Attached to the 3’ end of mRNAs, the poly(A) tail protects 
the mRNA molecule from enzymatic degradation in the cytoplasm and aids in 
transcription termination, nuclear export and translation (Guhaniyogi and Brewer, 
2001).   
 
 
Table 4.3 RNA-seq probes for the PCSK6 regions of interest. PCSK6 sequences were designated for 
interrogating the ENCODE RNA-seq datasets for quantification of the novel SI exon (3) and exons 
upstream (1,2) and downstream (4,5). Sequence probe locations were based on previous PCR primer 
sequences used in the ‘PCSK6 isoform profiling’ assay (see Figure 4.2) and as such known to be 
expressed. 
 
number exon of canonical PCSK6 location (chr15,hg38) span (bp) 
1 1 of 22 (5’UTR) 101489374-101489984 611 
2 7 of 22 101398404-101398576 173 
3 Not Applicable 101334191-101334254 63 
4 17 of 22 101324850-101325046 197 
5 22 of 22 (3’UTR) 101303928-101305355 1428 
 
 
 
 
 
 
Figure 4.6 RNA-seq probes for PCSK6 regions of interest. Red boxes indicate the location of the RNA-seq 
probes discussed in Table 4.3 
 
105 
 
Interrogation of the RNA-seq database indicates a consistent bias in the number of reads 
quantified at the 3’ UTR in all cell lines (Table 4.4). This most likely relates to selection 
bias due to RNA fragmentation during the poly(A) mRNA selection before the random 
priming cDNA synthesis. This inverse relationship between RNA stability and bias 
towards 3' UTRs is an effect well documented in the literature (e.g. Wang et al. (2012)) 
and especially prevalent when a combined oligo-dT and random hexamer approach is 
used during cDNA synthesis, as is the case for the ENCODE RNA-seq datasets. A bias 
towards reads mapping to the 3’ UTR can also occur due to the often larger size of the 
3’UTR in comparison to other exons.  
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Table 4.4 RNA-seq raw reads count for multiple PCSK6 exons. Each numbered entry indicates average 
count value of raw sequencing reads mapped to the respective exon in each cell line (see Table 4.3 & 
Figure 4.6 for probe locations).  
 
 
Note: Single 75 nucleotide (nt) directed reads and paired 75nt reads were combined to give an average 
value for mRNA with (Poly+) and without (Poly-) a Poly-A tail. Source data was provided by the ENCODE 
project Cold Spring Harbour lab and where marked (*), Caltech. Heat map indicates low (green) to high 
(red) expression levels. 
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Previous findings which suggest a signal peptide for K562 cell mRNAs containing the 
novel exon (Table 4.2) are not at odds with the results in Table 4.4; in the K562 RNA-
seq data 6.25 reads quantified have a poly(A) tail (compared to 11.25 poly(A)- reads), 
indicating possible export to the cytoplasm.  
 
So far a mixed picture emerges for the possible function of the SI: protein analysis 
suggests an inactive enzyme with a signal peptide that is probably not secreted but is 
predicted to possess a domain which influences the regulation of ligand binding to 
receptor domains. RNA-seq data allows for an export of SI mRNA to the cytoplasm in 
human embryonic stem cells, though in other cell lines a substantial bias exists for 
poly(A)- transcripts, indicating likely retention in the nucleus for, as yet, unknown 
reasons.  
 
This cursory finding, that the nuclear export of the short isoform is dominant in hESCs 
only, is curious in the context of the known role PCSK6 plays in the left-right axis 
determining pathway during embryonic development. An extensive search of the 
scientific literature provides minimal elucidation on PCSK6 isoform expression in the 
developing embryo though several recent large scale efforts such as the Brainspan atlas 
(BrainSpan, 2011) allow a survey of gene expression in specific brain regions. 
 
The Brainspan atlas of the developing human brain uses post-mortem human brain 
specimens for studying transcriptional mechanisms and gene expression involved in 
human brain development. Figure 4.7 displays the results following an interrogation of 
the Brainspan atlas RNA-seq dataset for the canonical PCSK6 gene expression across 
20 donors. Results are displayed in a tempo-spatial manner according to anatomical 
region and developmental period (8-38 PCWs). A first inspection of the data show 
PCSK6 is expressed primarily in the hippocampus (HIP) up to and including 13 PCWs 
after which expression shifts to the medial frontal cortex (MFC) and cerebellar cortex 
(CBC). There is also a spike in PCSK6 expression at week 16 in the dorsolateral 
prefrontal cortex (DFC), primary motor cortex (M1C) and ventrolateral prefrontal 
cortex (VFC). 
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Figure 4.7 PCSK6 gene expression in the developing human embryonic brain. (A) PCSK6 gene expression is displayed according to developmental transcriptome data of the 
Brainspan project and organised by anatomical region with blue boxes indicating higher relative expression in the Medial Frontal Cortex ((3) MFC, pink arrow), 
Hippocampus ((10), HIP, light blue arrow) and Cerebellar Cortex ((14), CBC, dark blue arrow) throughout the developmental period 8-38 PCW. Other regions interrogated 
are numbered as follows: (1) Dorsolateral prefontal cortex, (2) Ventrolateral profontal cortex, (4) Orbital frontal cortex, (5) Inferior parietal cortex, (6) Primary auditory 
cortex, (7) Posterior superior temporal cortex, (8) Inferolateral temporal cortex, (9) Primary visual cortex, (11) Amygdaloid complex, (12) Striatum, (13) Mediodorsal 
nucleus of thalamus (B) PCSK6 gene expression is displayed by developmental period. The heat map represents the normalised gene level RNA-Seq expression data in 
RPKM (Reads Per Kilobase of exon model per Million mapped reads) ranging from lower expression (dark blue) towards higher expression (light blue/turquoise). 
Dorsolateral prefrontal cortex (DFC), primary motor cortex (M1C), ventrolateral prefrontal cortex (VFC). Colour map scale ranges from dark blue (- log2 RPKM: 0.13) to 
bright turquoise (- log2 RPKM: 2.7).  
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The Brainspan atlas also provides for the analysis of gene isoform expression in the 
developing embryonic brain via exon microarray datasets (Figure 4.8). Four probes 
were available for PCSK6 gene expression analysis; 3 upstream of the novel exon and 1 
at the 3’ UTR. Such an arrangement allows an approximate estimation of the 
distribution of the SI throughout the brain’s anatomical regions since, unlike previous 
RNA-seq analysis, higher expression of the 3’UTR probe (A_23_P151907) isn’t likely 
to be a bias of cDNA synthesis since the RNA was fragmented in such a way so as to 
provide a more even distribution of reads across the length of the RNA molecules. In 
addition, random hexamer rather than oligo-dT primers were used throughout first-
strand cDNA synthesis. 
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Figure 4.8 PCSK6 expression in the developing human brain (A) The location of the 4 PCSK6 probes as 
used in the Brainspan prenatal LMD microarray are displayed in the UCSC genome browser 
(A_23_P151907, A_23_P390006, A_24_P189997 and CUST_9258_PI416261804). The shorter PCSK6 
isoform LN714797 (black) is included relative to the 3’ end of PCSK6 (blue) (B) Indicates PCSK6 probe 
expression in the corpus callosum (CC) in a male donor (H376.IIIA.02) aged 15 PCW. Microarray data is 
presented in a heat map format in the green - red scale; green represents low expression values while 
red represents high expression values. CC region displays higher expression of the 3’UTR probe 
(A_23_P151907) than probes upstream. Other brain regions displayed are neocortex (NCX), 
hippocampus (HIP), amygdala (AMY), medial dorsal nucleus (MD) and cerebellar cortex (CBC). Colour 
map FPKM values range from bright green (- z-score: -1.93, log2 intensity: 0.78) to bright red (- z-score: 
3.05, log2 intensity: 7.78). 
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On the whole, the neocortex (NCX) and HIP show equal expression of probes placed at 
the 3’UTR and the 5’ end of the gene. This differs to both the corpus callosum (CC) and 
CBC, which display a marked difference in expression between the higher expression of 
3’UTR probe (A_23_P151907) and the relatively lower expression of all other probes 
upstream of the novel exon. In this context, the previous Brainspan RNA-seq signal 
(track B, Figure 4.7) indicating PCSK6 expression in the CBC in the late prenatal 
developmental period (16 - 24 PCWs), may be driven in part by the shorter PCSK6 
isoform. 
 
The Allen Brain Atlas microarray analysis of PCSK6 isoform expression in adult 
human brain also displays relatively high expression in the CC of a probe downstream 
to the novel exon (track A&B, Figure 4.9). The blue tone of Figure 4.9 track D indicates 
a lower expression of the full length probe relative to the shorter probe visualised in 
track C. This graphic interpretation of probe quantification provides further 
confirmation of transcripts probed at the 3’ UTR to be more abundant across the 
midbrain, CC and spinal cord.  
 
Finally, I accessed an independent microarray dataset (NCBI dataset record GDS832, 
Johnson et al. (2003)) to interrogate for alternative pre-mRNA splicing of PCSK6 in 
various tissues. Track A of Figure 4.10 shows the location of the three microarray 
probes of interest spanning Exons 1-2 (5’UTR), Exons 13-14 (spanning the predicted 
secondary promoter) and Exons 21-22 (3’ UTR). Note exon 14 of the canonical PCSK6 
gene is also exon 2 of the shorter PCSK6 isoform. Interestingly, and in support of 
previous findings, of all 51 cell and tissue types analysed, the probe spanning exons 13-
14 of the canonical PCSK6 gene (and by extension the bidirectional promoter, 
rs11855415 SNP and VNTR) is highest in the CC (track C, Figure 4.10). The probe 
spanning exons 21-22 is second highest in expression terms in the CC. These results 
suggest exon 2 of the SI may be contributing towards the increased overall probe signal. 
The 5’UTR probe on the other hand reports the highest probe signal in the spinal cord, 
as reported previously (Figure 4.10, track B & Figure 1.3). 
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Figure 4.9 PCSK6 isoform expression in the adult human brain. (A) Microarray probes from the Allen Brain Atlas 
(Hawrylycz et al., 2012) both downstream (A_23_P151907) and upstream (A_23_P390006) of the novel exon are 
shown in the UCSC genome browser relative to the shorter PCSK6 isoform (black). Turquoise bar indicates predicted 
secondary promoter (B) Allen brain atlas microarray data indicates relatively high expression of the PCSK6 gene in 
the corpus callosum (CC), as indicated in bright red. Other areas of note for high PCSK6 expression are the basal 
forebrain (BF), thalamus (TH), mesencephalon (MES), metencephalon (MET) and medulla oblongata (MY). (C) The 
probe downstream of the novel exon (A_23_P151907) shows a higher expression in a 3-D representation for the 
sampled brain (Donor H0351.2001: 24yrs, male) relative to (D) a probe upstream of the novel exon 
(A_23_P390006). Colours indicate the level of expression for the PCSK6 probe selected with lower (blue), mid 
(yellow) and high (red) expression indicated across multiple regions. Anterior (left) and sagittal (right) views were 
generated using Brain Explorer 2 (v2.3.5).  
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Figure 4.10 Alternative pre-mRNA splicing of PCSK6 in various tissues. (A) Several PCSK6 microarray 
probes are shown relative to the 3’ end of the PCSK6 gene (blue) and shorter PCSK6 isoform (black). 
These tracks show the expression of the PCSK6 gene probed in the NCBI dataset record GDS832 at (B) 
Exons 1-2 (5’UTR), (C) Exons 13-14 (spanning the predicted secondary promoter) and (D) Exons 21-22 (3’ 
UTR). The orange arrow in track C indicates PCSK6 expression in the corpus callosum (sample 
GSM28784, grey code). See (Johnson et al., 2003) for further details on RNA preparation protocol. 
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4.4.5 RNA-seq analysis of PCSK6-AS 
 
Much of this chapter has been concerned with expression of the novel exon and by 
extension the shorter PCSK6 isoform, with results so far highly suggestive of 
transcription being driven from a secondary bidirectional promoter. On the antisense 
strand, the bidirectional promoter is suspected of driving transcription of a 3-exon 
lncRNA PCSK6-AS1 (639bp, chr15:101874641-101877633), first reported by the 
ENCODE sub-project GENCODE (Harrow et al., 2012). Like the novel exon, no 
microarray data exists in the literature for this lncRNA since no probes specific to the 3 
exons exist. As such we rely on existing RNA-seq data to help define the expression 
profile for PCSK6-AS1 (Figure 4.11). 
  
 
 
Figure 4.11 PCSK6-AS1 expression across a range of tissues. RNA-seq data expressed by Fragments Per 
Kilobase of transcript per Million mapped reads (FPKM) was sourced from the Human Body Map 2.0 
(Flicek et al., 2014). HLF=human lung fibroblasts. Samples labelled with R represent additional samples 
as submitted by the Rinn lab (Harvard).   
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4.4.6 Annotation of the PCSK6-AS isoforms 
 
Among human tissues, both protein-coding and lncRNA transcripts are reported to 
show the greatest heterogeneity in testes and brain (Ramskold et al., 2009) with 
PCSK6-AS1 displaying a similar trend (Figure 4.11). Furthermore, as a class in general, 
lncRNAs are preferentially localised to the nucleus and chromatin of the cell (Derrien et 
al., 2012). Although PCSK6-AS1 does appear in publicly available databases (e.g. 
http://www.noncode.org/), the UCSC genome browser still only classes PCSK6-AS1 as 
having a transcription support level of ‘tsl3’, meaning support for the existence of this 
lncRNA is from a single EST. As such, as a start point for any regulatory cis-acting role 
PCSK6-AS1 may have on the sense transcript, I confirmed both the existence (Figure 
4.12) and sequence (see Appendix C.1) of this lncRNA. Cell lines were selected based 
on previous PCSK6 profiling and RNA-seq findings in an effort to maintain consistency 
across experiments.  
 
 
Figure 4.12 PCSK6-AS1 expression across a range of cell lines. Lane (2)K562 (3)HeLa (4)1321N1 (5)hNSC 
(6)SH-SY5Y. Lane 1 50 bp NEB ladder where black triangle marks 200 bp. Expected product is 112 bp. 
Second upper band (white triangle) sequenced and annotated as PCSK6-AS2, 232 bp. 10 µl of PCR 
product was ran on a 2% TAE gel.  
 
Intriguingly, a second band was detected just below the 250 bp ladder band (Figure 
4.12). This band was excised from Lane 2 (K562) and sequenced; alignment appears to 
represent a second PCSK6-AS isoform (232 bp, PCSK6-AS2, accession #LN713952, 
white arrow Figure 4.12). This second isoform is also a 3-exon lncRNA but both exon 1 
 1            2           3          4           5          6                
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and 3 are extended in length in comparison to the ‘canonical’ PCSK6-AS1. A third 
isoform (PCSK6-AS3, accession #LN713953) was subsequently isolated and sequenced 
in the same manner; this isoform is similar to PCSK6-AS2, but has a middle exon 
spliced out. A graphic indicating the varying exon sizes of the three PCSK6-AS 
isoforms are shown in Figure 4.13. The function of each lncRNA isoform remains 
unknown however several databases allow annotation of the transcripts using existing 
datasets, including AnnoLnc (http://annolnc.cbi.pku.edu.cn/) which provides some 
curious differences between the AS1 and AS2 isoforms (PCSK6-AS3 wasn’t annotated 
since the sequence of the first exon is largely unknown). Antisense transcripts are 
similar to other long ncRNAs in that they can contain specific domains that interact 
with DNA, RNA or proteins. Appendix C.2 displays the TFs that are predicted to bind 
at the TSS of the lncRNA. This predictive service differs to the previous TRANSFAC 
analysis (Table 3.1) in that it predicts TF overlap at the lncRNA TSS rather than at a 
sequence centred on the rs11855415. Unsurprisingly, none of the TFs from either list 
overlap. Substantial differences exist between the two isoforms in the miRNA bind sites 
predicted on each. Additionally, curated CLIP-seq datasets which are used to annotate 
RNA-protein interactions indicate none for PCSK6-AS1 while PCSK6-AS2 has been 
shown to interact with FUS and ELAVL. According to RefSeq the FUS protein has 
been implicated in cellular processes that include regulation of gene expression, 
maintenance of genomic integrity and mRNA/microRNA processing while the ELAVL 
protein is known known to stabilise mRNAs. Interestingly the TSSs of both lncRNA are 
found to overlap with the predicted bind site of the FOXP2 transcription factor in 
neuronal cell lines (Appendix C.2). The PCSK6 gene’s main promoter has been found 
to be a direct target of FOXP2, a gene in which a mutation is thought to lead to severe 
forms of language or speech impairment (Lai et al., 2001).    
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Figure 4.13 UCSC Genome browser image of PCSK6-AS1 and two newly discovered isoforms PCSK6-AS2 
(accession #LN713952) and PCSK6-AS3 (accession #LN713953). Intron 13 of the canonical PCSK6 gene is 
shown in the top track in blue with PCSK6-AS1, PCSK6-AS2 and PCSK6-AS3 below. The ENCODE project 
H3K27Ac markings are indicative of promoter activity, with DNase clustering and TFBSs providing further 
evidence for a regulatory element at this location.  
 
 
Having detected PCSK6-AS1 in a number of cell lines and confirmed its sequence, I 
used publicly available ENCODE project RNA-seq data to validate these results and to 
posit which cell line(s) could be used in future functional analysis. Analysis of Figure 
4.14 suggests K562 is an obvious candidate since both PCSK6 and the lncRNA PCSK6-
AS are expressed in all cellular subcompartments analysed: whole cell, nucleus and 
cytosol (similar to the novel exon previously analysed in RNA-seq data). Apart from in 
the K562 cell line, PCSK6-AS is exclusively localised to the nucleus, as might be 
anticipated of a lncRNA. As expected PCSK6 was most prevalent in the HepG2 cell 
line (Figure 4.3, Table 4.4) however, unlike K562, it is notoriously difficult to transfect 
(p128, Cemazar et al. (2010)) and does not express cytosolic PCSK6-AS. Since the 
function and effect of PCSK6-AS remains, as yet, unknown, preference exists towards 
use of K562 as a cell model in which to perform functional analysis. 
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Figure 4.14 Expression of the PCSK6 gene (A) and antisense lncRNA gene PCSK6-AS1 (B) according to the 
ENCODE RNA-seq dataset (Djebali et al., 2012) as expressed by Fragments Per Kilobase of transcript per 
Million mapped reads (FPKM) in cytosol (blue), nucleus (red) and whole cell (green). The minimum 
expression level cut-off is 0.5 FPKM. This data supports K562 as a model cell line for PCSK6-AS1 
functional testing. 
 
 
 
 
 
 
 
 
0
2
4
6
8
10
12
14
16
FP
KM
 
PCSK6 Expression in ENCODE Cell Lines 
Cytosol
Nucleus
Whole Cell
0
0.5
1
1.5
2
2.5
FP
KM
 
PCSK6-AS1 Expression in ENCODE Cell Lines 
Cytosol
Nucleus
Whole Cell
A 
B 
 119 
 
4.5 Discussion 
 
Annotating all possible gene isoforms and their in vivo expression patterns in specific 
cell populations is a necessary first step in understanding the isoform-specific functions 
of a gene and the differentiation between trait-relevant gene isoforms and ‘bystander’ 
alternative forms of a gene. PCR analysis of the different PCSK6 gene isoforms 
observed within and across cell lines is an easily accessible though limited approach to 
cataloguing such transcription heterogeneity. Initial PCR results (Figure 4.2) would 
suggest PCSK6 does not display a consistent predominance of one isoform across cell 
lines and differences in gene expression levels were as equally varied as differences in 
splicing. Clearly then, PCSK6 undergoes alternative splicing and employs alternative 
transcription start and termination sites across multiple cell types and ontogenetic 
stages. Djebali et al. (2012) found that in general there was a plateau of 10 - 12 
expressed isoforms per gene per cell line analysed. Inspection of the 8 PCSK6 isoforms 
currently recognised by RefSeq (Table 4.1) suggests there might still be several 
isoforms left to be annotated, one of which may be the PCSK6 short isoform (SI) 
discussed throughout this chapter. Several cell lines were shown to express all RefSeq 
PCSK6 isoforms (K562, HEK293 and RPE-1) and as such make suitable candidate 
model cell lines for future functional analysis of genetic variation within the PCSK6 
locus.  
 
Results from a study by Pal et al. (2011) propose gene isoforms are predominantly 
generated via alternative transcriptional rather than splicing mechanisms, highlighting 
alternative promoters as primary sources of transcriptome diversity. Furthermore the 
authors suggest the majority of genes associated with neurological diseases expressed 
multiple transcripts through alternative promoters. One such type of promoter is the 
bidirectional gene pair promoter (BGP) driving transcription of a short PCSK6 isoform 
and a lncRNA. BGPs are a common feature of the human genome, and have also been 
described in drosophila (Graveley et al., 2011), mouse (Kanhere et al., 2010) and plants 
(Li et al., 2006) and a key point of discussion arising from this chapter centres on what 
the influence of these BGP divergent transcripts may have on PCSK6 gene expression 
and regulation.  
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Publicly available empirical data specific to the PCSK6-AS are quite limited, however a 
search of the literature can shed light on the possible function of this lncRNA. Hu et al. 
(2014) found that most of the lncRNAs expressed in the prefrontal cortex (39.8%) 
localize in close proximity (<4 kb) to known protein-coding genes, while lncRNAs such 
as PCSK6-AS which are located upstream of the protein-coding genes on the antisense 
strand, are particularly significant; these natural antisense transcripts (NATs) were 
shown to originate from a specific class of bidirectional promoters showing unique 
epigenetic features (see histone modifications, Figure 3.2), were highly enriched 
upstream of genes that are expressed in neurons and involved in neuronal functions (see 
PCSK6 expression in hNSC, Figure 4.2) and show a significantly positive correlation 
with the expression of the upstream protein-coding genes. Results presented in this 
chapter show the previous 4-exon transcript not to be a truncated divergent transcript, 
the result of stochasticity in the splicing process, but rather a fully extended, though 
predicted to be inactive, PCSK6 isoform complete with poly-A tail and signal peptide 
(Table 4.2).  
 
A prediction of function on a protein level suggests the SI undergoes nuclear export 
though not secretion from the cell. The exact mechanism by which an inactive enzyme 
such as the PCSK6 SI might have an effect remains unknown though a large-scale 
analysis by Pils and Schultz (2004) into the function and evolution of inactive enzyme-
homologues revealed startling insights, suggesting that inactive enzymes are conserved 
among metazoan species and even though they have lost their catalytic activity, they 
have evolved new functions; predominantly regulatory processes where the inactive 
enzyme-homologue regulates its active counterpart. It is worth noting that isoforms 
differing in their functional domains and driven by different promoters (such as the 
canonical PCSK6 and ‘short’ isoforms) are known to possess significantly different 
expression profiles. For example, Dijkmans et al. (2010) showed DCLK1, a member of 
the doublecortin gene family involved in neurogenesis and neuronal migration, is 
expressed from two distinct promoters and generates four transcript variants/protein 
isoforms. The first two isoforms are driven by the upstream promoter and are highly 
expressed in early P0–P5 stages while the downstream promoter derived isoforms 3 and 
4 that are P15 and adult specific. We know from results presented previously in this 
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chapter that PCSK6 is differentially expressed in various regions of the brain 
throughout development, namely hippocampus from 8-15 PCW and thereafter 
predominantly in the CBC and MFC up until 37 PCW. However we cannot state 
definitely which isoform(s) are driving these signals; microarray probes allow us to 
infer the isoform but there is still a shortage of publicly available data that allows one to 
explicitly track PCSK6 SI expression over developmental time. 
 
One method of definitively profiling the SI expression is by interrogating RNA-seq 
datasets for the presence of the shorter isoform’s novel exon, which previous PCR 
results suggest is not expressed in any other known RefSeq  PCSK6 isoform. Any 
biological interpretation of the RNA-seq results in Table 4.4 should include the caveat 
that due to the initial RNA fragmentation step when generating data, longer transcripts 
will contribute to more fragments and are thus more likely to be sequenced (see 3’UTR, 
Table 4.4). These read counts would usually be normalised for transcript length and 
sequence depth when quantifying transcripts by employing an expression level metric 
such as reads per kilobase and million mappable reads (RPKM). However for the 
purposes of this particular study, it was detection of the novel exon itself that was of 
primary importance, rather than relative quantification between the exons. Indeed, 
Ramskold et al. (2009) found that it is more accurate to simply exclude 3’ UTRs 
completely from gene models when calculating RPKM expression levels. Additionally, 
it is unlikely an absolute quantification of the novel exon is possible since the accuracy 
of transcript expression level estimates degrades progressively from high to low 
expressed transcripts (Kanitz et al., 2015). The novel exon also has extensive sequence 
overlap with the VNTR; reads that map to multiple genomic locations are known to 
present a problem when quantifying (Ramsköld et al., 2012). Results in Table 4.4 show 
quantification of the novel exon was consistently highest in the nucleus and in poly(A)-
 transcripts (K562, HeLa and Hep G2) though interestingly this trend is reversed for all 
other probes in the nucleus e.g. the nucleus poly(A)+ signal without exception exceeds 
the nucleus poly(A)- signal for all other exon probes (1,2,4,5). Together these data 
suggest the function of the SI, in K562, HeLa and Hep G2 cells at least, is localised to 
the nucleus. In hESC cells quantification was highest in transcripts with poly(A) tails 
which is consistent with all other probes i.e. nucleus poly(A)+ signal consistently 
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exceeds the poly(A)- signal, supporting the notion that in hESC cells the novel exon is 
present in transcripts that are exported to the cytosol for further processing. Finally, 
RNA-seq data also showed PCSK6-AS1 to display the highest relative expression in 
testes and brain (Figure 4.11), a potentially interesting finding for PCSK6 in light of the 
results published by Hu et al. (2014) who found divergent transcription of lncRNAs 
from bidirectional promoters to be highly enriched in neuronal genes.  
 
One of the inherent limitations of microarray data is the inability to define spliced 
isoforms if an exon is not probed for though the presence of an unprobed exon can still 
be inferred by analysis of exons upstream and downstream to the missing exon, as 
performed in Figure 4.8. In this microarray analysis of a 15 PCWs developing fetal 
brain I interrogated the Brainspan dataset for a visual quantification of probes upstream 
and downstream of the novel exon. There was a marked higher expression of the 
PCSK6 3’ UTR probe relative to all other probes upstream of the novel exon in the CC 
and CBC. The notion that the shorter PCSK6 isoform may be contributing to the 
relatively higher expression of the PCSK6 signal in the CC is supported by data from 
the Allen Brain atlas which also showed probes upstream of the novel exon to display 
relatively higher expression in the adult brain (Figure 4.9). Brain-specific isoforms are 
known to exert substantial phenotypic effects. For example, the aberrant expression of 
developmentally regulated mRNA isoforms has been observed in the cerebella of 
patients with psychiatric disorders like schizophrenia, autism, anxiety, attention-deficit 
hyperactivity disorders (Ten Donkelaar and Lammens, 2009, Grimmer and Weiss, 
2006). As such, given the high expression of PCSK6 within the corpus callosum, 
aberrant expression of PCSK6 isoforms could have an effect on CC development which 
in turn could influence a variety of traits and disorders including handedness.   
 
In summary, this chapter has shown that the bidirectional promoter drives the 
transcription of a bidirectional gene pair: a novel, though predicted to be inactive, 
PCSK6 isoform in the sense strand direction and several previously unknown lncRNA 
antisense transcripts. RNA-seq data suggests this PCSK6 shorter isoform to show 
relatively high expression in both the developing and adult corpus callosum. 
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5 Functional Analysis of the PCSK6 Genetic Variants 
 
5.1 Abstract  
 
The results of several functional assays which investigate the effect of lncRNA 
regulation on PCSK6 isoform expression in addition to a systematic analysis of the 
effects of genetic variation on bidirectional promoter activity at the PCSK6 locus 
associated with handedness are reported and discussed in this chapter.  
 
Electrophoretic mobility shift assay (EMSA) results provide conclusive in vitro 
evidence that the rs11855415 SNP shows significant differences in protein:DNA 
complex binding on allelic variation in all nuclear extracts analysed (SH-SY5Y, hNSC, 
hNSC-derived Neuronal and K562). A reverse-chromatin immunoprecipitation (Rev-
ChIP) assay using hNSC nuclear extract posited a number of proteins to bind to the 
rs11855415 minor A allele but not to the major T allele, one of which was a member of 
the SRY (sex determining region Y)-box (SOX) TF family, as previously predicted by 
in silico analysis (Chapter 3).  
 
A luciferase assay was used to test for bidirectional promoter activity, with results 
indicating a strong transcriptional bias in the sense strand direction. Luciferase results 
also indicate allelic variation at the rs11855415 SNP to have a weak effect on promoter 
activity in the HeLa and neural 1321N1 cell lines (P < 0.02) but not the K562 cell line. 
No significant difference in promoter activity was observed between the VNTR 6,9 and 
10 alleles in either K562 or 1321N1 cell lines however a slight increase in luciferase 
was reported for the HeLa 10 allele (P = 0.02, ANOVA single factor).          
 
In conclusion, the rs11855415 SNP is the most likely candidate to affect expression of 
the bidirectional gene pair through the creation/disruption of TFBSs. How this 
specifically relates to PCSK6 expression remains unknown; results from pilot PCSK6-
AS knockdown and overexpression assays on an SH-SY5Y cell line were inconclusive 
and it remains to be clarified if and how the PCSK6-AS lncRNA regulates PCSK6 
isoform expression. 
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5.2 Introduction 
 
The preceding chapters provide evidence for the existence of several previously 
unknown PCSK6-AS lncRNA gene isoforms in addition to a novel PCSK6 shorter 
isoform (SI), both of which are positively correlated in expression and driven from an 
RNA Polymerase II-binding bidirectional promoter. Most human promoters are thought 
to bind polymerase complexes in a bidirectional manner and are therefore capable of 
initiating transcription in both directions (Core et al., 2008). Thus, we cannot exclude 
that the expression of PCSK6-AS lncRNA may represent a passive by-product of gene 
transcription. As such, a series of experimental assays are required to elucidate both 
functionality and the effect genetic variation might have on the transcription of PCSK6-
AS from the bidirectional promoter. The lack of a poly(A) tail usually suggests an 
unstable transcript that is retained in the nucleus, a subcellular compartment lncRNAs 
as a class predominantly localise to. However the PCR detection of PCSK6-AS using 
oligo-dT synthesised cDNA suggests PCSK6-AS1, under certain conditions at least 
undergoes exportation to the cytosol. To this effect, Mercer and Mattick (2013) 
demonstrated a substantial proportion of lncRNAs reside within, or are dynamically 
shuttled, to the cytoplasm where they regulate protein localisation, mRNA translation 
and stability. For the PCSK6 SI, RNA-seq data for the hNSC cell line (Table 4.4) and 
the prediction of a signal peptide (Table 4.2) support the export of this transcript to the 
cytosol. As such, both sense and antisense strand transcripts are in theory amenable to 
short interfering RNA (siRNA) knockdown assays in which cells can be transfected 
with a molecule targeting the transcript and the resulting change in mRNA transcript 
abundance measured by quantitative PCR (qPCR).  The novel exon, as yet, is the only 
known exonic difference between the SI and the 3’ sequences of PCSK6 isoforms 
currently recognised by RefSeq. Such a distinction severely restricts the sequence to 
which a siRNA can target (<100 bp), thereby rendering any siRNA knockdown 
approach unfeasible. In addition, much of the third exon of the lncRNA appears to be an 
Alu short interspersed element (SINE) (Figure 5.1). Alu elements are ~300 bp long and 
are the most abundant transposable element in the human genome; about 10.7% of 
which consists of Alu sequences (Deininger, 2011).  
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Figure 5.1 UCSC Genome browser view of the SINE Alu element indicates overlap with the third exon of 
the PCSK6-AS. The H3K27Ac markings indicate the position of the bidirectional promoter relative to the 
PCSK6-AS1 lncRNA (blue) and the rs11855415 SNP (green). Alu SINE transposable elements are marked 
by black boxes.  
 
Alu elements have been shown to bind to the 3'UTR of actively transcribed target genes. 
For example, Batista and Chang (2013) showed that under stress conditions the lncRNA 
antisense to Ubiquitin Carboxyl-Terminal Esterase L1 (Uchl1) moves from the nucleus 
to the cytoplasm and binds to the 5’ end of the Uchl1 mRNA to promote its translation. 
Additionally, Alu elements in cytoplasmic lncRNA can form imperfect complementary 
RNA duplexes with Alu elements in the 3′ UTRs of target mRNAs (Gong and Maquat, 
2011). In any case, the Alu overlap with the third exon of PCSK6-AS effectively 
restricts any siRNA design to the remaining ~250 bp sequence of exon 1 and 2 due to an 
inevitable non-specific knockdown for a probe designed against such a repetitive 
element. 
 
In theory, the function of the PCSK6-AS lncRNA can also be assessed via 
overexpression of the lncRNA in a relevant cell line – an overexpression in the nucleus 
should highlight what effect the antisense transcript has on sense strand expression and 
whether the mechanism of function is via the act of transcribing the lncRNA transcript 
itself rather than, for example, chromatin remodelling (Gupta et al., 2010).  
 
Previous results have highlighted rs11855415 as a primary candidate for functional 
analysis for a number of reasons: (1) its consistent presence in handedness GWAS 
results and association with PegQ (P = 2 x 10−8, Scerri et al. 2011a) (2) presence of the 
SNP within an evolutionary conserved sequence (Figure 3.5) (3) the substantial number 
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of TFBSs predicted via in silico analysis to bind at that location (Table 3.1) (4) the 
proximity of the SNP to a bidirectional promoter and its intronic location within a 
lncRNA (Figure 5.1). Its core location within the bidirectional promoter and significant 
association with degree of handedness (P = 0.001, Arning et al., 2013) means the 
VNTR is also a candidate for functional analysis, though to a lesser extent since only 
two TFs (Ets-1, Tel-2) are predicted to bind at the tandem boundaries and neither in 
multiplex. An assessment of genetic variation and allele-specific protein binding is vital 
given that the majority of regulatory functions (such as transactivation and chromatin 
looping) are mediated through TFs and other proteins (Edwards et al., 2013).  
 
A common approach to evaluating the potential of a genomic region to drive 
transcription involves the use of reporter assays such as luciferase products whose 
luminescence can be used to infer promoter activity of a cloned region. This is 
particularly useful when limited information regarding the regulatory potential is 
available, as in this case where the products of a putative promoter have limited support 
in the literature and whose directional bias is unknown. The findings of Chapter 3 
provided a defined region of interest approximately 1.8 kb in size, a sequence short 
enough to clone via traditional cloning techniques. As previously discussed, the choice 
of cell type is also considered since cis-regulatory elements are highly tissue- and cell-
type specific.  
 
Several other approaches can be used to elucidate the effects of allelic variation in vitro. 
One important technique for determining protein:DNA interactions is the 
electrophoretic mobility shift assay (EMSA), an approach here which uses a 21 bp 
oligomer centred on the allele of interest that acts as a bait to which proteins will bind 
(Revzin, 1989). Another advantage of the EMSA is the source of the DNA-binding 
protein may be inexpensive crude nuclear or whole cell extract. Chromatin 
immunoprecipitation sequencing (ChIP-seq) technologies provide a complementary 
approach to predicting TF-binding sites however they are limited in that each 
experiment profiles just one TF. As a way around this constraint and based on an assay 
originally provided by Dr Ashwin Unnikrishnan (Tursky et al., 2015), I have performed 
a series of Rev-ChIP experiments to utilise quantitative mass spectroscopy in the 
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screening of SNPs for differential TF binding. An advantage of this powerful technique 
is that multiple SNPs can be assayed simultaneously if necessary and the binding TF(s) 
identified in a single experiment.  
 
To conclude, previous findings suggest the PCSK6 SI may be expressed in both the 
developing and adult human brain. If this is the case, the bidirectional promoter and its 
inherent genetic variants would be in a primary position to influence such an expression 
profile, possibly via epigenetic regulation since lncRNA are known to play a pivotal 
role in embryonic and adult neurogenesis (Yao and Jin, 2014). The purpose of this 
chapter therefore is not necessarily to take forward the previously identified strongest 
genetic variants to test their causative association with the handedness trait per se, but to 
understand their functional impact on a molecular level, thereby offering insights into 
the complex regulatory network between gene, isoform splicing and their regulating 
lncRNAs. 
 
5.3 Methods 
 
5.3.1 PCSK6-AS Knockdown 
  
The 20 nmole Stealth siRNA (Invitrogen) was suspended in 1 ml RNase-free H2O to 
make a 20 µM solution (20 pmol/µl). Transfection with the BLOCK-iT fluorescent 
oligo (Invitrogen) was performed to assess the transfection efficiency of siRNAs in SH-
SY5Y cell line. SH-SY5Y cells were seeded at a 1x105 density 24 hours before 
transfection on a 12-well plate (CLS3513, Corning). The Stealth RNAi and the 
BLOCK-iT fluorescent oligo were transfected into SH-SY5Y cells using RNAiMAX 
(Invitrogen) as follows: 60 pmol Stealth RNAi (5’-
GGGUUUCAGAAUGUUUGCCAGGAUG) and 60 pmol of  BLOCK-iT fluorescent 
oligo were each diluted in 100 μl Opti-MEM I Reduced Serum Medium (Invitrogen) 
and mixed gently. RNAiMAX (2 μl) was diluted in 100 μl Opti-MEM I Reduced Serum 
Medium and incubated for 15 minutes at room temperature (RT). After a 15 minute 
incubation, the diluted Stealth RNAi and BLOCK-iT fluorescent oligo were combined 
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with the diluted RNAiMAX and incubated for 15 minutes at RT to allow the oligomer-
RNAiMAX complex formation. The culture medium was changed with 1 ml fresh 
DMEM/F12 without antibiotics before transfection, and the oligomer-RNAiMAX 
complexes were added to each well and mixed gently. After transfection, the cells were 
incubated at 37 °C in a CO2 incubator for 24 hours after which fluorescent uptake was 
observed under an immunofluorescence microscope. The cells were harvested and the 
RNA extracted (RNeasy Mini Kit, Qiagen). Five μg of DNase-treated RNA (Ambion 
DNA-free Kit, Invitrogen) was used for cDNA synthesis using oligo-dT primers as part 
of the Superscript III assay (Invitrogen). Quantitative real-time PCR (qPCR) was 
performed on the Applied Biosystems ViiA™ 7 Real-Time PCR System using SYBR 
Select Master Mix (Invitrogen). Results represent four independent plates (MicroAmp 
Fast 96-Well Reaction Plate, Invitrogen) with each sample in technical triplicate. Each 
15 μl qPCR reaction consisted of SYBR Select 2 X (Invitrogen), 0.3 μM of each primer, 
50 ng cDNA and up to 15 μl H2O. Primer pair for PCSK6-AS quantification were 5’-
GGTGCAGAAAACAAGCCTG and 5’- CTTCCCTGCTGGCGTTTTTG. For the 
PCSK6 SI (see 5.3.2) the primer pair 5’-GCAGCGGTGAGAACAACTT and 5’-
CTGATGGGCACTGAAGGTGT were used. Reaction conditions were as follows: 2 
min at 50 °C, 2 min at 95 °C then 40 cycles of 95 °C for 1 s and 60 °C for 30 s. The data 
was normalised using a housekeeping gene (HKG) primer pair for Glyceraldehyde 3-
phosphate dehydrogenase (GAPDH) and DNA-directed RNA polymerases I, II, and III 
subunit RPABC2 (POLR2F). Primers were designed to avoid binding to SNP locations 
and to bridge exon-exon junctions in order to avoid amplification of human genomic 
DNA (gDNA). qPCR reactions were run on 1.8% agarose gels to verify the correct 
product size and the melt curves also checked for evidence of nonspecific amplification. 
All primers were designed using Primer3 (Rozen and Skaletsky, 2000), tested for 
primer specificity with Primer-BLAST (Ye et al., 2012) and are listed in Appendix A. 
To confirm the knockdown efficacy of the assay a known positive control siRNA for 
use in SH-SY5Y cells was purchased (SNCA gene, Invitrogen). To minimize non-
specific amplification, primer pair concentration was optimised and efficiency validated 
with a standard curve for GAPDH (400 nmole forward primer, 600 nmole reverse: 
102% amplification efficiency), POLR2F (400:600, 103%), SHORT (600:400, 98%), 
BOTH (600:600, 96%), LONG (300:600, 103%), SNCA positive control (600:200, 
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90%) and PCSK6-AS (300:300,100%). As with all qPCR analysis conducted, melt 
curve analysis ensured the qPCR signal was not driven by primer-dimer pairs. 
 
5.3.2 PCSK6-AS Overexpression  
 
For overexpression of PCSK6-AS both gDNA and cDNA sequences of the lncRNA 
were cloned in to a pcDNA3.1 vector (V790-20, Addgene Vector Database) and 
transfected in to a neuronal cell line (SH-SY5Y). In summary, a primer pair was 
designed to isolate the gDNA sequence 3,425 bp in size. The DNA had been genotyped 
previously for SNP rs11855415 (T/T alleles) and VNTR (6/6 alleles). The primer pair 
(5’-CCCGGGGGATCCGGTGACAGCGACACAGGAA and 5’- 
CCCGGGCTCGAGAGGAAAGAGCCCAGGAGGAA) includes BamHI and XhoI 
restriction enzyme (RE) sites respectively for downstream cloning. PCR was performed 
using Phusion High-Fidelity DNA Polymerase (NEB, 7.5 µl HF buffer, 300 nmole of 
each primer, 1 unit of polymerase, 50 ng of gDNA and H2O for a total volume of 15 µl) 
under the following thermo-cycler conditions: 30 sec at 98 °C followed by 35 cycles of 
10 s at 98 °C, 20 s at 54.5 °C, and 2 min at 72 °C before finishing on 10 min at 72 °C. 
The PCSK6-AS1 cDNA was purchased and arrived as part of a lyophilised 2,450 bp 
pEX-A2 plasmid (Eurofins). 11.4 µl TE was added to bring it to a 500 ng/µl 
concentration and performed a double-digest on the backbone RE sites for Bam and 
XhoI to remove the PCSK6-AS1 cDNA (3 µl of NEB buffer 3.1, 2 µg DNA, 21 µl H20, 
1 µl of each RE, 37 °C 30 min) and thereafter performed a gel extraction for clean-up of 
the PCSK6-AS1 cDNA using the QIAquick Gel extraction kit according to the 
manufacturer’s instructions. Both the PCSK6-AS1 gDNA PCR product and the elute 
from the gel extraction kit (PCSK6-AS1 cDNA) were separately cloned into the 
pcDNA3.1 vector via the BamHI and XhoI RE sites and ligated using T4 ligase 
according to the manufacturer’s instructions (NEB). pcDNA3.1 plasmids containing the 
3,425 bp PCSK6-AS1 gDNA and 655 bp cDNA were then transformed into One Shot® 
TOP10 Chemically Competent E. coli cells (Invitrogen) before plating on ampicillin-
resistant plates and overnight incubation. Colonies were tested for PCSK6-AS1 
expression using the primer pair 5’-GGTGCAGAAAACAAGCCTG and 5’-
TTGGTCCCACTGCTTCTTCC with the same PCR conditions as previously. Colonies 
 130 
 
were suspended in 10 µl H20 and then immediately transferred to 10 ml luria broth 
(12795-027, Invitrogen) with 0.01% Ampicillin, cultured at 200 rpm 37 °C overnight 
before extraction of the plasmids 12 hours later using the Qiagen Plasmid Midi 
extraction kit according to the manufacturer’s instructions. Plasmids were quantified 
using a Nanodrop 2000 and brought to a concentration of 500 ng/µl in TE for storage. 
SH-SY5Y cells were seeded 4 x 105  per well on a 12-well plate (CLS3513, Corning) 24 
hours before transfection. 1.5 µg of DNA was added to 2.5 µl of P3000 reagent and 
Opti-MEM (Invitrogen) to give a total 5 µl volume which was allowed to incubate for 
up to 10 minutes. To this, 0.4 µl Lipofectamine 3000 and 4.6 µl Opti-MEM were added 
to give a total volume of 10 µl which was then added to each well after 5 minutes 
incubation at RT. The cells were harvested after 24 hours and the RNA extracted 
(RNeasy Mini Kit, Qiagen). Five μg of DNase-treated RNA (Ambion DNA-free Kit, 
Invitrogen) was used for cDNA synthesis using oligo-dT primers as part of the 
Superscript III assay (Invitrogen). For qPCR quantification GAPDH was used as the 
HKG using conditions as described previously (4.3.5). All primer pair sequences have 
been included in Appendix A.  
 
5.3.3 Electrophoretic Mobility Shift Assay (EMSA)  
 
SH-SY5Y, K562 and HEK-293 cells were maintained to ECACC guidelines in 
DMEM/F12 supplemented with 10% FBS and 5% penicillin/streptomycin at 37 °C with 
5% CO2 in TC-treated T-75 flasks (Nunc 156499). Human Neural Stem Cells (hNSC) 
were H9 hESC-derived, cultured and differentiated into neurons according to 
manufacturer’s protocol (N7800-100, Life Technologies). Isolation of nuclear protein 
extract was performed using the Nuclear Extraction Kit (SK-000, Signosis) according to 
the manufacturer’s protocol. Briefly, up to 107 cells were washed in 1 x PBS before the 
addition of Buffer I (7.5 ml 1 X Buffer 1 solution, 75 μl DTT solution and 75 μl 
Protease inhibitor), placed on ice and rocked at 200 rpm for 10 minutes. The cells were 
released using a sterile scraper, transferred to a 15 ml falcon tube and centrifuged at 10 
x g for 5 minutes at 4 °C. The supernatant was discarded before the addition of Buffer II 
(250 μl 1 X Buffer II solution, 2.5 μl DTT and 2.5 μl Protease inhibitor). The pellet was 
resuspended and transferred to a 1.5 ml microcentrifuge tube and placed vertically in an 
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icebox on a shaking platform for 2 hours at 200 rpm. Finally the sample was centrifuged 
at 10 x g for 5 minutes at 4 °C and the nuclear extract supernatant transferred to a new 
tube. Protein concentrations were determined using a Qubit fluorometer and Qubit 
Protein Assay (Invitrogen). Single-stranded probes 21 bp in length and centred on the 
SNP allele of interest (for sequences see Appendix D) were synthesized with 5′-biotin 
labels and purified by HPLC (Eurofins MWG operon, Ebersberg, Germany). Equimolar 
amounts of double-stranded oligonucleotide probe stock (100 mmol) were prepared by 
annealing 5’-biotin labelled oligonucleotides in annealing buffer (10 mM Tris pH 7.5-8, 
1 mM EDTA, 50 mM NaCl). The annealing oligos were heated at 95 °C for 2 minutes 
before being left to cool overnight to RT and storage at 4 °C. A 15 μl binding reaction 
of nuclear protein extract (7.5 µg), 0.5 µg poly d(I-C) (Sigma Aldrich, UK) and 3 μl of 
5 X Binding Buffer (1 mL 1 M Hepes pH 8.0, 2.5 mL 1 M KCl, 25 μl 1 M DTT, 5 μl 
0.5 M EDTA, 50 μl 1 M MgCl2, 2.5 mL glycerol dH2O to 10 mL) was incubated with 
labelled probe (20 fmol) alone or with 10 X/100 X unlabelled competitor or scrambled 
probe at RT for 20 minutes. Following incubation, 2 μl of 6 X Orange-G dye was added 
to each 15 μl sample before electrophoresis at 200V for 5 minutes followed by 100V for 
30 minutes. The samples were electrophoresed through non-denaturing 5% 
polyacrylamide minigels (8x8x0.1 cm 4.46 mL ddH20, 591 μl 5 X TBE, 895 μl 40% 
acrylamide/bisacrylamide (29:1), 60 μl 10% APS, 4.18 μl TEMED). Note gels had 
previously been left to polymerise overnight at 4 °C wrapped in 5 X TBE soaked white 
tissue and cellophane. The gels were then electroblotted to a Nylon B positive 
membrane (Thermo Scientific) for 45 minutes at 100 V in 4 °C 0.5 X TBE buffer. The 
protein:DNA complexes were autocross-linked to the nylon membrane with a 
Stratalinker 1800 UV transilluminator using 312 nm bulbs. Blocking of the membrane 
and subsequent chemiluminescent detection of the biotin-labelled DNA was performed 
using an enhanced luminol substrate for horseradish peroxidase (HRP) (Thermo 
Scientific) and visualised using a Fuji LAS-3000 imaging system. EMSA experiments 
were performed at least four times for each cell line. 
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5.3.4 Rev-ChIP 
 
Cell cultures 
HeLa (ATCC CCL-2) and 1321N1 (86030402 Sigma) cells were maintained to ECACC 
guidelines in DMEM/F12 supplemented with 10% FBS and 5% penicillin/streptomycin 
at 37°C with 5% CO2 in TC-treated T-75 flasks (156499, Nunc). Human Neural Stem 
Cells (hNSC) were cultured according to the manufacturer’s protocol (Cat N7800-100, 
Life Technologies). Isolation of nuclear protein extract was performed using the 
Signosis Nuclear Extraction Kit (SK-0001, Signosis) according to the manufacturer’s 
protocol.  
 
Preparation of bait oligonucleotides 
Double-stranded oligonucleotide probe were prepared by annealing 700 ng of 5’-biotin 
labelled oligonucleotides with 800 ng of non-labelled oligonucleotide in annealing 
buffer (10 mM Tris pH 7.5-8, 1 mM EDTA, 50 mM NaCl). The annealing oligomers 
were heated at 95 °C for 2 minutes before being left to cool overnight to RT. Double-
strand annealing was confirmed on a 2% TAE agarose gel before storage at -20°C. See 
Appendix G for bait oligonucleotide sequences. 
 
Beads preparation  
Dynabeads M-280 Streptavidin (30 µl) (11205D, Invitrogen) were concentrated on a 
magnetic particle concentrator and the supernatant removed before washing twice with 
TE + 0.01% NP-40 (120 μl/wash) and twice with Buffer DW (250 μl/wash, 20 mM 
Tris, pH 8.0, 2 M NaCl, 0.5 mM EDTA, 0.03% NP-40). Beads were resuspended in 
Buffer DW (120 μl Buffer DW for 30 μl beads), DNA added (1.5 μg for 30 μl beads) 
and rotated on a wheel at RT. After 3 hours, beads were washed once with 120 μl TE + 
0.02% NP-40 and 3 times with Buffer DW (120 μl/wash). For blocking 200 μl of 
Blocking Buffer (20 mM HEPES-NaOH pH7.9, 0.05 mg/ml BSA, 0.3M KCL, 5 mg/ml 
Polyvinylpyrrolidone, 0.05 mg/ml Glycogen, 2.5 mM fresh DTT, fresh Protease 
Inhibitors (P8340, Sigma Aldrich) and fresh Phosphatase Inhibitors (P0044, Sigma 
Aldrich)) was added to the beads and left to incubate on a rotator for 1 hour at RT. The 
beads were concentrated, supernatant removed and washed in 200 μl of NEB Buffer 3 + 
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0.02% NP-40 followed by 2 washes (400 μl/wash) of Buffer G (20 mM Tris HCL 
pH7.4, 10% Glycerol, 0.1 M KCL, 0.2 mM EDTA, 10 mM Potassium Glutamate, 
0.04% NP-40, 2 mM fresh DTT, 4 μl fresh Protease Inhibitors and 4 μl fresh 
Phosphatase Inhibitors). The beads were stored on ice while the protein nuclear extract 
was prepared.  
 
Clearing and incubating nuclear extract 
A graphic summarising the Rev-ChIP protocol is provided in Figure 5.2. Briefly, 
nuclear extract (200 μg) was thawed on ice before spinning at 15,000 g at 4 °C for 10 
minutes to remove denatured insoluble material. Supernatant was removed to a fresh 
tube and adjusted to a final concentration of 10 mM Potassium Glutamate. The extract 
was diluted with one volume of Buffer G (with 0.2 mg/ml poly dA.dT (P0883, Sigma 
Aldrich), fresh Protease Inhibitors and fresh Phosphatase Inhibitors). The extract was 
again centrifuged at 15,000 g for ten minutes at 4 °C to remove the insoluble pellet and 
the supernatant moved to a fresh tube and placed on ice. Next a fresh 30 μl aliquot of 
Dynabeads® was washed with 100 μl TE containing 0.02% NP-40, concentrated and 
the supernatant removed before a 100 μl wash of Buffer DW and a 100 μl wash of 
Buffer G (add fresh Protease Inhibitor and Phosphatase Inhibitor to both buffers). The 
Buffer G wash was repeated before combining the beads with the previously prepared 
extract on a rotator at 4 °C for 1 hour. The beads were concentrated and the supernatant 
(cleared extract) removed to a fresh tube and incubated overnight on a rotator with the 
previously blocked DNA-conjugated beads at 4 °C. Next the beads were concentrated 
and the supernatant saved as unbound extract. The beads were washed 5 times (500 
μl/wash) in Buffer GS (20 mM Tris HCl pH 7.4, 0.1 M KCl, 0.2 mM EDTA, fresh 2 
mM DTT and 4.2 µl fresh Phosphatase Inhibitor).          
 
Digestion and LC-MS mass spectrometry 
Beads were briefly washed in 50 mM ammonium bicarbonate and resuspended in 20 μl 
ammonium bicarbonate. For reduction, 2.5 μl of 8 M Urea (final concentration 1 M) and 
1 μl of 100 mM DTT (final concentration 5 mM) were added before incubation at 56 °C 
for 40 minutes. The sample was alkylated by adding 2.4 μl of freshly prepared 
iodoacetamide (final concentration 5 mM) followed by incubation for 30 minutes in the 
 134 
 
dark at RT. 1 μl of 100 mM DTT was added and left for 5 minutes, before adding 1 μl 
of 20 mM CaCl2. Freshly prepared trypsin at 1:20-1:50 concentration to protein (i.e. if 
0.1 mg/mL protein, add 1 μl etc.) was added (V5111, Promega) and incubated at 30°C 
overnight in a thermoshaker at 400 rpm. To halt the reaction 3.5 μl of 10% acetic acid 
was added and the beads removed prior to sending for mass spectrometry analysis. 
 
nanoLC-ESI (electrospray) tandem mass spectrometry analysis on the TripleTOF 
5600+   
The peptides were then separated on an Acclaim PepMap 100 C18 trap and an Acclaim 
PepMap RSLC C18 column (ThermoFisher Scientific), using a nanoLC Ultra 2D plus 
loading pump and nanoLC as-2 autosampler (Eksigent). The peptides were eluted with a 
gradient of increasing acetonitrile, containing 0.1 % formic acid (5-50% acetonitrile in 
90 minutes, 50-95% in a further 1 minute, followed by 95% acetonitrile to clean the 
column, before re-equilibration to 5% acetonitrile). The eluent was sprayed into a 
TripleTOF 5600+ electrospray tandem mass spectrometer (ABSciex, Foster City, CA) 
and analysed in Information Dependent Acquisition (IDA) mode, performing cycles of 
250 msec of MS followed by 100 msec MSMS analyses on the 15 most intense peaks 
seen by MS. The MS/MS data file generated via the ‘Create mgf file’ script in 
PeakView (ABSciex) was analysed using the Mascot algorithm (Matrix Science), 
against the NCBInr database Apr 2015 both restricted to human and with no species 
restriction, trypsin as the cleavage enzyme and carbamidomethyl as a fixed modification 
of cysteines and methionine oxidation as a variable modification. The Mascot search 
results were exported a Mascot.dat files and loaded into Scaffold v4.4.5 for further 
interrogation. All common contaminants (keratin etc.) were retained. 
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Figure 5.2 Reverse ChIP protocol summary. The protocol consists primarily of 4 major steps: (1) The 
annealing of biotinylated double-stranded oligonucleotide baits to streptavidin magnetic beads. Note 
the baits match those as used in the EMSA assay (see 5.3.3) (2) binding the nuclear extract protein from 
the relevant cell line with the biotinylated DNA/streptavidin complex (3) performing on-bead in-solution 
trypsin digest and isolation of the resulting protein peptides (4) performing mass spectrometry and the 
preparation of results for analysis. See Methods (5.3.4) for full protocol.  
 
5.3.5 Luciferase Reporter Assay 
 
Previous in silico analysis predicted a locus within PCSK6 to contain a secondary 
bidirectional promoter (chr15:101873803-101875608, hg19). A PCR using gDNA 
homozygous for both SNP rs11855415 and VNTR rs10523972 was performed (5’- 
CTGGCTCTAAATGGCAGCCT and 5’-ACCCCGAGTACTACTGCTTTT) to 
produce an amplicon for luciferase reporter cloning. PCR product sizes depended on the 
VNTR alleles: 1,707 bp for the 6 allele, 1,806 bp for the 9 allele and 1,839 for the 10 
allele. PCR was performed using Phusion High-Fidelity DNA Polymerase (NEB, 7.5 µl 
HF buffer, 300 nmole each primer, 1 unit polymerase, 50 ng of gDNA and H2O for a 
1 
2 
3 
4 
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total volume of 15 µl) under the following cycle conditions: 1 min at 98 °C followed by 
35 cycles of 10 s at 98 °C, 20 s at 63.2 °C, and 2 min at 72 °C before finishing on 5 min 
at 72 °C. Resulting blunt-end products were cloned into the pCR™-Blunt II-TOPO 
vector (Invitrogen) and transformed into One Shot® TOP10 Chemically Competent E. 
coli cells (Invitrogen) before plating on ampicillin-resistant plates and overnight 
incubation. Colonies were suspended in 10 µl H20 and immediately transferred to 10 ml 
luria broth (12795-027, Invitrogen) with 0.01% Ampicillin, cultured at 200 rpm 37 °C 
overnight before extraction of the plasmids 12 hours later using the Qiagen Plasmid 
Maxi extraction kit according to the manufacturer’s instructions.. A double digest was 
performed between the KpnI and XhoI restriction sites and the resulting sticky-end PCR 
products were then cloned in both directions (see plasmid maps Appendix E) into a 
pGL4.10 luciferase vector (Promega) and cells seeded in 96-well clear-bottom white 
plates (VWR, 734-1610) at 3 × 104 cells per well 24 hours prior to transfection. Cells 
were transiently co-transfected in quadruplicate in antibiotic-free medium with 80 ng 
pGL4.10 promoter construct and 20 ng pRL-TK renilla luciferase control plasmid using 
Lipofectamine 3000™ (Invitrogen) according to the P3000 protocol (Appendix E). 
Cells were assayed 24 hours after transfection using the Dual-Luciferase System 
(Promega). Relative luciferase activity (RLA) was determined using a MicroBeta2 Plate 
Counter (Perkin-Elmer) and normalised to the pRL-TK luciferase activity. A minimum 
of 3 independent transfection experiments were performed. For the assessment of a 
minimal promoter constructs containing accumulative deletions were designed by 
removing the sequence between the restriction sites for KpnI (-1,171 bp from the TSS 
of the novel PCSK6 isoform) and the following: Ndel (-1,067 bp), AvrII (-783 bp), 
SanDI (-637 bp), StuI (-507 bp), PfIMI (-378/-246 bp), AcII (-155 bp) and BsaAI 
(+100bp). Orientation and allele identity of recombinant clones were verified by Sanger 
sequencing (DNA Sequencing and Services, Dundee); mismatches relative to the 
reference genome were permitted if represented in dbSNP Build 143 (Smigielski et al., 
2000). Site-directed mutagenesis using GeneArt Site-Directed Mutagenesis System 
(Invitrogen) was performed to synthesise constructs not available from source gDNA.  
Constructs for 6/6A and 10/10T were synthesised from the previously cloned 6/6T and 
10/10A plasmids respectively (see Appendix A for sequences). Mutagenesis protocol 
was according to manufacturer’s instructions using 50 ng of source plasmid DNA. PCR 
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was performed using Phusion High-Fidelity DNA Polymerase (NEB, 7.5 µl HF buffer, 
300 nmole each primer, 1 unit polymerase, 50 ng of gDNA and H2O for a total volume 
of 15 µl) under the following cycle conditions: 1 min at 98 °C followed by 35 cycles of 
15 s at 98 °C, 20 s at 57 °C, and 2 min at 72 °C before finishing on 5 min at 72 °C.  
 
5.4 Results 
 
5.4.1 Knockdown of the PCSK6-AS lncRNA 
 
To detect any potential regulatory effect PCSK6-AS has on PCSK6 expression I 
performed a siRNA-mediated knock-down of the PCSK6-AS lncRNA in a neuronal cell 
line (SH-SY5Y) and measured the effect via qPCR quantification (see Figure 5.3 for the 
location of primer pairs used). This siRNA knockdown reduced PCSK6-AS expression 
by approximately half (versus untransfected) and showed no discernible impact on 
either the ‘both’ or ‘long’ PCSK6 expression. There was an upregulation in the ‘short’ 
primer pair (Figure 5.4). A similar siRNA knockdown on the shorter isoform was not 
possible due to the restrictions imposed by the short length of the novel exon. siRNA 
target mRNA in the cytoplasm but considering (1) lncRNA as a class typically localise 
to the nucleus and (2) previous PCSK6-AS RNA-seq analysis showed relatively high 
expression in the brain (Figure 4.11), I repeated the knockdown but this time using an 
antisense oligonucleotide (ASO, Integrated DNA Technologies) in the same neuronal 
cell line (SH-SY5Y). ASOs are oligomers 15 – 25 bp in length and designed to block 
expression of specific targeted proteins in the nucleus by degradation of the targeted 
mRNA. The results were inconsistent and difficult to interpret (not shown), most likely 
due to the knockdown probe targeting of the third exon which mostly consists of an 
SINE Alu transposable element, thereby rendering the target sequence non-specific. The 
difficulties discussed make the siRNA approach to knocking down PCSK6-AS and 
PCSK6 SI untenable.  
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Figure 5.3 Location of the PCSK6 primers used for qPCR quantification. PCSK6 SI (black arrows), PCSK6-
AS1 (green) and the isoforms already recognised by RefSeq ranked by length: ‘Short’ (light blue), ‘Long‘ 
(red) and short and long combined (‘Both’, dark blue). Top track indicates acetylation marking from the 
UCSC genome browsers ENCODE track and indicates the approximate location of the bidirectional 
promoter.  
 
 
 
Figure 5.4 siRNA knockdown of the PCSK6-AS lncRNA. Quantification was for Short (light blue), Long 
(red), Both (dark blue) and PCSK6-AS (green). Bar colour reflects primer pair used to quantify expression 
(arrows in Figure 5.3). PCR products are from SH-SY5Y-derived cDNA synthesised using oligo-dT primers. 
qPCR experiments were performed in triplicate on 3 independent plates (N = 3) and quantified relative 
to the untransfected cells equal to ‘1’. Bars indicate mean (SD). * indicates significant difference to the 
untransfected at a value of P≤0.05 (Student’s T-test, two-tailed unpaired). 
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5.4.2 Overexpression of the PCSK6-AS lncRNA 
 
To investigate whether the PCSK6-AS lncRNA affected expression of the PCSK6 SI 
and other known PCSK6 isoforms in vitro, I overexpressed the lncRNA by cloning both 
the gDNA and cDNA sequence in to the CMV-driven pcDNA3.1 vector followed by a 
transient transfection of the SH-SY5Y cell line. qPCR quantification confirms that 
when compared with the mock and untransfected cells, an induced overexpression of 
the lncRNA records no significant effect in any other PCSK6 isoform’s expression. 
Both gDNA and cDNA sequences for the PCSK6-AS1 lncRNA were cloned since the 
mechanism of action of the lncRNA is still unknown, though clearly the lncRNA 
undergoes alternative splicing (Figure 4.13). Since lncRNA stability is affected by 
genetic variation, all haplotype combinations of both rs11855415 and VNTR were 
cloned with all showing similar results. For the purpose of clarity only the gDNA 
plasmid containing the rs11855415 T allele and VNTR 6 allele has been included in 
Figure 5.5 and Figure 5.6.  
  
 
Figure 5.5 Overexpression of the PCSK6-AS lncRNA. qPCR quantification for Both (blue), PCSK6-AS 
(green) and PCSK6 SI (black) PCR products from SH-SY5Y-derived cDNA synthesised using oligo-dT 
primers. qPCR experiments were performed in triplicate on 3 independent plates (N = 3). Results were 
log10 expressed due to the vast discrepancy between PCSK6-AS and the other results and measured 
relative to the untransfected cells. Bars indicate mean (SD). See Figure 5.3 for primer pair locations. * 
indicates significant difference to the untransfected at a value of P≤0.01 (Student’s T-test, two-tailed 
unpaired) prior to log transformation. 
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Figure 5.6 Overexpression of the PCSK6-AS lncRNA. qPCR quantification for Both (dark blue), Long (red), 
PCSK6-AS (green) and Short (light blue) PCR products from SH-SY5Y-derived cDNA synthesised using 
oligo-dT primers. qPCR experiments were performed in triplicate on 3 independent plates (N = 3). 
Results were log10 expressed due to the vast discrepancy between PCSK6-AS and the other results and 
measured relative to the untransfected cells. Bars indicate mean (SD). See Figure 5.3 for primer pair 
locations. * indicates significant difference to the untransfected at a value of P≤0.01 (Student’s T-test, 
two-tailed unpaired) prior to log transformation. 
  
5.4.3 EMSA 
 
Based primarily on previous in silico predictions (Table 3.1) and GWAS findings 
(Brandler et al., 2013), rs11855415 and rs7182874 were selected for an analysis of each 
SNP’s ability to modulate TF binding. EMSAs were conducted primarily with 
embryonic hNSC nuclear extract which provides a good model to test the effect of 
genes expressed in early development as in the case of PCSK6. No difference in binding 
affinity was observed for rs7182874 while a significant allelic difference was observed 
for rs11855415 in the hNSC cell line in addition to the K562 and Neuronal cell lines 
(Figure 5.7). Specifically, the rs11855415 minor allele A created a protein binding band 
which was absent for the major T allele. The specificity of this finding was confirmed 
by the failure of a 100-fold excess of specific-competitor probe or a 10-fold excess of 
scrambled probe to significantly affect the visible band (e.g. lanes 4 and 5, panel C, 
Figure 5.7). A similar pattern was observed for rs11855415 across a range of cell lines 
(see Appendix D.2 for additional cell lines analysed). These EMSA results support 
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previous in silico predictions and show rs11855415 to have a substantial effect on in 
vitro protein:DNA interaction.  
 
 
Figure 5.7 EMSA gel images for protein:DNA binding at the rs11855415 SNP. Displayed is the binding of 
hNSC nuclear extract to probes containing the rs11855415 SNP A versus T alleles (A), the binding of 
Neuronal nuclear extract to probes containing the rs11855415 SNP A versus T alleles (B), the binding of 
K562 nuclear extract to probes containing the rs11855415 SNP A versus T alleles (C) and the binding of 
SH-SY5Y nuclear extract to probes containing the rs7182874 SNP C versus T alleles (D). Arrow indicates 
the protein:DNA complex band. The presence of a competitor is denoted above each lane: -, no 
competitor; S, scrambled competitor; and *, 10-fold and **, 100-fold excess of competitor respectively.  
 
5.4.4 Rev-ChIP 
 
Rev-ChIP is a method which allows for the detection of SNP sequences that 
differentially bind protein in an allele-specific manner using all the TFs of a nuclear 
crude extract at once. Since Rev-ChIP employs an agnostic approach in the 
identification of multiple proteins on a single DNA sequence using a powerful mass-
spectrometry resolution, one should expect to see non-specific binding in subsequent 
results. To address this I implemented a stringent protocol to reduce the identification of 
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such false positives – all proteins identified were required to have at least two peptide 
sequences identified by Mascot (Perkins et al., 1999) and any proteins that were found 
to bind to the A or T allele and a non-related control oligo were removed from further 
consideration. Since we are primarily interested in how genetic variation affects TF 
binding at a bidirectional promoter I suspect to be active (though not exclusively) in 
fetal and adult neurogenesis, I restricted my analysis to neuronal cell line nuclear 
extracts (hNSC and 1321N1). 
 
For the hNSC cell line the most intriguing result was the finding that the SRY (sex 
determining region Y)-box 5, a member of the SOX TF family as predicted by in silico 
analysis (Table 3.1) also appears here to bind to the minor A allele and not the T or 
control allele (Table 5.1). Another interesting result from the hNSC analysis and the 
only result found specific to the T allele was what Mascot defines as ‘signal recognition 
particle 14 kDa (homologous Alu RNA binding protein), isoform CRA_b ‘. Note in 
Figure 5.1 the proximity of the SNP to the nearby Alu element (~60 bp). This is an 
interesting correlate for the possible function of the PCSK6-AS and a future line of 
investigation might be to perform a similar pull down assay using the whole third exon 
sequence of the PCSK6-AS, a region which displays substantial overlap with an Alu 
element. Suitably controlled, such an assay would provide a list of prime candidates 
which interact with the PCSK6-AS lncRNA. For the 1321N1 cell line’s A allele Mascot 
identified ‘forkhead box C2 (MFH-1, mesenchyme forkhead 1), isoform CRA_b 
(FOXC2)’, the specific function of which has yet to be determined though it is known to 
be involved in the ‘heart development’ pathway 
(http://www.ncbi.nlm.nih.gov/biosystems/198802) where it interacts directly with Sonic 
Hedgehog (SHH), a gene instrumental in patterning the early embryo.  No one single 
TF was observed to bind to either rs11855415 allele in both nuclear extracts indicating 
no overlap between the nuclear extracts (Table 5.1). 
 
Using the Mascot results list from Table 5.1, I arranged the proteins according to 
molecular function using the PantherDB functional classification service 
(http://www.pantherdb.org/).  All alleles display the binding of proteins with catalytic 
activity. hNSC A allele analysis also suggests the proteins binding to have enzyme 
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regulator activity (GO:0030234) while the T allele in 1321N1 cells is thought to display 
receptor activity (GO:0004872), possibly indicative of the ‘Chain A, Core Of The Alu 
Domain Of The Mammalian Srp’ binding as indicated in Table 5.1 previously. Such 
findings seem contrary to the results from the EMSA assay where use of the same 
hNSC nuclear extract displayed little or no binding to the T allele (Lanes 6 – 10, Figure 
5.7A). However this discrepancy is most likely due to the vast difference in resolution 
offered by both assays; the mass spectrometry-based assay’s ability to detect single 
protein-binding events versus the limited visual inspection of protein:DNA binding 
offered by EMSA. Though it is difficult to interpret these data since the identity of the 
proteins binding have not yet been validated, the most significant difference in terms of 
molecular functional classification between the A and T-binding proteins in both 
1321N1 and hNSC nuclear extracts is the presence of translation/enzyme regulator 
activity for the A but not the T alleles (see cyan/turquoise sectors in Figure 5.8).   
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Table 5.1 Binding preference of proteins to both rs11855415 alleles according to Rev-CHiP mass spectrometry output. At least 2 peptides were required for each 
protein identified (99.5% homology with the reference sequence, 1% FDR).Mass spectrometry data were generated for amino acid (AA) identification in both hNSC 
and 1321N1 cell lines. – indicates no protein detected and * indicates unrelated biotinylated molecule. Dashed boxes highlight the proteins discussed in text. 
   rs11855415 allele    
  A T Control* 
Cell  Protein # unique 
peptides 
% AAs 
identified 
Quantitative  
value 
# unique 
peptides 
% AAs 
identified 
Quantitative 
value 
# unique 
peptides 
% AAs 
identified 
Quantitative 
value 
 unnamed protein product 2 8% 5 - - - 0 0 0 
 microtubule-associated protein 
1B, isoform CRA_a 2 1% 3 - - - 0 0 0 
 SRY (sex determining region 
Y)-box 5, isoform CRA_d 2 4% 3 - - - 0 0 0 
 signal recognition particle 
14kDa (homologous Alu RNA 
binding protein), isoform 
CRA_b 
- - - 2 26% 2 0 0 0 
 ribosomal protein S16, isoform 
CRA_b 
- - - 2 12% 2 2 14% 1 
 CUG triplet repeat, RNA 
binding protein 1, isoform 
CRA_e 
- - - 2 7% 2 2 9% 1 
 hnRNP-E1 - - - 4 18% 6 4 23% 4 
 poly(rC)-binding protein 2 
isoform b - - - 7 28% 8 6 23% 4 
hN
SC
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  rs11855415 allele  
  A T Control* 
Cell  Protein # unique peptides 
% AAs 
identified 
Quantitative 
value 
# unique 
peptides 
% AAs 
identified 
Quantitative 
value 
# unique 
peptides 
% AAs 
identified 
Quantitative 
value 
 microtubule-associated protein 4 6 7% 9 - - - 0 0 0 
 forkhead box C2 (MFH-1, mesenchyme 
forkhead 1), isoform CRA_b 
5 14% 7 - - - 0 0 0 
 heat shock-related 70 kDa protein 2 2 4% 4 - - - 0 0 0 
 general transcription factor II, i, isoform 
CRA_a 2 7% 3 - - - 1 3% 1 
 actinin, alpha 4, isoform CRA_c 2 3% 3 - - - 0 0 0 
 dermcidin preproprotein 2 20% 3 - - - 0 0 0 
 unnamed protein product 2 3% 3 - - - 0 0 0 
 Chain A, Core Of The Alu Domain Of 
The Mammalian Srp - - - 2 26% 3 0 0 0 
 DNA topoisomerase 1 - - - 2 2% 3 3 4% 2 
 ribosomal protein S19, partial - - - 2 12% 3 2 15% 1 
 Apolipoprotein B mRNA editing 
enzyme, catalytic polypeptide-like 3C - - - 2 16% 3 0 0 0 
 cold inducible RNA binding protein, 
isoform CRA_b 
- - - 3 20% 4 4 14% 2 
 SWI/SNF related, matrix associated, 
actin dependent regulator of chromatin, 
subfamily a-like 1 
- - - 5 8% 7 4 5% 2 
 unnamed protein product - - - 8 30% 12 5 30% 3 
13
21
N
1 
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Figure 5.8 The distribution of hNSC and 1321N1 nuclear proteins identified by mass spectrometry and 
arranged according to molecular function. Each cell line hNSC (A) and 1321N1 (B) is subdivided in to 
proteins showing greater binding affinity to the rs11855415 A or T allele bait (see Table 5.1). Charts 
were generated by the PantherDB functional classification service (http://www.pantherdb.org/).  
 
 
 
 
rs11855415 A allele rs11855415 T allele 
hN
SC
 
       rs11855415 A allele          rs11855415 T allele 
13
21
N
1 
A 
B 
 147 
 
5.4.5 Luciferase assays  
 
The presence of a genetic variant can perturb the function and expression of a gene 
product through a range of mechanisms including mRNA splicing, translation efficiency 
and TF binding (Pal et al., 2015). However the presence of a transcription regulatory 
factor binding site as predicted by in silico analysis does not imply that binding affects 
transcription, and in many instances that is likely not the case (Doolittle, 2013, Graur et 
al., 2013). As such, it is imperative to empirically test for the effects of genetic variation 
on gene expression using a range of functional assays, one of which is the luciferase 
reporter assay.  
As previously discussed, the SNP rs11855415 is located in close proximity to a 
predicted secondary promoter within intron 13 of PCSK6, a region which appears to 
bidirectionally regulate the PCSK6-AS lncRNA and the PCSK6 SI. To assess whether 
this potential promoter is active in either a unidirectional or bidirectional manner and 
what effect genetic variation has on such expression I cloned the locus in to a luciferase 
gene reporter construct in both strand directions (beige box, track B, Figure 3.2). The 
cloned fragment was up to 1,839 bp long, spanning the predicted promoter region and 
nearby genetic markers associated with handedness, including rs11855415 and the 
VNTR. In total, I cloned 6 constructs in both a sense and antisense strand direction 
carrying all possible rs11855415/VNTR allele combinations including those not 
available from human gDNA (acquired via site-directed mutagenesis) (see Appendix 
E.2). Transfections were conducted in both neuronal (1321N1, hNSC) and non-neuronal 
(K562, HeLa) cell lines. Neuronal cells were chosen due to the high expression of 
PCSK6 in the central nervous system (Johnson et al., 2003, Tsuji et al., 1997), HeLa is 
a commonly used cellular model easily transfected while K562 showed the strongest 
signals for potential promoter activity in the ENCODE tracks at this locus (Bernstein et 
al., 2012). No significant difference in luciferase expression was observed on allelic 
variation for either the rs11855415 SNP or the VNTR. The subsequent luciferase 
expression is displayed in Figures 5.9 and 5.10.  
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Figure 5.9 Dual luciferase assay results testing for allelic effects on promoter activity. Luciferase assay were conducted in K562 (A, E, F and G) and 1321N1 (B, H, I and 
J) cell lines. The alleles at rs1185415 (A as solid bars; T as stripe bars) and at the VNTR (6 is red; 9 is orange; and 10 is blue) were compared in different haplotypic 
combinations both in the antisense (A) and sense (S) direction (A and B). The rs11855415 alleles were compared regardless of the VNTR background (G and J). The 
VNTR alleles were analysed individually (E and H) or as short (6 repeats in bright red) and long (9 and 10 repeats in light blue; F and I), regardless of the SNP 
background. Luciferase expression was measured relative to the empty pGL4 vector following renilla normalisation. Data are representative of at least 3 independent 
experiments performed in triplicate and are expressed as Mean±SD of normalized luciferase activity (N = 3).*P-value of less than 0.05. 
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Figure 5.10 Dual luciferase assay results testing for allelic effects on promoter activity. Luciferase assay were conducted in HeLa (C, K, L and M) and hNSC (D, N, O 
and P) cell lines. The alleles at rs1185415 (A as solid bars; T as stripe bars) and at the VNTR (6 is red; 9 is orange; and 10 is blue) were compared in different 
haplotypic combinations both in the antisense (A) and sense (S) direction (C and D). The rs11855415 alleles were compared regardless of the VNTR background (M 
and P). The VNTR alleles were analysed individually (K and N) or as short (6 repeats in bright red) and long (9 and 10 repeats in light blue; L and O), regardless of the 
SNP background. Luciferase expression was measured relative to the empty pGL4 vector following renilla normalisation. Data are representative of at least 3 
independent experiments performed in triplicate and are expressed as Mean±SD of normalized luciferase activity (N = 3).*P-value of less than 0.05.
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Analysis of luciferase expression in Figure 5.9 (A, B) and Figure 5.10 (C, D) showed 
strongest promoter activity in the sense strand direction. A combination of all sense and all 
antisense luciferase expression in each cell line is summarised in Figure 5.11. In agreement 
with the ENCODE data (track C, Figure 3.2), the K562 cells were shown to have the most 
active promoter according to luciferase product detected.  
 
 
Figure 5.11 Bidirectional activity of the PCSK6 secondary promoter across multiple cell lines. The genomic 
region spanning the regulatory region at the PCSK6 locus was cloned into a luciferase reporter vector in both 
sense (grey) and antisense (green) strand directions. The bars are an average value of the sense and antisense 
luciferase expression as displayed in the four cell lines in Figure 5.10 (A,B) and Figure 5.11 (C,D). Bars show 
relative luciferase activity (RLA): mean fold change of luciferase expression following renilla normalisation and 
expression relative to the empty pGL4 vector. All assays were performed in triplicate and repeated at least 
four times. Error bars indicate Mean (SD) (N = 4) 
  
To further characterise this promoter I generated a series of progressive deletions from the 
1,839 bp-long cloned sequence using the 10T construct in the sense direction as the baseline 
(top bar, Figure 5.12). Analysis was conducted in the top three cell lines according to 
promoter activity in Figure 5.11 (K562, HeLa and 1321N1). The analysis revealed a minimal 
core promoter located in the region up to -155 bp relative to the TSS of the shorter PCSK6 
isoform in all cell lines (Figure 5.12).  
 
0 10 20 30 40 50 60
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K562 
1321N1 
hNSC 
HeLa 
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Figure 5.12 Luciferase minimal promoter analysis. Luciferase-expressing constructs containing different segments of the region upstream to the short sense PCSK6 
isoform TSS were analysed for promoter activity in K562, 1321N1 cells. Restriction sites used to create the segments are shown on the top segment. The rs11855415 
SNP and the VNTR location are indicated by a white circle and a stripe bar, respectively. An arrow indicates the position of the TSS of the PCSK6 SI. Luciferase 
expression was measured relative to the empty pGL4 vector following renilla normalisation and log transformed. All assays were performed in triplicate and 
repeated at least three times. Error bars represent the Mean (SD) (N = 3).  
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So far, luciferase assay results indicate a bidirectional promoter with a minimal 
presence within 155 bp of the SI TSS to display a bias in transcriptional orientation 
towards the sense strand direction.  
 
Analysis of the minimal promoter results indicates the construct displaying the highest 
luciferase expression in both HeLa and 1321N1 cell lines is the shortest construct that 
contains both the rs11855415 SNP and the VNTR (3rd horizontal bar, Figure 5.12), a 
construct 284 bp shorter than the 1.8 kb insert of Figures 5.9 and 5.10. As such given 
the higher luciferase expression, I was interested to see what effect, if any, genetic 
variation of SNP rs11855415 and the VNTR would have on luciferase expression but 
this time using a shorter construct than previously. I tested for a difference in luciferase 
expression upon variation of the SNP rs11855415 alleles using the AvrII (-783 bp) 
construct from the Minimal Promoter assay (3rd horizontal bar, Figure 5.12). Results 
indicate the only allelic difference was observed for the rs11855415 A vs T constructs 
in the 1321N1 and HeLa cell lines. However this was not consistent across different 
tests. Overall the experiments do not demonstrate any allelic effects. Curiously, as in the 
longer constructs (Figures 5.9 & 5.10), HeLa displays an allelic difference in the 
opposite direction to all other cell lines tested (Figure 5.13, panel A). K562 shows the 
same direction of effect as 1321N1 though is not significant. In analysing what effect 
the VNTR might have on inferred transcriptional activity at the bidirectional promoter, 
no substantial allelic difference was observed in either K562 or 1321N1 cell lines 
however a slight increase in luciferase was reported for the HeLa 10 allele (P = 0.02, 
ANOVA single factor, CI = 0.89), though it is important to remember the PCSK6 SI 
was not detected in the HeLa cell line in previous analysis (lane 3, Panel A, Figure 4.4). 
There was no difference in the 1321N1 or K562 cell lines either when the VNTR data 
was defined as ‘short’ or ‘long’ according to the definition used by Arning et al., 2013 
which reported association between the rs11855415 SNP and degree of handedness. 
Note a similar analysis for all experiments has also been conducted in the antisense 
strand direction however, as indicated in Figure 5.11, luciferase expression was very 
low (RLA < 5) in all but one cell line and as such difficult to interpret (see Appendix 
E.4).  
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Finally, I performed site-directed mutagenesis on the TFBS centred at chr15:101875123 
(site of rs11855415), replacing 6 bp with a scrambled sequence not predicted to contain 
a TFBS of any known TF according to TRANSFAC v2014.4 (see Appendix A for 
mutagenesis sequences, Appendix E.5 for confirmation Sanger sequencing and 
chromatograms of post-mutagenesis plasmids). Removal of the 6bp centred at 
chr15:101875123 (SNP rs11855415 location) leads to a significant increase in 
luciferase expression when comparing the rs11855415 A allele to the scrambled 6 bp 
construct in all cell lines tested (K562, HeLa, 1321N1 and hNSC). Refer to Figure 5.14 
for luciferase expression results.  
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Figure 5.13 Dual luciferase assay results testing for allelic effects on promoter activity. Luciferase assay were conducted in K562, 1321N1 and HeLa cell lines using a 
shorter insert (3rd horizontal bar Figure 5.13) than the 1.8 kb insert of Figures 5.10 and 5.11; this was the shortest construct that would contain both rs11855415 SNP 
and VNTR. The alleles at rs1185415 (A as black bars; T as grey stripe bars) and at the VNTR (6 red; 9 orange; and 10 blue) were compared in the sense strand 
direction. The rs11855415 alleles were compared regardless of the VNTR background (A). The VNTR alleles were analysed individually (B) or as short (6 repeats in 
bright red) and long (9 and 10 repeats in light blue; C), regardless of the SNP background. Luciferase expression was measured relative to the empty pGL4 vector 
following renilla normalisation. Data are representative of at least 3 independent experiments performed in triplicate and are expressed as Mean±SD of normalized 
luciferase activity (N = 3).*P-value of less than 0.05.
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Figure 5.14 Luciferase-expressing constructs testing the effect of removing the TFBS centred on rs11855415. Both constructs were based on the 10A AvrII (-783 bp) 
construct from the Minimal Promoter assay with site-directed mutagenesis used to disrupt the 6 base pairs centred at rs11855415. An arrow indicates the position 
of the TSS of the PCSK6 SI. 10A construct is pale blue, post-mutagenesis construct in dark blue. Luciferase expression was measured relative to luciferase activity 
(RLA) of the empty pGL4 vector following renilla normalisation. This fold change (FC) has been log transformed for easier interpretation (log2 fold change). White 
circle and striped bar indicate rs11855415 SNP and VNTR respectively. All assays were performed in triplicate and repeated at least three times. Error bars represent 
the Mean(SD) (N = 3). * indicates significant difference at a value of P≤0.05 (Student’s T-test, two-tailed unpaired). 
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5.5 Discussion 
 
There exist several mechanisms by which a SNP or other genetic variant may affect the 
level of activity of a protein nearby in the DNA sequence. Any effect rs11855415 might 
have as a functional variant is most likely not on the RNA regulatory level; PCSK6-AS 
has previously been shown to undergo splicing in to multiple isoforms in which the 
intronic SNP is removed. miRNA databases (e.g. http://www.mirbase.org/) also return 
no predicted or curated miRNA bind sites within the lncRNA transcript. Alternatively, 
rs11855415 allelic variation may have a direct impact on a splice junction. Therefore 
any functional effect is most likely to be at the DNA level through effects on TF 
binding.  
 
EMSA results provided in this chapter strongly support rs11855415, one of the top 
associated SNPs in previous handedness GWA studies, to have a significant direct 
effect on protein:DNA binding affinity (Figure 5.7). Results clearly demonstrate that the 
rs1185415 alleles create/disrupt the binding of transcription factor/s across a range of 
neuronal and non-neuronal cell lines in an in vitro context. Although an EMSA is useful 
in demonstrating the effect of allelic variation on the gain/loss of TF binding sites, it 
lacks the specificity to determine which TF exactly is binding to the probe and whether 
it is in complex or not; for example up to 12 different TFBSs are predicted for a 21 bp 
oligomer centred on the rs11855415 A allele (Table 3.1).  
 
A subsequent Rev-ChIP assay using nuclear extract from the hNSC cell line identified, 
among others, SOX5 to bind to a probe centred on the rs11855415 A allele. A repeat of 
the experiment using the 1321N1 nuclear extract did not identify the SOX5 TF. A more 
robust approach to reducing background noise would be desirable in tailoring future 
Rev-ChIP experiments; for example to eliminate background and false positives 
typically seen in mass spectrometry results (e.g. keratin) researchers have used the 
stable isotope labelling by amino acids in cell culture (SILAC) method (see Ong and 
Mann (2006) for details). Nevertheless, Rev-ChIP results do support a previous in silico 
prediction (Table 3.1) in suggesting a binding of a SOX TF family member to the A 
allele and not the T allele at the rs11855415 site, suggesting a functional mechanism by 
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which the SNP rs11855415 A allele might affect gene expression from the bidirectional 
promoter through the creation of a binding site for the SOX5 TF. Future experiments 
should be directed towards testing the binding of SOX5 to the rs11855415 A allele 
through use of a supershift EMSA assay, an assay similar to EMSA but with the 
addition of an antibody of choice to confirm binding specificity. 
 
Luciferase assay results suggest that the PCSK6 locus containing a bidirectional 
promoter is within a region that is transcriptionally complex, with genetic variants and 
choice of cell line both influencing transcription from the promoter in a significant way. 
The term ‘bidirectional promoter’ may be considered a misnomer since nascent sense 
strand transcripts are at least eight times more abundant than divergent transcripts at 
more than half of yeast promoters (Churchman and Weissman, 2011); approximations 
that are in line with my own findings of sense vs antisense transcriptional activity 
(Figure 5.11). Luciferase results also support a rejection of the ‘steric interference’ 
model in which transcribing RNA PolII transcription units are thought to collide when 
transcribing on opposite strands. Polymerase collision is most likely when there are two 
strong convergent transcription units however my data shows a strong bias for 
transcription in the sense strand direction suggesting the collision of transcriptional 
complexes during simultaneous transcription to be unlikely at this PCSK6 locus. 
Furthermore, luciferase data supports previous EMSA findings in identifying a 
difference between the rs11855415 A and T alleles though why this result occurs in an 
opposite direction in the HeLa cell line (Figure 5.14, panel A) or whether this simply 
represents a false positive result remains unknown. Whether this reversal is related to 
the notion that HeLa expresses no isoforms at this locus (Figure 4.2, panel E) also 
remains to be clarified. Overall and across cell lines, for both short and long luciferase 
constructs there was no consistent difference observed between alleles for either the 
rs11855415 SNP or VNTR genetic variants. While these results did not support an 
allelic effect on promoter activity they do not rule it out either. Intronic promoters, 
lncRNAs, enhancers and other non-coding functional elements are likely to have roles 
that are tightly regulated in a tempo-spatial manner (Corradin and Scacheri, 2014, Rinn 
and Chang, 2012) and therefore putative allele-specific modulations might be detected 
only when all the relevant transcriptional machinery is in place. Therefore, it is possible 
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that any genuine allele-specific effects might not be detectable through in vitro 
methodologies such as a luciferase assay, or might require specific cell types not used in 
this study. 
 
Results displayed in Figure 5.14, in which luciferase expression from a construct with 
the 6 bp centred on the rs11855415 A allele is compared to a scrambled ‘null’ construct 
with the same 6 bp removed, suggest the TF(s) binding to the rs11855415 A allele in 
vitro have a prohibitive effect on transcription at the bidirectional promoter in the cell 
lines tested. When interpreting these results it is worth noting that the EMSA assay 
showed significant protein binding at the rs11855415 A allele, and not the T allele. This 
is a potentially interesting finding considering the previous in silico TFBS analysis 
(Table 3.1) and hNSC Rev-ChIP results (Table 5.1) which suggest the protein binding at 
the rs11855415 A allele may be SOX5, a TF known to act as a transcriptional silencer 
(Huang et al., 2008, Kwan et al., 2008), though further validation is required. 
  
Luciferase assay results, coupled with a lack of predicted TFBSs within the tandem 
repeats support the VNTR to have no effect; the difference between the long and short 
VNTR alleles observed in the HeLa cell line (Figure 5.13, panel B&C) was not 
recorded in any other cell line or in the original ‘longer’ luciferase constructs (Figures 
5.9 & 5.10) and remains ambiguous.   
 
Finally, in this chapter I sought to identify whether the PCSK6-AS lncRNA has an 
effect on sense strand PCSK6 expression and if so what that mechanism of action might 
be. Using siRNA to affect a knockdown of PCSK6-AS did suggest a potential 
upregulation in transcripts upstream of the bidirectional promoter though all other 
isoforms remained unaffected. The difficulty in interpreting any such data however is 
that lncRNAs are expressed at very low levels, sometimes only at specific 
developmental stages and in specific tissues and, unlike most other RNA molecules, the 
function of a lncRNA antisense transcript can be mediated by either the transcript itself 
or via the act of its transcription. Antisense transcripts can remain at their location of 
transcription (such as through stalled polymerases, triple helices or R-loops which 
protect promoters from de novo methylation) which allows the RNA to exert its 
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function in cis (Pelechano and Steinmetz, 2013). Therefore if PCSK6-AS1 does exert a 
regulatory influence through steric interference (though unlikely as discussed) then a 
cytosol or nucleus-directed knockdown will have little effect on the expression of sense-
strand transcripts downstream of the PCSK6-AS site such as the PCSK6 long isoforms. 
Additionally, the limiting of the knockdown assay to one cell line, the modest 
transfection efficiency of a ‘difficult to transfect’ cell line (SH-SY5Y) and designing an 
effective siRNA knockdown probe in a restricted sequence which includes an Alu 
transposable element means the knockdown assay provides ambiguous results at best.  
 
Results from the overexpression of the PCSK6-AS lncRNA in the SH-SY5Y cell line 
show no effect on expression levels of either the PCSK6 SI or any of the RefSeq-
recognised PCSK6 isoforms, although future experiments should investigate the effects 
of overexpression across a range of both neuronal and non-neuronal cell lines. 
Combining previous epigenetic markings at the bidirectional secondary promoter’s 
location (Figure 3.2, track C) with both knockdown and overexpression data, it’s 
reasonable to suggest that the PCSK6-AS might have a regulatory effect not through a 
steric interference model but rather as an anchor point which recruits epigenetic 
remodelling proteins to allow transcription of the sense strand’s PCSK6 SI to 
commence. Alternatively the very act of antisense transcription itself, rather than the 
produced transcript, has also been shown to induce chromatin modifications which are 
deposited during transcription and subsequently regulate the expression of the modified 
regions (Su et al., 2012). Such a model fits the overexpression assay data though 
whether this occurs in vivo and what exactly the functional effect of the PCSK6 SI 
isoform is remains unknown. However considering lncRNAs have been shown to 
regulate multiple major biological processes, including development  (Ponting et al., 
2009),  differentiation (Guttman et al., 2011)  and carcinogenesis (Gupta et al., 2010) 
such a hypothesis would appear plausible. Using constructs that harbour stretches of 
DNA for overexpression gene studies represents a useful though increasingly 
anachronistic tool in accessing the regulation of genes. An attempt to understand the 
role of the PCSK6 SI through overexpression was attempted using the CRISPR-Cas9 
system (Ran et al., 2013) however owing to its novelty as an assay with unestablished 
design parameters, meant inconclusive and enigmatic results (data not shown). 
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In conclusion, the results of this chapter indicate that the SNP rs11855415 has a 
functional effect on sense strand expression, most likely by affecting a TFBS in the 
proximity of the bidirectional promoter and, by extension, the expression of the 
transcribed SI and lncRNA.   
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6 Concluding remarks & future perspectives 
 
6.1 Summary of findings 
 
A primary objective of this thesis was to identify and characterise the functional 
variant(s) contributing to the GWAS signal previously found to associate a locus of the 
PCSK6 gene with handedness.  
 
The results in this project demonstrate that a common polymorphism (rs11855415) 
residing upstream of a secondary bidirectional promoter within intron 13 of PCSK6 has 
an effect on transcription factors which bind at that location. By influencing promoter 
activity, genetic variation could affect expression of the PCSK6 shorter isoform, a 
transcript which RNA-seq and microarray analysis of the developing and adult human 
brain suggest to be expressed in the corpus callosum, a region of the brain thought to 
influence the handedness phenotype.  
 
Handedness is a complex phenotype which represents multiple characteristics including 
manual dexterity, visual-spatial awareness and grip. In Chapter 2 an examination of a 
correlation matrix between 5 such performance-based measures for relative hand skill 
revealed a marking task and not the peg-board task to have the highest correlation with 
a measure for hand preference (Hand7) across all subgroups analysed. A weak 
correlation between the PegQ and other measures for hand performance was observed 
across all subgroups (r = -0.1 – 0.3) with little variation in correlation between the 
subgroups. The only measure for hand performance to display significant genetic 
association with the SNP rs11855415 was the PegQ measure (RD & Affected 
subgroups, Table 2.11). A further filtering of the Affected subgroup in to its constituent 
disorder cohorts of pure SLI, ADHD and RD resulted in no one disorder cohort 
displaying significant association between rs11855415 and PegQ7. The same allelic 
trend was observed across these disorder cohorts i.e. individuals with the minor ‘A’ 
allele of rs11855415 have significantly greater relative right-hand skill compared with 
those carrying the major ‘T’ (ancestral) allele. This is in contrast to the general 
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population which displays a trend towards reduced laterality of hand skill for the minor 
allele. Such a finding supports the notion that PegQ data should be collected in children 
across a range of neurodevelopmental disorders rather than just in dyslexic individuals. 
My data also shows hand preference to be only weakly correlated with foot preference, 
although the correlation between handedness and eyedness was weaker than the 
correlation between handedness and footedness.  
 
The data generated in Chapter 3 defined a 12.7 kb region with the marker rs11855415 
predicted to affect the largest number of TFBSs. A multi-sequence alignment also 
suggests the first exon of PCSK6-AS to be within a CNS, though there appears to be a 
lack of homology for the lncRNA on the whole; an unsurprising finding given 
evolutionary evidence for selected effect functionality of lncRNAs, in general, is 
meagre (Haerty and Ponting, 2013) and the proportion of lncRNA sequence that is 
under purifying selection appears to be small, approximately 5% (Ponjavic et al., 2007). 
Chapter 4 provided confirmation for the first time of the existence of a novel, though 
predicted to be inactive, PCSK6 isoform whose transcription is driven by a secondary 
bidirectional promoter within the 12.7 kb region previously defined. This promoter was 
also shown to generate several novel gene isoforms of a lncRNA PCSK6-AS in the 
antisense strand direction. Exploratory RNA-seq data suggests PCSK6 SI expression to 
be relatively high in the developing and adult corpus callosum. 
 
Finally, the EMSA protocol in Chapter 5 provided a relatively cost-effective and 
accessible way of validating candidate genetic variants for further study. A significant 
and robust allelic difference was observed for rs11855415 in all neuronal and non-
neuronal cell lines analysed, results which supported previous in silico predictions and 
show rs11855415 to have a substantial effect on in vitro protein:DNA interaction. The 
Rev-ChIP assay also demonstrated the usefulness in employing an unbiased approach 
linking detected SNPs from GWA studies directly to a TF protein without a 
priori knowledge, though as a hypothesis-generating assay any results still require 
validation (via, for example, the supershift EMSA assay). This assay, using hNSC 
nuclear extract, posited a number of proteins to exclusively bind to the rs11855415 
minor A allele but not to the major T allele; one of which was a member of the SRY 
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(sex determining region Y)-box (SOX) TF family, as previously predicted by in silico 
analysis in Chapter 3. Reporter gene studies identified a minimal promoter capable of 
controlling expression of the PCSK6 SI and show that replacement of the 6 bp centred 
at chr15:101875123 (SNP rs11855415 location) with a scrambled ‘null’ sequence leads 
to a significant increase in luciferase expression when comparing the rs11855415 A 
allele to the scrambled 6 bp construct in all cell lines tested (K562, HeLa, 1321N1 and 
hNSC) suggesting the TFs which bind, in vitro at least, to have a prohibitive effect on 
luciferase expression and, by inference, transcriptional activity at the secondary 
promoter. The luciferase assay also supports the notion that overall across all cell lines 
there was no consistent difference observed between alleles for either the rs11855415 
SNP or VNTR genetic variants. While these results did not support an allelic effect on 
promoter activity they do not rule it out either. Though inconclusive, siRNA-mediated 
knock-down of PCSK6-AS in the SH-SY5Y neuronal cell line also showed a specific 
increase in PCSK6 shorter isoforms, while overexpression of the PCSK6-AS had no 
regulatory effect on PCSK6 expression.  
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6.1.1 A proposed model derived from the findings of this thesis 
 
 
 
 
Figure 6.1 A proposed model derived from thesis findings. The PCSK6-AS lncRNA (green transcript) is 
transcribed from the PCSK6 secondary bidirectional promoter in an antisense strand direction. Allelic 
variation of the rs11855415 SNP (red nucleotides) may have an effect on chromatin-modifying enzymes 
such as PRC1/2 and LSD1 binding to the subsequent transcribed lncRNA (1) or could affect transcription 
factors in activating/repressing transcription in the sense strand direction (2). Several scenarios might 
exist once the sense strand PCSK6 SI is transcribed and exported to the cytosol for further processing: 
remain in zymogen form in the ER (3), interact with substrate proteins within the cell (4) or tether to the 
cell membrane where the canonical PCSK6 protein is known to cleave the Nodal morphogen during early 
embryogenesis (5). An extended discussion on the figure can be found in the discussion immediately 
below.  
 
EMSA results from Chapter 5 indicated a significant difference on allelic variation in 
the proteins that will bind to the sequence centred on SNP rs11855415. The downstream 
ramifications of such a finding are best approached by discussing potential effects 
according to the direction of transcription. In the antisense strand direction (Figure 6.1 
(1)) a specific secondary structure could potentially permit the PCSK6-AS lncRNA 
(shown in green) to act as a scaffold and interact with different chromatin-modifying 
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enzymes (e.g. PRC1/2, LSD1), thereby coordinating their action and directing specific 
epigenetic modifications of the nearby chromatin (altering the accessibility of the 
genome to RNA Polymerase II and its associated factors is arguably the most efficient 
means to activate or repress transcription broadly). Multiple lncRNAs have been found 
to mediate changes in chromatin structure (e.g. HOTAIR, Gupta et al. (2010)) and this 
is currently the fastest growing class of lncRNAs known to regulate transcription. 
Sequencing of PCSK6-AS confirmed Exon 1 of the lncRNA transcript to have 
substantial overlap with the VNTR’s tandem repeat sequence, in theory permitting the 
Exon 1 to bind and act as an anchor for the lncRNA to interact with the chromatin-
modifying enzymes. Such a model would not only explain why an 
overexpression/knockdown of the lncRNA had no effect on PCSK6 SI expression but 
also why VNTR allelic variation in the luciferase assay had no effect on expression in 
the majority of cell lines analysed and why our genetic association studies discounted 
the VNTR from having any effect. Such a model would also accommodate the positive 
correlation between PCSK6 SI and PCSK6-AS expression while discounting the ‘steric 
interference’ model (i.e. when RNA polymerase collide when transcribing on opposite 
strands) such a correlation suggests.  
 
Alternatively in the sense strand direction (Figure 6.1 (2)), and if we are to consider the 
presence of the lncRNA as an expected by-product of endogenous bidirectional 
behaviour thought to exist at all promoters, then SNP rs11855415 allelic variation 
(nucleotides shown in red) could simply be influencing transcription factor bind sites 
(TFBSs), as demonstrated in the EMSA assay in Chapter 5. Disruption of this TFBS in 
the luciferase assay suggests the TFs to bind to the rs11855415 A allele to have a 
repressive effect; Rev-ChIP results propose this to be SOX5, a TF known to have a 
repressive effect on transcription although further validation is required. It’s also worth 
noting that lncRNAs can themselves act in an enzymatic manner by functioning as 
ligands for transcription factors (e.g. MALAT1, Ma et al. (2015)) and though PCSK6-
AS1 is not predicted to be active, the newly-discovered PCSK6-AS2 is predicted to 
interact directly with other proteins (see Appendix C.2). 
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RNA-seq data from a human neural stem cell (hNSC) line in addition to protein 
prediction software support PCSK6 SI to have a signal peptide/transmembrane domain 
at the N-terminus (Figure 6.1 (2), red box), which directs translocation in to the 
endoplasmic-reticulum (ER) for further processing. Based on software analysis the 
PCSK6 SI could enact several roles. The loss of a prodomain means PCSK6 SI lacks an 
autoproteolytic initial cleavage step, rendering the protein inactive and localised to the 
ER as in Figure 6.1 (3); several PCSK6 isoforms are thought to remain in zymogen 
form in the ER (see Table 4.1). The SI is predicted to lack a catalytic domain which 
contains the catalytic triad necessary for cleavage however an insulin-like growth factor 
receptor domain IV which confers protein-protein interaction properties (Figure 6.1 (4)) 
and directs cell surface tethering (Figure 6.1 (5)) is retained. This fourth extracellular 
domain is common to all receptor tyrosine protein kinases and regulates ligand binding 
to receptor domains (Cho and Leahy, 2002). As discussed in Figure 1.4 since Nodal is 
known to regulate its own expression via a feedback circuit (Shen, 2007) then PCSK6 
SI could play a regulatory role early in embryogenesis in the Nodal pathway by binding 
the Nodal proprotein at the cell surface without cleaving it, thereby acting as a tempo-
spatial fine-tuning mechanism for controlling available Nodal morphogens. Such a 
scenario clearly extends my hypothesis beyond the empirical findings of this project but 
such a model could accommodate my results while acknowledging how allelic variation 
at a single nucleotide polymorphism could induce phenotypic variation for a complex 
trait such as handedness.     
 
6.2 Future Perspectives 
 
The findings and subsequent discussion arising from Chapter 2 raise several points 
worthy of note here. For example, the MLRA model derived in this chapter employed a 
combination of performance measures to best predict hand preference and provides a 
complimentary approach to a questionnaire-based measure of preference such as the 
WHQ (Elias et al., 1998) or the Edinburgh Handedness Inventory (Oldfield, 1971). 
Such an alternative approach may prove useful in future studies since no handedness 
questionnaire has been designed for explicit use with younger and special populations 
even though several challenges exist, for example the inherent verbal requirements and 
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inability to assess children’s familiarity of specific items and tasks are particularly 
problematic. Another challenge facing researchers is the modality of the hand 
performance distribution; because of their asymmetry and bimodality, J-shaped 
distributions such as hand preference cannot be easily analysed with parametric 
measures of central tendency such as means - the failure of the MarkQ hand 
performance measure to show significant genetic association with SNP rs1185545 may 
arise from its inherent bimodal distribution (see Discussion section 2.5). Alternatively, 
SNP rs11855415 might just influence a particular aspect of handedness or combination 
of traits (fine-motor control, spatial awareness etc.) which are more accurately recorded 
with the peg-board task. Either way it is clear that researchers must choose carefully 
which performance measures to use in analysing hand skill differences, particularly in 
children.  
 
Chapter 4 displayed results for PCSK6 SI expression by interrogating the ENCODE 
datasets related to RNA-seq, a technology that is quickly making microarrays 
increasingly obsolete for gene expression analysis such that just a few million reads are 
needed for detecting expressed transcripts with a sensitivity below a single transcript 
per cell (Ramskold et al., 2009). Nevertheless, the functional relevance of the majority 
of gene isoforms, including PCSK6 SI, remains difficult to ascertain, particularly in 
light of the rapid change of isoform usage in evolution, indicating relatively weak 
selection pressure in the process (Barbosa-Morais et al., 2012). Future analyses 
therefore will primarily involve defining both the functional role and mechanism of the 
PCSK6 SI, particularly in the corpus callosum; a region of the brain in which it is 
thought to be highly expressed. In general, the increased availability of RNA-seq 
datasets derived from a broad range of cell and tissue types will help broaden our 
understanding of the transcriptome’s influence on complex phenotypes such as 
handedness. 
 
Like gene isoforms, our interpretation of the role of bidirectional promoters and 
lncRNAs in influencing complex phenotypes is continuously evolving. Several studies 
have shown that lncRNAs are transcribed from genomic regions associated with disease 
risk and complex traits. For example, Cunnington et al. (2010) showed modulation of 
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ANRIL lncRNA expression mediates susceptibility to several important human diseases 
including coronary disease, stroke, diabetes, melanoma, and glioma though further 
research is required for elucidating exactly how genetic variation affects lncRNA 
function. Future experiments involving genome editing tools such as CRISPR 
(Clustered Regularly Interspaced Short Palindromic Repeats), a genome editing system 
which can be used for the introduction of specific variants into engineered cell lines, 
might be useful in removing or overexpressing PCSK6-AS and measuring subsequent 
gene expression. For example, an investigation in to the effects of overexpression via 
the pcDNA-dCas9-p300 Core CRISPR plasmid (#61357, Addgene) would be useful in 
measuring the effect acetylation has on the secondary promoter region in a cell line that 
previously displayed low PCSK6-SI expression (such as HeLa).  
 
Currently, there is a scarcity of structural information illustrating lncRNAs bound to 
their protein targets. Crystal or nuclear magnetic resonance (NMR) structures of 
lncRNA/protein complexes, even consisting of the minimal domains that interact, will 
provide highly valuable pictures of the complexes, enabling experiments to test directly 
structure/function relationships. Less labour-intensive computational approaches are 
also beginning to predict how lncRNAs interact with DNA or chromatin by suggesting 
the involvement of lncRNA in transcriptional repression/enhancement by identifying 
complementary DNA sequences within lncRNA-associated regions that might indicate 
direct RNA–DNA–DNA triplex formation (Buske et al., 2012, Vance et al., 2014). An 
alternative method by which the PCSK6-AS may be having an effect is via the 
lncRNA’s third exon, an Alu repeat that might be mediating intermolecular interactions 
between RNA molecules and leading to functional consequences; several other systems 
have previously provided similar examples of Alu repeats and other abundant repeated 
sequences in mammalian genomes to have a role in gene expression regulation (Wang 
et al., 2013, Gong et al., 2013, Holdt et al., 2013).  
 
Many post-GWAS studies have focused on cis-regulatory variation to explain disease 
associations. However it is becoming increasingly clear that genetic variants can also 
affect the expression or function of not just lncRNAs such as PCSK6-AS but other 
ncRNAs too. For example, miRNAs typically regulate gene expression through binding 
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to 3′ UTRs of target mRNAs to direct their post-transcriptional repression and several 
studies (Richardson et al., 2011, Gamazon et al., 2012) have demonstrated genetic 
variants within the 3′ UTRs of susceptibility genes at miR-binding sites are associated 
with disease risk and should be routinely considered in post-GWAS functional studies. 
miRNA databases such as miRBASE (www.mirbase.org) fail to return a predicted or 
curated miRNA bind site within the PCSK6-AS lncRNA transcript though there does 
appear to be a miRNA bind site centred at rs1030, a SNP in the 3’UTR of the PACE4C 
and PACE4CS isoforms (Figure 4.2) and in moderate LD with rs11855415 (r2 = 0.59, 
D’ = 0.95, CEU population HapMap 3rel2 dataset). rs1030 was imputed in the previous 
handedness GWAS (Brandler et al. 2013) though owing to its weaker association with 
the PegQ phenotype (P = 0.0002, MAF = 0.26) it is perhaps unlikely to represent the 
etiologic variant. 
 
Allele-specific protein binding effects via the EMSA and Rev-ChIP assays were 
investigated in Chapter 5. However, due in part to their in vitro nature, such assays will 
have a propensity for giving false-positive results. Future experiments might involve the 
combination of technologies such as 5C/Hi-C, assays which assess chromosome 
interactions on a genome-wide scale, and CRISPR may prove highly influential in 
identifying and validating the gene(s) directly affected by candidate variants detected by 
GWAS. 
 
Modelling the effect of validated variants via in vitro and in vivo model organism 
experiments will provide further avenues for studying genetic traits and disease since 
one of the biggest challenges in post-GWAS validation is being able to accurately 
evaluate the effects of SNPs and their associated genes in an intact organism. The 
mouse is usually the mammalian model of choice because of the multiple 
methodologies which allow for genetic manipulation, its genome similarity and the 
ability to mimic human multifactorial disease phenotypes (Cho et al., 2013). 
Additionally, selected mice lines have shown to be a useful mammalian genetic 
resource for studying the neurobiology of cerebral lateralisation since multiple factors 
of handedness, previously identified in humans and other primates, also exist in mice 
(Li et al., 2013). Zebrafish is another popular model organism for studying the effect of 
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allelic variation on function and has a number of advantages for post-GWAS analysis 
over its rodent mammalian counterpart including ease of genetic manipulation, rapid 
production of large numbers of organisms of a specific genotype, and the capacity to 
study tissue-specific gene expression in live organisms (Edwards et al., 2013). For 
zebrafish, regulatory elements can also be assessed by the generation of transgenic 
zebrafish by means of reporter constructs and the microinjection of mRNA, DNA, or 
morpholinos into early embryos; a strategy being pursued by our group through the 
work of my colleague Monika Gostic.  
 
6.3 Concluding remarks 
 
Functional assays are the major bottleneck in the identification and functional 
characterisation of causal variants responsible for the association signals detected by 
GWAS. While EMSA, ChIP and luciferase assays are widely applied and are the 
backbone to many molecular genetic analyses, the development of high-throughput 
screening methods that can accurately and sensitively screen functional candidate 
variants, possibly via the field of genome engineering, would represent a significant 
breakthrough. 
 
There are several key findings from this project and points of discussion elsewhere that 
I have considered in deriving my concluding hypothesis (see Figure 6.1): 
 
• PCSK6 has a known fundamental role in the body LR patterning Nodal 
pathway. Brandler et al. (2013), provide support for the notion that the mechanisms 
responsible for setting up LR body asymmetry might influence handedness and brain 
asymmetry. 
 
• The corpus callosum (CC) is a fundamental component in the 
neurodevelopmental process of cerebral midline development. Previous research 
suggests both dyslexia and handedness are influenced by the size and function of the 
CC e.g. the CC in dyslexic individuals is of different size and shape (see section 4.2).  
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• Brain-specific isoforms are known to exert substantial phenotypic effects (e.g. 
the morphogenic signalling of CDC42-palm in hippocampal neurons, Wirth et al. 
(2013)). Though it is possible to detect PCSK6 SI in various cell lines, the in vivo 
expression profile of this novel gene isoform and its specificity to brain tissue is as yet 
unknown. 
 
• Data from this project support a high expression of PCSK6 SI relative to other 
PCSK6 isoforms in the corpus callosum of the developing brain, aberrant expression of 
such a PCSK6 isoform could have an effect on CC development which in turn could 
influence a variety of traits and disorders including handedness. 
 
As such it seems reasonable to hypothesise that allelic variation of the rs11855415 SNP 
affects the transcription factors binding at that location, thereby effecting promoter 
activity at the bidirectional promoter which influences expression levels of PCSK6 SI, a 
transcript thought to be highly expressed in the developing corpus callosum.  
 
Conversely, as indicated in Figure 6.1, PCSK6 SI may enact its presence much earlier 
during embryogenesis through interaction with the Nodal morphogen. Ultimately, and 
on a broader scale, it may be that the functional change in PCSK6 subtly alters the 
initial left–right patterning of the early embryo, and this has a downstream effect during 
neuronal migration on the development of cerebral asymmetry. 
 
In summary, this project described the first functional characterisation of a locus 
associated with human handedness within PCSK6, a gene controlling the establishment 
of structural asymmetries. Data suggest that the association between handedness and 
common variants is mediated by an intronic bidirectional promoter controlling both 
sense (PCSK6 SI) and antisense (PCSK6-AS) transcripts; observations which are in 
agreement with the increasing evidence that support the role of genetic variants within 
non-coding regions in influencing complex phenotypes (Ward and Kellis, 2012). The 
reduction in sequencing costs and the expansion of the publicly-available RNA-seq 
datasets will ultimately enable differential expression of the PCSK6 SI in both clinical 
and general population cohorts across a range of tissue types and thus enable a greater 
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understanding of the complex web of association between handedness, dyslexia and 
cerebral/body asymmetry pathways. Future studies will aim to understand the function 
of the transcripts regulated by the bidirectional promoter in order to elucidate the 
mechanisms by which genes controlling structural laterality are also implicated in 
behavioural and functional asymmetries. 
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APPENDICIES 
 
 Primer Catalogue Appendix A
 
A.1 PCSK6 isoform profiling 
 
Isoform PACE4-AI  
5’- CACCCCAGGCTCTGCTAATA 
5’-ATGCTGCTCCTGGGGAGATA 
 
Isoform PACE4-AII 
5’- TCCTGAAGATGAGGAAGATTACAC 
5’-ATGCTGCTCCTGGGGAGATA 
 
Isoform PACE4B  
5’- CTCGGGAACCAAGTCTCAAC 
5’-TTGGAGGACTCGCACTTTCT 
 
Isoform PACE4C  
5’- TCCTGTTGCAAATCAACTGACC 
5’-TGGCTTTGGTCATCTGTCCC 
 
Isoform PACE4CS 
5’- GAGCATCCCCTTAGTGCAGG 
5’-TGTTCAATCTGCCACCGGAA 
 
Isoform PACE4D  
5’- CCTGGGCTCCATTTTCGTCT 
5’-GTGACCTGAGGGTTCTTCCG 
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Isoform PACE4E-I  
5’- TCCTGAAGATGAGGAAGATTACAC 
5’-GTCCACCAATGGGGTGTGAG 
 
Isoform PACE4E-II  
5’- CACCCCAGGCTCTGCTAATA 
5’-GTCCACCAATGGGGTGTGAG 
 
A.2 PCR primers 
 
See Figure 4.13 for primer locations 
 
PCSK6-AS1 (Exon 1 – Exon 2) 
5’-GGTGCAGAAAACAAGCCTG  
5’- CTTCCCTGCTGGCGTTTTTG 
 
PCSK6-AS1 (Exon 1 – Exon 3) 
5’-GGTGCAGAAAACAAGCCTG  
5’-AAAGGCAGGAAAACCAAAGT 
 
PCSK6-AS2/3 
5’-GGTGCAGAAAACAAGCCTG  
5’-TGCCAAAAGAGTTATAGGTGATT  
 
Annotating the shorter PCSK6 isoform (Fig 4.4) 
 
PCSK6 Exon 13 -14 (dark blue arrows) 
5’- GTTGCTGGATCTTTCCAATG 
5’- CTGATGGGCACTGAAGGTGT 
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PCSK6 Short F – Short R (light blue arrows) 
5’-GAACAACTTCCTGTGTCACTGC 
5’-ATGCTGCTCCTGGGGAGATA 
 
Novel exon – Exon 13 
5’-CGCTGCAGCAGTGACACAGGA 
5’-ATGCTGCTCCTGGGGAGATA  
 
Beta-Actin 
5’- GCTCGTCGTCGACAACGGCTC 
5’- AAACATGATCTGGGTCATCTTCTC 
 
VNTR genotyping (Figure 4.16) 
5’- ACAGGGCTCGGTTCATTAAG 
5’- TCGGAATGTGGCTGTAACTG 
 
A.3 qPCR primers 
 
See Figure 5.3 for PCSK6 primer locations 
 
PCSK6-AS 
5’-GGTGCAGAAAACAAGCCTG 
5’-TTGGTCCCACTGCTTCTTCC  
 
PCSK6 shorter isoform (SI) 
5’- GCAGCGGTGAGAACAACTT 
5’- CTGATGGGCACTGAAGGTGT 
 
FANCC Housekeeping gene 
5’- AGCTGCGGTTTGCACTCA 
5’- GTCCCCGAGGGATATCTTGA 
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GAPDH housekeeping gene 
5’-TCTATAAATTGAGCCCGCAGCC 
5’-GACCAAATCCGTTGACTCCG 
 
POLR2F housekeeping gene 
5’-CCCGAAAGATCCCCATCAT 
5’-CACCCCCCAGTCTTCATAGC 
 
PCSK6 ‘short’  
5’-TGACGCCTTTCCCCAAAACT 
5’-TTGGTTGCATTTCTCCCCGA 
 
PCSK6 ‘both’ 
5’-CTGGTTTCTCCCTCGGGAAC 
5’-CCTGGGATGGCAGATCTTGG 
 
PCSK6 ‘long’ 
5’-GGAGTGTGGTGACAAAGGCT 
5’-TGCTGTGTCCCCAAAGTAGC 
 
TaqMan rs11855415 genotyping probe (Figure 4.15) 
VIC: 
ACTGGAATGGAAGAGAGACTTCATTATTATTACACTCTCTGTTTGACTTTA 
FAM: 
ACTGGAATGGAAGAGAGACTTCATTTTTATTACACTCTCTGTTTGACTTTA 
 
A.4 Overexpression & Knockdown primers 
 
PCSK6-AS Stealth siRNA (targets Exon 2 of PCSK6-AS1) 
 5’-GGGUUUCAGAAUGUUUGCCAGGAUG 
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PCSK6-AS ASO Knockdown (targets Exon 3 of PCSK6-AS1) 
5’-GCGTGCCTCCCAAAGTGCTG 
 
For isolating PCSK6-AS gDNA for overexpression 
5’-CCCGGGGGATCCGGTGACAGCGACACAGGAA 
5’- CCCGGGCTCGAGAGGAAAGAGCCCAGGAGGAA 
 
SNCA gene positive control for Stealth siRNA knockdown 
5’-CAUGCUUCCAGAGAAUGCAUAUUCU 
 
For SNCA Stealth siRNA positive control knockdown qPCR quantification 
5’-TAAAACCTGCAAATTCACATCTTC 
5’-AAGTAGGTAAGTAGGGCAGTGCAT 
 
A.5 Luciferase assay primers 
 
Produce an amplicon for cloning into the pCR™-Blunt II-TOPO vector 
5’-CTGGCTCTAAATGGCAGCCT  
5’-ACCCCGAGTACTACTGCTTTT 
 
Mutagenesis from 6/6T -> 6/6A for rs11855415 
5’-AGAGAGACTTCATTATTATTACACTCTCT 
5’-AGAGAGTGTAATAATAATGAAGTCTCTCT 
 
Mutagenesis from 10/10A -> 10/10T for rs11855415 
5’-AGAGAGACTTCATTTTTATTACACTCTCT 
5’-AGAGAGTGTAATAAAAATGAAGTCTCTCT 
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Mutagenesis to disrupt the TFBS centred on rs11855415 
Note: The 6 base pairs in bold indicate the sequence replacing the original 6 base pairs 
at that location. The replacement oligomer sequence was not predicted to create a TFBS 
according to TRANSFAC v2014.4. See Appendix E.5 for sequencing chromatograms 
confirming this replacement sequence. 
 
5’-TCAAACAGAGAGTGTAAGCTAGCTGAAGTCTCTCTTC 
5’-GAAGAGAGACTTCAGCTAGCTTACACTCTCTGTTTGA 
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 Supplementary Materials and Methods Appendix B
 
Table B.1 Indicates linkage disequilibrium (LD) between the SNP rs11855415 and all available SNPs 
within the defined PCSK6 locus of interest (chr15:101863220-101875949,hg19) from a CEPH population. 
Genotype data was downloaded from the 1000 Genomes Pilot project (Genomes Project et al., 2010) 
and LD calculated using the Broad Institute SNAP v2.2 service (Johnson et al., 2008). Bold indicates SNPs 
located within a non-coding conserved sequence across 14 eutherian mammals (see Methods, Chapter 
3). Where available a P-value has been provided indicating that marker’s association with the PegQ 
measure of relative hand skill (taken from a GWA meta-analysis of individuals with reading disability, 
Brandler et al. (2013)) 
 
SNP Distance r2 D' Position(hg18) Major Minor MAF CNS P-value 
rs9806256 11550 0.8 1 99681096 T C 0.2 No 1.7×10−7 
rs1871978 11834 0.8 1 99680812 C T 0.2 No 1.23×10−7 
rs7182874 9651 0.6 1 99682995 C T 0.25 No 8.68×10−9 
rs1871976 11991 0.6 1 99680655 A G 0.25 No  
rs752028 5938 0.527 1 99686708 C T 0.275 No 5.02×10−8 
rs3825921 12960 0.385 1 99679686 C T 0.342 No 4.69×10−6 
rs12900794 282 0.29 1 99692364 C T 0.408 Yes  
rs882422 5868 0.2 1 99686778 G A 0.5 No  
rs752026 5752 0.175 1 99686894 A G 0.467 No  
rs1471656 7636 0.175 1 99685010 C T 0.467 No  
rs2220055 10527 0.167 0.55 99682119 G A 0.1 No  
rs12916087 360 0.093 1 99692286 A G 0.317 Yes  
rs1871975 12153 0.089 0.80 99680493 T C 0.408 No  
rs9806218 11569 0.079 1 99681077 G A 0.283 No  
rs2073592 2817 0.076 1 99689829 G A 0.275 Yes  
rs2277593 10126 0.053 1 99682520 G A 0.208 Yes  
rs1947942 6072 0.05 1 99686574 A G 0.2 No  
rs755867 4795 0.047 1 99687851 C T 0.192 No  
rs11855415 0 1 1 99692646 T A 0.21 Yes 6.96×10−8 
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Table B.2 Mammalian genome assemblies as used for multi species alignment of 14 eutherian 
mammalian genomes (see section 3.3.4) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 181 
 
 Isoform Analysis Appendix C
C.1 PCSK6-AS2/AS3 cDNA 
 
The following sequences were acquired through Sanger sequencing using the primers 
indicated. See Section 4.3.2 for further details. 
 
Forward: 5’-GGTGCAGAAAACAAGCCTG  
Reverse: 5’-TGCCAAAAGAGTTATAGGTGATT  
 
>PCSK6-AS2 accession LN713952.1 
ccattcgaccattaagagtgtttcactccattggaagataaatggggaat 
ctttacataaccgggggtacaacaagaagttgttctcaccccccggggat 
cccacaggaagttgttctcaccgctgcaggtgcagaaaacaagcctggtg 
aggaacctctgactctcctcagctccttagggtccagttacggccacatt 
ccgaccacaaaggaatccgagcactttaaccaccaagtggtgcactgaga 
ttggctggggttgtgatgacgatactcatgacagcctatgaggggccagg 
cactgagctaacaacctgcggagctgagagctgggagctccaaaaacgcc 
agcagggaagaagcagtgggaccaaagcaacccctccctgcatgtgcctc 
caaaagagacctttccttttctaatagatggtgtctcgctctgttgcccg 
gctggagtgcagtggcaccatctcagctcactgcaagctccgcctcctgg 
gttcacgccattctcctgcctcagcctcctgagtagctgggactacaggc 
gcccgccaccatgcccggctaatttttgtatttttagtagagatggggtt 
tcagaatgtttgccaggatggtcttggtctcttgaccttgtgatccgcgt 
gcctcccaaagtgctgggattacaggcatgagccactgcacctggcctat 
ctcccctttctagtacttaaatgcttttttcactttctcaaccaagggag 
tcactttggttttcctgcctttggaagacgtaaaaatgagaattccatac 
ctatggcataaagtgtatggcataaatttgaagagtgattcttttttaaa 
attactttttccctagttagaataaaaattattaaatgttgaagatttta 
aagggaaa 
 
 
>PCSK6-AS3 accession LN713953.1 
aaggaaacccgaacacttttaccaccaagtggtgcactgagattggctgg 
ggttgtgatgacgatggtgtctcgctctgttgcccggctggagtgcagtg 
gcaccatctcagctcactgcaagctccgcctcctgggttcacgccattct 
cctgcctcagcctcctgagtagctgggactacaggcgcccgccaccatgc 
ccggctaatttttgtatttttagtagagatggggtttcagaatgtttgcc 
aggatggtcttggtctcttgaccttgtgatccgcgtgcctcccaaagtgc 
tgggattacaggcatgagccactgcacctggcctatctcccctttctagt 
acttaaatgcttttttcactttctcaaccaagggagtcactttggttttc 
ctgcctttggaagacgtaaaaatgagaattccatacctatggcataaagt 
gtatggcataaatttgaacaatgattcttttttaaaaatttttttcccta 
attaaaataaaaattattaaat 
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C.2 PCSK6-AS1 vs PCSK6-AS2 
   
Table C.1 Annotation of both PCSK6-AS isoforms according to the AnnoLnc serviceTargetScan (Agarwal 
et al., 2015) used to predict miRNA-binding sites. For TF binding annotation 498 ChIP-Seq datasets 
covering 159 transcription factors (TFs) in 45 cell lines from the ENCODE project were used. For CLIP-Seq 
annotation 112 CLIP-Seq datasets covering 51 RNA binding proteins (RBPs) were collected and cross-
linking sites calculated (P-values indicated). The differing secondary structure for PCSK6-AS1 and PCSK6-
AS2 are indicated below. Structures were predicted using the RNAfold algorithm in the Vienna Package 
(Lorenz et al., 2011). 
  
 PCSK6-AS1 (639bp) PCSK6-AS2 (871bp) 
location 
(hg19) 
 
chr15:101874642-101877633 
Exon 1:101874642-101874718 
Exon 2:101876983-101877142 
Exon 3:101877232-101877633 
 
chr15:101874642-101877744 
Exon 1:101874642-101874840 
Exon 2:101876983-101877142 
Exon 3:101877232-101877744 
 
miRNA 
families 
miR-148ab-3p/152, miR-146ac/146b-
5p, miR-133abc, miR-146ac/146b-5p, 
miR-9/9ab 
 
miR-93/93a/105/106a/291a-
3p/294/295/302abcde/372/373/428/519a/520
be/520acd-3p/1378/1420ac, miR-17/17-
5p/20ab/20b-5p/93/106ab/427/518a-3p/519d, 
miR-148ab-3p/152, miR-216a, miR-146ac/146b-
5p, miR-148ab-3p/152, miR-1ab/206/613, miR-
133abc, miR-146ac/146b-5p, miR-9/9ab 
 
TFs (cell 
type) 
 
JunB (K562), Pol2 (HCT-116, K562) 
TRIM28 (K562), ATF1 (K562), ELF1 
(GM12878, HepG2, K562) and FOXP2 
(PFSK-1, SK-N-MC) 
 
 
JunB (K562), Pol2 (HCT-116, K562) TRIM28 
(K562), ATF1 (K562), ELF1 (GM12878, HepG2, 
K562) and FOXP2 (PFSK-1, SK-N-MC) 
CLIP-Seq None FUS (P=1.943158e-45, HEK293),  ELAVL (P=1.951124e-11, HEK293) 
 
                                                                                                                
PCSK6-AS1 PCSK6-AS2 
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C.3 PCSK6 SI cDNA 
 
Below is the cDNA sequence acquired through Sanger sequencing and submitted 
(accession #LN714797). Matching bases in coding regions of cDNA and genomic 
sequences are coloured blue and capitalized. Matching bases in UTR regions of cDNA 
and genomic sequences are coloured red and capitalised. Light blue (coding) or orange 
(UTR) bases mark the boundaries of gaps in either sequence (often splice sites). 
 
GAACAACTTC CTGTGTCACT GCTGCAGCGG GGAAGTTGAA AGAATGGAGC  50 
CTCATACTGT ATGGCACAGC AGAGCACCCG TACCACACCT TCAGTGCCCA  100 
TCAGTCCCGC TCGCGGATGC TGGAGCTCTC AGCCCCAGAG CTGGAGCCAC  150 
CCAAGGCTGC CCTGTCACCC TCCCAGGTGG AAGTTCCTGA AGATGAGGAA  200 
GATTACACAG GTGTGTGCCA TCCGGAGTGT GGTGACAAAG GCTGTGATGG  250 
CCCCAATGCA GACCAGTGCT TGAACTGCGT CCACTTCAGC CTGGGGAGTG  300 
TCAAGACCAG CAGGAAGTGC GTGAGTGTGT GCCCCTTGGG CTACTTTGGG  350 
GACACAGCAG CAAGACGCTG TCGCCGGTGC CACAAGGGGT GTGAGACCTG  400 
CTCCAGCAGA GCTGCGACGC AGTGCCTGTC TTGCCGCCGC GGGTTCTATC  450 
ACCACCAGGA GATGAACACC TGTGTGACCC TCTGTCCTGC AGGATTTTAT  500 
GCTGATGAAA GTCAGAAAAA TTGCCTTAAA TGCCACCCAA GCTGTAAAAA  550 
GTGCGTGGAT GAACCTGAGA AATGTACTGT CTGTAAAGAA GGATTCAGCC  600 
TTGCACGGGG CAGCTGCATT CCTGACTGTG AGCCAGGCAC CTACTTTGAC  650 
TCAGAGCTGA TCAGATGTGG GGAATGCCAT CACACCTGCG GAACCTGCGT  700 
GGGGCCAGGC AGAGAAGAGT GCATTCACTG TGCGAAAAAC TTCCACTTCC  750 
ACGACTGGAA GTGTGTGCCA GCCTGTGGTG AGGGCTTCTA CCCAGAAGAG  800 
ATGCCGGGCT TGCCCCACAA AGTGTGTCGA AGGTGTGACG AGAACTGCTT  850 
GAGCTGTGCA GGCTCCAGCA GGAACTGTAG CAGGTGTAAG ACGGGCTTCA  900 
CACAGCTGGG GACCTCCTGC ATCACCAACC ACACGTGCAG CAACGCTGAC  950 
GAGACATTCT GCGAGATGGT GAAGTCCAAC CGGCTGTGCG AACGGAAGCT  1000 
CTTCATTCAG TTCTGCTGCC GCACGTGCCT CCTGGCCGGG TAAGGGTGCC  1050 
TAGCTGCCCA CAGAGGGCAG GCACTCCCAT CCATCCATCC GTCCACCTTC  1100 
CTCCAGACTG TCGGCCAGAG TCTGTTTCAG GAGCGGCGCC CTGCACCTGA  1150 
CAGCTTTATC TCCCCAGGAG CAGCAT 
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C.4 PCSK6 protein sequences  
 
Protein sequences used for PCSK6 canonical Vs PCSK6 SI prediction (see 4.4.3) 
 
>Canonical PCSK6 969aa Isoform PACE4A-I (identifier: P29122-1) 
MPPRAPPAPGPRPPPRAAAATDTAAGAGGAGGAGGAGGPGFRPLAPRPWRWLLLLALPAA 
CSAPPPRPVYTNHWAVQVLGGPAEADRVAAAHGYLNLGQIGNLEDYYHFYHSKTFKRSTL 
SSRGPHTFLRMDPQVKWLQQQEVKRRVKRQVRSDPQALYFNDPIWSNMWYLHCGDKNSRC 
RSEMNVQAAWKRGYTGKNVVVTILDDGIERNHPDLAPNYDSYASYDVNGNDYDPSPRYDA 
SNENKHGTRCAGEVAASANNSYCIVGIAYNAKIGGIRMLDGDVTDVVEAKSLGIRPNYID 
IYSASWGPDDDGKTVDGPGRLAKQAFEYGIKKGRQGLGSIFVWASGNGGREGDYCSCDGY 
TNSIYTISVSSATENGYKPWYLEECASTLATTYSSGAFYERKIVTTDLRQRCTDGHTGTS 
VSAPMVAGIIALALEANSQLTWRDVQHLLVKTSRPAHLKASDWKVNGAGHKVSHFYGFGL 
VDAEALVVEAKKWTAVPSQHMCVAASDKRPRSIPLVQVLRTTALTSACAEHSDQRVVYLE 
HVVVRTSISHPRRGDLQIYLVSPSGTKSQLLAKRLLDLSNEGFTNWEFMTVHCWGEKAEG 
QWTLEIQDLPSQVRNPEKQGKLKEWSLILYGTAEHPYHTFSAHQSRSRMLELSAPELEPP 
KAALSPSQVEVPEDEEDYTAQSTPGSANILQTSVCHPECGDKGCDGPNADQCLNCVHFSL 
GSVKTSRKCVSVCPLGYFGDTAARRCRRCHKGCETCSSRAATQCLSCRRGFYHHQEMNTC 
VTLCPAGFYADESQKNCLKCHPSCKKCVDEPEKCTVCKEGFSLARGSCIPDCEPGTYFDS 
ELIRCGECHHTCGTCVGPGREECIHCAKNFHFHDWKCVPACGEGFYPEEMPGLPHKVCRR 
CDENCLSCAGSSRNCSRCKTGFTQLGTSCITNHTCSNADETFCEMVKSNRLCERKLFIQF 
CCRTCLLAG 
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Figure C.1 cDNA sequence of the PCSK6 SI(accession #LN714797) overlaid with codon/protein prediction 
according to Ensembl (Transcript: PCSK6-020,  ENST00000632686). Top row represents the queried 
sequence, middle row reference sequence (hg19) and bottom row amino acid predicted. 
      1 GAGAACAACTTCCTGTGTCACTGCTGCAGCGGTGAGAACAACTTCCTGTGTCACTGCTGC 
       ............................................................ 
       ............................................................ 
    61 AGCGGGAAGTTGAAAGAATGGAGCCTCATACTGTATGGCACAGCAGAGCACCCGTACCAC 
       ............................................................ 
       ............................................................ 
   121 ACCTTCAGTGCCCATCAGTCCCGCTCGCGGATGCTGGAGCTCTCAGCCCCAGAGCTGGAG 
       ..............................ATGCTGGAGCTCTCAGCCCCAGAGCTGGAG 
       ..............................-M--L--E--L--S--A--P--E--L--E- 
 
   181 CCACCCAAGGCTGCCCTGTCACCCTCCCAGGTGGAAGTTCCTGAAGATGAGGAAGATTAC 
    31 CCACCCAAGGCTGCCCTGTCACCCTCCCAGGTGGAAGTTCCTGAAGATGAGGAAGATTAC 
    11 -P--P--K--A--A--L--S--P--S--Q--V--E--V--P--E--D--E--E--D--Y- 
 
   241 ACAGGTGTGTGCCATCCGGAGTGTGGTGACAAAGGCTGTGATGGCCCCAATGCAGACCAG 
    91 ACAGGTGTGTGCCATCCGGAGTGTGGTGACAAAGGCTGTGATGGCCCCAATGCAGACCAG 
    31 -T--G--V--C--H--P--E--C--G--D--K--G--C--D--G--P--N--A--D--Q- 
                    
   301 TGCTTGAACTGCGTCCACTTCAGCCTGGGGAGTGTCAAGACCAGCAGGAAGTGCGTGAGT 
   151 TGCTTGAACTGCGTCCACTTCAGCCTGGGGAGTGTCAAGACCAGCAGGAAGTGCGTGAGT 
    51 -C--L--N--C--V--H--F--S--L--G--S--V--K--T--S--R--K--C--V--S- 
          
   361 GTGTGCCCCTTGGGCTACTTTGGGGACACAGCAGCAAGACGCTGTCGCCGGTGCCACAAG 
   211 GTGTGCCCCTTGGGCTACTTTGGGGACACAGCAGCAAGACGCTGTCGCCGGTGCCACAAG 
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    71 -V--C--P--L--G--Y--F--G--D--T--A--A--R--R--C--R--R--C--H--K- 
    
   421 GGGTGTGAGACCTGCTCCAGCAGAGCTGCGACGCAGTGCCTGTCTTGCCGCCGCGGGTTC 
   271 GGGTGTGAGACCTGCTCCAGCAGAGCTGCGACGCAGTGCCTGTCTTGCCGCCGCGGGTTC 
    91 -G--C--E--T--C--S--S--R--A--A--T--Q--C--L--S--C--R--R--G--F- 
                                
   481 TATCACCACCAGGAGATGAACACCTGTGTGACCCTCTGTCCTGCAGGATTTTATGCTGAT 
   331 TATCACCACCAGGAGATGAACACCTGTGTGACCCTCTGTCCTGCAGGATTTTATGCTGAT 
   111 -Y--H--H--Q--E--M--N--T--C--V--T--L--C--P--A--G--F--Y--A--D- 
   
   541 GAAAGTCAGAAAAATTGCCTTAAATGCCACCCAAGCTGTAAAAAGTGCGTGGATGAACCT 
   391 GAAAGTCAGAAAAATTGCCTTAAATGCCACCCAAGCTGTAAAAAGTGCGTGGATGAACCT 
   131 -E--S--Q--K--N--C--L--K--C--H--P--S--C--K--K--C--V--D--E--P- 
       
   601 GAGAAATGTACTGTCTGTAAAGAAGGATTCAGCCTTGCACGGGGCAGCTGCATTCCTGAC 
   451 GAGAAATGTACTGTCTGTAAAGAAGGATTCAGCCTTGCACGGGGCAGCTGCATTCCTGAC 
   151 -E--K--C--T--V--C--K--E--G--F--S--L--A--R--G--S--C--I--P--D- 
             
   661 TGTGAGCCAGGCACCTACTTTGACTCAGAGCTGATCAGATGTGGGGAATGCCATCACACC 
   511 TGTGAGCCAGGCACCTACTTTGACTCAGAGCTGATCAGATGTGGGGAATGCCATCACACC 
   171 -C--E--P--G--T--Y--F--D--S--E--L--I--R--C--G--E--C--H--H--T- 
          
   721 TGCGGAACCTGCGTGGGGCCAGGCAGAGAAGAGTGCATTCACTGTGCGAAAAACTTCCAC 
   571 TGCGGAACCTGCGTGGGGCCAGGCAGAGAAGAGTGCATTCACTGTGCGAAAAACTTCCAC 
   191 -C--G--T--C--V--G--P--G--R--E--E--C--I--H--C--A--K--N--F--H- 
 
   781 TTCCACGACTGGAAGTGTGTGCCAGCCTGTGGTGAGGGCTTCTACCCAGAAGAGATGCCG 
   631 TTCCACGACTGGAAGTGTGTGCCAGCCTGTGGTGAGGGCTTCTACCCAGAAGAGATGCCG 
   211 -F--H--D--W--K--C--V--P--A--C--G--E--G--F--Y--P--E--E--M--P- 
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   841 GGCTTGCCCCACAAAGTGTGTCGAAGGTGTGACGAGAACTGCTTGAGCTGTGCAGGCTCC 
   691 GGCTTGCCCCACAAAGTGTGTCGAAGGTGTGACGAGAACTGCTTGAGCTGTGCAGGCTCC 
   231 -G--L--P--H--K--V--C--R--R--C--D--E--N--C--L--S--C--A--G--S- 
 
  901 AGCAGGAACTGTAGCAGGTGTAAGACGGGCTTCACACAGCTGGGGACCTCCTGCATCACC 
   751 AGCAGGAACTGTAGCAGGTGTAAGACGGGCTTCACACAGCTGGGGACCTCCTGCATCACC 
   251 -S--R--N--C--S--R--C--K--T--G--F--T--Q--L--G--T--S--C--I--T- 
                             
   961 AACCACACGTGCAGCAACGCTGACGAGACATTCTGCGAGATGGTGAAGTCCAACCGGCTG 
   811 AACCACACGTGCAGCAACGCTGACGAGACATTCTGCGAGATGGTGAAGTCCAACCGGCTG 
   271 -N--H--T--C--S--N--A--D--E--T--F--C--E--M--V--K--S--N--R--L- 
          
  1021 TGCGAACGGAAGCTCTTCATTCAGTTCTGCTGCCGCACGTGCCTCCTGGCCGGGTAAGGG 
   871 TGCGAACGGAAGCTCTTCATTCAGTTCTGCTGCCGCACGTGCCTCCTGGCCGGGTAA... 
   291 -C--E--R--K--L--F--I--Q--F--C--C--R--T--C--L--L--A--G--*-... 
                
  1081 TGCCTAGCTGCCCACAGAGGGCAGGCACTCCCATCCATCCATCCGTCCACCTTCCTCCAG 
       ............................................................ 
       ............................................................ 
                                 
  1141 ACTGTCGGCCAGAGTCTGTTTCAGGAGCGGCGCCCTGCACCTGACAGCTTTATCTCCCCA 
       ............................................................ 
       ............................................................ 
               
  1201 GGAGCAGCAT 
       .......... 
       .......... 
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 EMSA Appendix D
 
D.1 Oligonucleotide Sequences 
 
(1) 5’-BIO-AGACTTCATTATTATTGGACT 
(2) 5’-AGTCCAATAATAATGAAGTCT 
(3) 5’-BIO-AGACTTCATTTTTATTGGACT 
(4) 5’-AGTCCAATAAAAATGAAGTCT 
(5) 5’-AGACTTCATTATTATTGGACT 
(6) 5’-AGACTTCATTTTTATTGGACT 
(7) 5’-GCCTGTCACCCGTCATGTAT 
(8) 5’-ATACATGACGGGTGACAGGC 
(9) 5’-BIO-AAGCTGGCCCCGCTGGAAGG 
(10) 5’-BIO-AAGCTGGCCCTGCTGGAAGG 
(11) 5’-CCTTCCAGCAGGGCCAGCTT 
(12) 5’-CCTTCCAGCGGGGCCAGCTT 
(13) 5’-AAGCTGGCCCTGCTGGAAGG 
(14) 5’-AAGCTGGCCCCGCTGGAAGG 
 
All double-stranded EMSA probes are combinations of the above, allele values (in bold) refer 
to the sense strand (-) hg19. 
 
rs11855415 biotinylated probes = T: (1)+(2), A: (3)+(4) 
rs11855415 cold probes = T: (2)+(5), A: (4)+(6) 
rs7182874 biotinylated probes = G: (9)+(12), A: (10)+(11) 
rs7182874 cold probes = G: (12)+(14), A: (11)+(13) 
Scrambled probe: (7)+(8) 
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D.2 Additional EMSA images 
 
 
 
   
 
Figure D.1 EMSA for SH-SY5Y nuclear extract and the rs11855415 alleles. The gel image displays the 
binding of SH-SY5Y nuclear extract to probes containing the rs11855415 SNP A versus T alleles. Midway 
band indicates the protein:DNA complex with the unbound DNA probe at the bottom of each lane.  The 
presence of a competitor is denoted above each lane: -, no competitor; S, scrambled competitor; and *, 
10-fold and **, 100-fold excess of competitor respectively  
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Figure D.2 EMSA for HEK293 nuclear extract and the rs11855415 alleles. The gel image displays the 
binding of HEK293 nuclear extract to probes containing the rs11855415 SNP A versus T alleles. Arrow 
indicates the protein:DNA complex with the unbound DNA probe at the bottom of each lane.  The 
presence of a competitor is denoted above each lane: -, no competitor; S, scrambled competitor; and *, 
10-fold and **, 100-fold excess of competitor respectively 
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 Luciferase Assay Appendix E
 
E.1  Lipofectamine P3000 transfection protocol 
 
1 µl of the Renilla vector pRL-TK (20ng/µl) was added to 1 µl of DNA plasmid 
(80ng/µl), 0.2 µl of P3000 reagent and 2.8 µl of Opti-MEM (Invitrogen) to give a 5 µl 
volume which was allowed to incubate for up to 10 minutes. To this, 0.3 µl 
Lipofectamine 3000 and 4.7 µl Opti-MEM were added to give a total volume of 10 µl 
which was then added to each well. Note for the GFP positive control 100ng was added 
to each well instead of Renilla and DNA. 
 
E.2  Luciferase construct table 
 
Table E.1 Luciferase assay reporter plasmids. The 6 pairs of pGL4.10 luciferase plasmids were designed 
to include the 1707-1839bp PCSK6 secondary promoter region containing rs11855415 SNP A and T 
alleles and VNTR 6,9 and 10 alleles in both sense and antisense strand directions 
 
 
VNTR rs11855415 Strand 
Direction 
Size (bp) 
6x33bp A Sense 
Antisense 
1707 
6x33bp T Sense 
Antisense 
1707 
9x33bp A Sense Antisense 1806 
9x33bp T 
Sense 
Antisense 1806 
10x33bp A 
Sense 
Antisense 1839 
10x33bp T 
Sense 
Antisense 1839 
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E.3 Luciferase assay plasmids 
 
Figure E.1 Plasmid map of the pCR-BluntII-TOPO entry vectorcomplete with inserted PCR product 
containing the VNTR 10 and rs11855415 A alleles. The PCR product here has been inserted in a direction 
corresponding to the sense strand direction. This was the entry-level vector used for all future cloning. 
For primers used to produce PCR product insert see Appendix A. 
 
  
Figure E.2 Plasmid map of the pGL4.10 luciferase reporter vectorcomplete with inserted PCR product 
containing the VNTR 6 and rs11855415 A alleles. The PCR product in Figure X was excised from the pCR-
BluntII-TOPO vector by KpnI and XhoI restriction enzymes and cloned in to this pGL4.10 luciferase 
reporter plasmid (Promega). In this plasmid the PCR product was inserted in a direction corresponding 
to the sense strand direction. 
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Figure E.3 Plasmid map of the pGL4.10 luciferase reporter 10A vectorcomplete with inserted PCR 
product containing the VNTR 10 and rs11855415 A alleles. The 10A pGL4.10 vector was used as the 
template vector from which increasingly-sized segments were removed to define the minimal promoter 
capable of driving transcription in a sense strand direction (see Methods section 5.3.5). The relevant 
restriction enzyme sites are noted. 
 
 
 
Figure E.4 Minimal Promoter construct used for allelic variation assays.This plasmid map represents the 
3rd bar from Figure 5.12. Following the minimal promoter assay, this was the plasmid with the shortest 
sequence that would include the rs11855415 SNP. The plasmid was subsequently used when disrupting 
the predicted transcription factor bind site centred at allele A of the SNP rs11855415 (Figure 5.14). 
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E.4  Luciferase assay antisense strand results 
 
 
 
 
 
Figure E.5 Antisense luciferase-expressing construct results which tested the effect of allelic variation for 
(A) the rs11855415 SNP and (B,C) the VNTR in the antisense strand direction. Allelic differences in 
promoter activity were measured with luciferase constructs transfected in  K562, 1321N1 and HeLa cell 
lines for the (B) VNTR 6,9 and 10 alleles (C) VNTR alleles classified as short (allele 6) and long (alleles 9 
and 10) according to the association analysis performed by Arning et al., (2013). Luciferase expression 
was measured relative to the empty pGL4 vector following renilla normalisation. Data are 
representative of at least 3 independent experiments performed in triplicate. Luciferase expression was 
measured relative to the empty pGL4 vector following renilla normalisation and log transformed (log2 
fold change). Bars represent Mean(SD) (N = 3). *P-value of less than 0.05 was considered significant. 
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E.5 Sequencing data for mutagenesis of rs11855415 TFBS 
 
The sequence below confirms the rs11855415 T allele (red) and the surrounding 
sequence underlined which is to be replaced by ‘nonsense’ sequence via mutagenesis. 
The plasmid is based on the 10A AvrII (-783 bp) construct from the Minimal Promoter 
assay (see Figure 5.11) with site-directed mutagenesis used to disrupt the 5 base pairs 
centred at rs11855415 entirely. The accompanying chromatogram indicates the resulting 
Sanger sequencing.    
 
>sanger sequencing of the 10A plasmid  
CCCAGTCAGACATTTCTCTGGCTACTGGCCGCTAGGCAACAGAGTGAGACCCTAGGTCTAAATACACACA
TACACACATACACACACACACACATAAAGTCAAACAGAGAGTGTAATAAAAATGAAGTCTCTCTTCCATT
CCAGTCCAGCCTCCTCCCATGAGGCTGCCTGTCTGCTGGGTCCCTGGGAATTCTTCCTGCTCTCTTTTTC
CACACAGTGCACACCACTGACCCTGAGTGTGGAGCAGCCCCTCTTGTTTGTCCCACCAAAACTATATCTG
AAAATAAAAATCCAGTTTT 
 
 
Figure E.6 Chromatogram confirming the sequence of the 10A plasmid as used in the rs11855415 TFBS 
mutagenesis luciferase assay experiment (see Section 5.4.5) 
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The sequence below confirms the rs11855415 SNP and the surrounding sequence has 
been replaced with ‘nonsense’ sequence (GCTAGC) via mutagenesis (see Appendix 
A.5 for primers used). The plasmid is based on the 10A AvrII (-783 bp) construct from 
the Minimal Promoter assay. The accompanying chromatogram indicates the resulting 
Sanger sequencing. Note Transfac v2014.4 did not return any known TFBSs for the 10 
base pair sequence surrounding the inserted ‘GCTAGC’ sequence using the 'vertebrate 
non redundant min FP profile. 
  
>sanger sequencing of the 10A plasmid post-mutagenesis   
CCCGGTCATACATTTCTCTGGCTAACTGGCCGCTAGGCAACAGAGTGAGACCCTGTCTAAATACACACAT
ACACACATACACACACACACACATAAAGTCAAACAGAGAGTGTAAGCTAGCTGAAGTCTCTCTTCCATTC
CAGTCCAGCCTCCTCCCATGAGGCTGCCTGTCTGCTGGGTCCCTGGGAATTCTTCCTGCTCTCTTTTTCC
ACACAGTGCACACCACTGACCCTGAGTGTGGAGCA 
 
 
 
 
Figure E.7 Chromatogram confirming the sequence of the 10A plasmid following mutagenesis as used in 
the rs11855415 TFBS mutagenesis luciferase assay experiment (see Section 5.4.5) 
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 RNA-Seq Appendix F
F.1 Source and shell script developed to download RNA-Seq files 
 
# 
http://hgdownload.cse.ucsc.edu/goldenPath/hg19/encodeDCC/wgEncodeCa
ltechRnaSeq/ 
$ wget 
http://hgdownload.cse.ucsc.edu/goldenPath/hg19/encodeDCC/wgEncodeCa
ltechRnaSeq/ 
$ grep ".bam" index.html | grep -v ".bai" | awk -F "\"" '{ print $2 
}' > names.txt 
$ for i in `cat names.txt`; do echo $i; wget 
http://hgdownload.cse.ucsc.edu/goldenPath/hg19/encodeDCC/wgEncodeCa
ltechRnaSeq/$i; done; 
 
 
$ wget 
http://hgdownload.cse.ucsc.edu/goldenPath/hg19/encodeDCC/wgEncodeCs
hlLongRnaSeq/ 
$ grep ".bam" index.html | grep -v ".bai" | awk -F "\"" '{ print $2 
}' > names.txt 
$ for i in `cat names.txt`; do echo $i; wget 
http://hgdownload.cse.ucsc.edu/goldenPath/hg19/encodeDCC/wgEncodeCs
hlLongRnaSeq/$i; done; 
 
 
$ wget 
http://hgdownload.cse.ucsc.edu/goldenPath/hg19/encodeDCC/wgEncodeCs
hlShortRnaSeq/ 
$ grep ".bam" index.html | grep -v ".bai" | awk -F "\"" '{ print $2 
}' > names.txt 
$ for i in `cat names.txt`; do echo $i; wget 
http://hgdownload.cse.ucsc.edu/goldenPath/hg19/encodeDCC/wgEncodeCs
hlShortRnaSeq/$i; done; 
 
 
$ wget 
http://hgdownload.cse.ucsc.edu/goldenPath/hg19/encodeDCC/wgEncodeGi
sRnaSeq/ 
$ grep ".bam" index.html | grep -v ".bai" | awk -F "\"" '{ print $2 
}' > names.txt 
$ for i in `cat names.txt`; do echo $i; wget 
http://hgdownload.cse.ucsc.edu/goldenPath/hg19/encodeDCC/wgEncodeGi
sRnaSeq/$i; done; 
 
 
$ wget 
http://hgdownload.cse.ucsc.edu/goldenPath/hg19/encodeDCC/wgEncodeHa
ibRnaSeq/ 
$ grep ".bam" index.html | grep -v ".bai" | awk -F "\"" '{ print $2 
}' > names.txt 
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$ for i in `cat names.txt`; do echo $i; wget 
http://hgdownload.cse.ucsc.edu/goldenPath/hg19/encodeDCC/wgEncodeHa
ibRnaSeq/$i; done; 
 
 
$ wget 
http://hgdownload.cse.ucsc.edu/goldenPath/hg19/encodeDCC/wgEncodeSy
dhRnaSeq/ 
$ grep ".bam" index.html | grep -v ".bai" | awk -F "\"" '{ print $2 
}' > names.txt 
$ for i in `cat names.txt`; do echo $i; wget 
http://hgdownload.cse.ucsc.edu/goldenPath/hg19/encodeDCC/wgEncodeSy
dhRnaSeq/$i; done; 
 
 
F.2 Script for creating BAM files 
 
echo $1 
module add samtools 
module add bwa 
 
if [ -e $1.bam ] 
then 
        echo "$1.bam exist" 
        exit 
fi 
 
if [ -e $1.sam ] 
then 
        samtools view -Sbh $1.sam > $1.bam 
        samtools sort -@ 5 $1.bam $1.sorted 
        mv $1.sorted.bam $1.bam 
        samtools index $1.bam 
        rm $1.sam 
else 
        if [ -e $1.fastq.gz ] 
        then 
                bwa mem -t 10 ../ref/chr15.txt $1.fastq.gz > $1.sam 
        else 
                bwa mem -t 10 ../ref/chr15.txt $1.fastq.tgz > 
$1.sam 
        fi 
        samtools view -Sbh $1.sam > $1.bam 
        samtools sort -@ 5 $1.bam $1.sorted 
        mv $1.sorted.bam $1.bam 
        samtools index $1.bam 
        rm $1.sam 
fi 
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F.3 Script for alignment with SAMtools 
 
echo $1 
if [ ! -d $1 ]; then 
        mkdir $1 
else 
        rm $1/* 
fi 
 
 
## 1 
echo data_1 
samtools view -b $1.bam CM000677.2:101300000-101490000 | samtools 
view - | grep -w "CM000677.2" | awk ' { if ( $4 >= 101489374-
length($10) && $4 <= 101489984+length($10) ) { print $0 } } ' > 
$1/dashat.txt 
 
## 2 
echo data_2 
samtools view -b $1.bam CM000677.2:101300000-101490000 | samtools 
view - | grep -w "CM000677.2" | awk ' { if ( $4 >= 101398404-
length($10) && $4 <= 101398576+length($10) ) { print $0 } } ' > 
$1/dashat.txt 
 
## 3b 
echo data_3b 
samtools view -b $1.bam CM000677.2:101300000-101490000 | samtools 
view - | grep -w "CM000677.2" | awk ' { if ( $4 >= 101873769-
length($10) && $4 <= 101873844+length($10) ) { print $0 } } ' > 
$1/dashat.txt 
 
## 4 
echo data_4 
samtools view -b $1.bam CM000677.2:101300000-101490000 | samtools 
view - | grep -w "CM000677.2" | awk ' { if ( $4 >= 101324850-
length($10) && $4 <= 101325046+length($10) ) { print $0 } } ' > 
$1/dashat.txt 
 
## 5 
echo data_5 
samtools view -b $1.bam CM000677.2:101300000-101490000 | samtools 
view - | grep -w "CM000677.2" | awk ' { if ( $4 >= 101303928-
length($10) && $4 <= 101305355+length($10) ) { print $0 } } ' > 
$1d/dashat.txt 
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 Rev-ChIP Supplemental Materials and Methods Appendix G
 
The following biotinylated probes (MWG Eurofins) were used as probe baits in the 
Rev-ChIP assay (reverse complement sequences not shown) 
 
rs11855415 T allele 5’ - CGTAGAAAGTGTAATAATAATGAAGTCT 
rs11855415 A allele  5’ - CGTAGAAAGTGTAATAAAAATGAAGTCT 
 
Mascot database searching 
Charge state deconvolution and deisotoping were not performed. All MS/MS samples 
were analysed using Mascot (Matrix Science, London, UK; version 2.5.1). Mascot was 
set up to search the NCBInr_20150331 database (selected for Homo sapiens, unknown 
version, 304051 entries) assuming the digestion enzyme trypsin. Mascot was searched 
with a fragment ion mass tolerance of 0.100 Da and a parent ion tolerance of 20 PPM. 
O+18 of pyrrolysine and iodoacetamide derivative of cysteine were specified in Mascot 
as fixed modifications. Oxidation of methionine was specified in Mascot as a variable 
modification. 
 
Criteria for protein identification 
Scaffold (version Scaffold_4.4.3, Proteome Software Inc., Portland, OR) was used to 
validate MS/MS based peptide and protein identifications. Peptide identifications were 
accepted if they could be established at greater than 99.5% probability to achieve an 
FDR less than 1.0% by the Peptide Prophet algorithm (Keller et al., 2002). Protein 
identifications were accepted if they could be established at greater than 99.0% 
probability and contained at least 2 identified peptides.  Protein probabilities were 
assigned by the Protein Prophet algorithm (Nesvizhskii et al., 2003). Proteins that 
contained similar peptides and could not be differentiated based on MS/MS analysis 
alone were grouped to satisfy the principles of parsimony. Proteins were annotated with 
GO terms from NCBI (downloaded May 16, 2015) (Ashburner et al., 2000). 
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Table G.1 Full mass spectrometry output for Rev-ChIP assay rs1185545 A vs T alleles using hNSC cell line nuclear extract
 
(1) Data is  presented according to proteins binding to the A allele: 
 
  
rs11855415 allele 
 
MS/MS Identified Proteins  Accession Number Mol. Weight 
A† T† 
Control* 
unnamed protein product gi|189069149 (+2) 34 kDa 5 0 0 
microtubule-associated protein 1B, isoform CRA_a gi|119616102 (+4) 257 kDa 3 0 0 
SRY (sex determining region Y)-box 5, isoform CRA_d gi|119616895 (+14) 64 kDa 3 0 0 
histone H1x gi|5174449 22 kDa 3 2 1 
hCG2016250, isoform CRA_a  gi|119618532 (+9) 21 kDa 3 1 2 
nucleophosmin isoform 1  gi|10835063 (+13) 33 kDa 2 1 1 
myristoylated alanine-rich C-kinase substrate  gi|153070260 (+2) 32 kDa 3 2 1 
hCG1640785, isoform CRA_a  gi|119569329 (+1) 14 kDa 6 2 1 
ribosomal protein S10, isoform CRA_a  gi|119624187 (+2) 20 kDa 5 4 2 
ubiquitin associated protein 2-like, isoform CRA_a  gi|119573598 (+22) 114 kDa 5 4 1 
translation elongation factor 1 alpha 1-like 14  gi|15277711 (+14) 43 kDa 5 4 3 
ceruloplasmin (ferroxidase), isoform CRA_b  gi|119599289 (+9) 123 kDa 5 4 1 
transcription factor SOX-3  gi|30061556 (+1) 45 kDa 5 4 1 
YTH domain family protein 2 isoform 1  gi|116812575 (+3) 62 kDa 6 5 1 
filamin-A isoform 1  gi|116063573 (+13) 280 kDa 6 5 0 
YTH domain family protein 3  gi|116235460 (+7) 64 kDa 8 5 1 
unnamed protein product  gi|194376170 (+1) 26 kDa 8 6 0 
unnamed protein product  gi|194387670 (+1) 19 kDa 8 6 0 
MYL6 protein  gi|113812151 (+4) 16 kDa 14 8 4 
musashi homolog 2 (Drosophila), isoform CRA_a  gi|119614912 (+11) 37 kDa 9 8 3 
unnamed protein product  gi|158255914 (+3) 42 kDa 13 11 2 
RNA-binding protein Musashi homolog 1  gi|4505255 39 kDa 16 11 4 
histone H1.5  gi|4885381 23 kDa 22 14 3 
liver histone H1e  gi|126035028 (+3) 22 kDa 27 15 4 
 202 
 
PRO2619  gi|11493459 (+22) 57 kDa 19 17 7 
keratin 10 isoform CRA_b  gi|119581085 (+4) 63 kDa 22 19 16 
vimentin  gi|340219 (+1) 54 kDa 35 21 13 
tropomyosin alpha-1 chain isoform 4  gi|63252900 33 kDa 27 21 6 
actin, beta, partial  gi|14250401 41 kDa 49 41 15 
myosin-10 isoform 2  gi|367460087 (+3) 229 kDa 83 63 19 
poly [ADP-ribose] polymerase 1  gi|156523968 (+2) 113 kDa 108 81 3 
myosin-9  gi|12667788 227 kDa 143 112 38 
 
(2) Data is presented according to proteins binding to the T allele: 
   rs11855415 allele  
MS/MS Identified Proteins  Accession Number Mol. Weight 
A† T† 
Control* 
signal recognition particle 14kDa (homologous Alu RNA binding protein), 
isoform CRA_b  
gi|119612797 (+1) 17 kDa 0 2 0 
ribosomal protein S16, isoform CRA_b  gi|119577297 (+2) 16 kDa 0 2 1 
CUG triplet repeat, RNA binding protein 1, isoform CRA_e  gi|119588316 (+12) 31 kDa 0 2 1 
hnRNP-E1  gi|460771 (+1) 38 kDa 0 6 4 
poly(rC)-binding protein 2 isoform b  gi|14141166 (+5) 38 kDa 0 8 4 
DAZ-associated protein 1 isoform b  gi|25470886 (+9) 43 kDa 2 4 3 
unnamed protein product  gi|189066545 (+3) 29 kDa 2 5 2 
A0=heterogeneous nuclear ribonucleoprotein [human, placenta, Peptide, 305 aa] gi|1911429 (+1) 31 kDa 2 8 5 
ribosomal protein L23a, isoform CRA_a  gi|119571516 (+3) 22 kDa 3 4 1 
caldesmon 1, isoform CRA_a  gi|119604232 (+14) 94 kDa 3 7 1 
RNA-binding protein 4 isoform 1  gi|93277122 40 kDa 5 9 2 
Heterogeneous nuclear ribonucleoprotein U-like 1  gi|12803479 (+5) 96 kDa 6 8 5 
replication protein A 70 kDa DNA-binding subunit  gi|4506583 68 kDa 6 14 5 
myosin regulatory light chain 12B  gi|15809016 (+2) 20 kDa 8 11 3 
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tubulin beta-2B chain [Mus musculus] gi|21746161 50 kDa 8 12 8 
TDP43  gi|130750552 (+2) 45 kDa 8 12 5 
ribosomal protein S18, isoform CRA_c  gi|119624101 (+1) 15 kDa 9 11 3 
tubulin beta-5 chain [Mus musculus] gi|7106439 (+1) 50 kDa 9 12 9 
keratin, type II cytoskeletal 2 epidermal  gi|47132620 65 kDa 9 15 11 
drebrin 1, isoform CRA_a  gi|119605395 (+5) 76 kDa 11 12 1 
unnamed protein product  gi|194387362 (+3) 35 kDa 11 18 9 
heterogeneous nuclear ribonucleoprotein D-like isoform a  gi|14110407 (+7) 46 kDa 13 18 9 
heterogeneous nuclear ribonucleoprotein M isoform a  gi|14141152 (+1) 78 kDa 16 39 24 
heterogeneous nuclear ribonucleoprotein D (AU-rich element RNA binding 
protein 1, 37kDa), isoform CRA_f  
gi|119626284 30 kDa 17 21 12 
*Unrelated biotinylated molecule 
† Indicates a quantative value for the normalised value of total spectra 
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Table G.2 Full mass spectrometry output for Rev-ChIP assay rs1185545 A vs T alleles using 1321N1 cell line nuclear extract.
  
(1) Data is  presented according to preferential binding to the A allele 
   rs11855415 allele 
MS/MS Identified Proteins  Accession Number Mol. Weight 
A† T† 
Control* 
microtubule-associated protein 4  gi|187383 (+31) 121 kDa 9 0 0 
forkhead box C2 (MFH-1, mesenchyme forkhead 1), isoform CRA_b  gi|119615822 (+1) 49 kDa 7 0 0 
heat shock-related 70 kDa protein 2  gi|13676857 (+6) 70 kDa 4 0 0 
general transcription factor II, i, isoform CRA_a  gi|119590000 (+23) 42 kDa 3 0 1 
actinin, alpha 4, isoform CRA_c  gi|119577215 (+7) 104 kDa 3 0 0 
dermcidin preproprotein  gi|16751921 (+1) 11 kDa 3 0 0 
unnamed protein product  gi|193786488 (+5) 83 kDa 3 0 0 
transcriptional activator protein Pur-beta  gi|15147219 33 kDa 1 0 1 
unnamed protein product  gi|158259911 (+11) 52 kDa 9 1 0 
beta-polymerase  gi|190156 (+14) 38 kDa 7 1 0 
zinc-finger homeodomain protein 4  gi|109638254 (+1) 397 kDa 7 1 0 
SET translocation (myeloid leukemia-associated), isoform CRA_c  gi|119608226 (+7) 29 kDa 7 1 0 
leucine-zipper protein FKSG13  gi|11034809 (+3) 43 kDa 6 1 2 
60S ribosomal protein L13 isoform 1  gi|15431295 (+1) 24 kDa 3 1 3 
60S ribosomal protein L14  gi|78000181 23 kDa 3 1 2 
ribosomal protein L18, isoform CRA_b  gi|119572744 (+5) 19 kDa 3 1 2 
unnamed protein product  gi|189065517 (+8) 80 kDa 3 1 1 
A kinase (PRKA) anchor protein 8  gi|119604880 (+3) 76 kDa 3 1 1 
protein transport protein Sec61 subunit beta  gi|5803165 (+1) 10 kDa 3 1 1 
40S ribosomal protein S14  gi|5032051 16 kDa 3 1 1 
transcription factor 7-like 2 (T-cell specific, HMG-box), isoform CRA_b  gi|119569892 (+62) 59 kDa 3 1 0 
60S acidic ribosomal protein P2  gi|4506671 (+1) 12 kDa 3 1 3 
60S ribosomal protein L11 [Mus musculus] gi|13385408 (+4) 20 kDa 3 1 2 
Ribosomal protein S6  gi|15342049 (+5) 29 kDa 3 1 2 
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ribosomal protein L9, isoform CRA_a  gi|119613332 (+2) 15 kDa 3 1 1 
X-ray repair cross-complementing protein 5  gi|10863945 (+1) 83 kDa 15 3 0 
polynucleotide kinase 3'-phosphatase, isoform CRA_c  gi|119572952 (+3) 65 kDa 13 3 0 
lamin A/C, isoform CRA_a  gi|119573381 (+7) 78 kDa 7 3 1 
chromodomain helicase DNA binding protein 4, isoform CRA_a  gi|119609183 (+11) 218 kDa 7 3 0 
ras-related protein Rab-1B  gi|13569962 (+1) 22 kDa 4 3 2 
unnamed protein product  gi|158259071 (+1) 40 kDa 4 3 2 
hCG23783, isoform CRA_a  gi|119621875 (+5) 23 kDa 4 3 2 
high mobility group AT-hook 1, isoform CRA_b  gi|119624168 (+5) 34 kDa 4 3 1 
replication factor C (activator 1) 1, 145kDa, isoform CRA_a  gi|119613328 (+5) 115 kDa 4 3 0 
ribosomal protein S5, isoform CRA_b  gi|119592989 (+3) 22 kDa 4 3 1 
lactotransferrin  gi|119585171 (+31) 78 kDa 4 3 1 
Chain A, Cyclophilin B Complexed With [d-(Cholinylester)ser8]-Cyclosporin gi|1310882 (+5) 20 kDa 4 3 0 
ligase III, DNA, ATP-dependent  gi|19550955 (+5) 96 kDa 22 4 0 
ribosomal protein, partial  gi|337518 (+1) 22 kDa 10 4 2 
unnamed protein product  gi|158255940 (+5) 61 kDa 7 4 1 
DNA repair protein XRCC1  gi|190684675 (+3) 69 kDa 7 4 0 
glyceraldehyde-3-phosphate dehydrogenase  gi|31645 (+4) 36 kDa 6 4 1 
unnamed protein product  gi|193786502 (+3) 46 kDa 13 6 7 
Cart-1  gi|1098654 (+1) 37 kDa 9 6 0 
filamin-A isoform 1  gi|116063573 (+7) 280 kDa 9 6 1 
unnamed protein product  gi|194387670 (+1) 19 kDa 7 6 0 
N-methylpurine-DNA  gi|14336679 (+5) 33 kDa 10 7 0 
histone 1, H1t  gi|119575933 (+4) 24 kDa 10 7 0 
78 kDa glucose-regulated protein precursor  gi|16507237 (+2) 72 kDa 9 7 1 
hCG1640785, isoform CRA_a  gi|119569329 (+1) 14 kDa 9 7 2 
CCAAT/enhancer-binding protein beta  gi|28872796 (+2) 36 kDa 12 9 1 
X-ray repair cross-complementing protein 6  gi|4503841 (+1) 70 kDa 22 10 1 
extracellular matrix protein 1  gi|1488324 (+2) 61 kDa 13 10 4 
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YTH domain family protein 3  gi|116235460 (+6) 64 kDa 12 10 3 
collagen, type VI, alpha 3, isoform CRA_c  gi|119591511 (+5) 321 kDa 21 12 2 
keratin, type II cytoskeletal 5  gi|119395754 (+4) 62 kDa 10 12 4 
ribosomal protein S18, isoform CRA_c  gi|119624101 (+1) 15 kDa 15 13 5 
elongation factor 1-alpha 1  gi|4503471 (+8) 50 kDa 16 15 4 
heterogeneous nuclear ribonucleoprotein U isoform b  gi|14141161 (+4) 89 kDa 22 17 16 
histone H1.5  gi|4885381 23 kDa 25 20 6 
cytokeratin 9  gi|435476 (+1) 62 kDa 37 22 20 
liver histone H1e  gi|126035028 (+4) 22 kDa 37 25 8 
PRO2619  gi|11493459 (+22) 57 kDa 27 25 11 
actin, beta, partial  gi|14250401 (+9) 41 kDa 36 26 13 
neuroblast differentiation-associated protein AHNAK isoform 1  gi|61743954 (+4) 629 kDa 39 28 5 
poly [ADP-ribose] polymerase 1  gi|156523968 (+2) 113 kDa 156 134 10 
 
(2) Data is  presented according to preferential binding to the A allele 
 
  
rs11855415 allele 
MS/MS Identified Proteins  Accession Number Mol. Weight 
A† T† 
Control* 
Chain A, Core Of The Alu Domain Of The Mammalian Srp gi|11513832 (+1) 10 kDa 0 3 0 
DNA topoisomerase 1  gi|11225260 (+15) 91 kDa 0 3 2 
ribosomal protein S19, partial  gi|16924231 (+1) 17 kDa 0 3 1 
Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3C  gi|15079888 (+2) 23 kDa 0 3 0 
cold inducible RNA binding protein, isoform CRA_b  gi|119589927 (+1) 20 kDa 0 4 2 
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, 
subfamily a-like 1  
gi|16741295 (+3) 106 kDa 0 7 2 
unnamed protein product  gi|189066545 (+2) 29 kDa 0 12 3 
ribosomal protein S4, X-linked, isoform CRA_a  gi|119592221 (+4) 43 kDa 1 3 3 
KIAA0185  gi|1136430 (+2) 210 kDa 1 3 3 
ubiquitin associated protein 2-like, isoform CRA_f  gi|119573603 (+18) 105 kDa 1 3 2 
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PSIP1 protein  gi|116283688 (+11) 30 kDa 1 3 1 
ribosomal protein S16, isoform CRA_b  gi|119577297 (+2) 16 kDa 1 3 2 
replication protein A3, 14kDa, isoform CRA_a  gi|119614009 (+2) 9 kDa 1 4 1 
SUB1 homolog (S. cerevisiae)  gi|16307067 (+2) 14 kDa 1 6 2 
DNA topoisomerase 3-alpha  gi|10835218 (+4) 112 kDa 1 7 2 
RNA binding protein fox-1 homolog 2 isoform 5  gi|133925803 (+5) 47 kDa 1 16 2 
hCG2016250, isoform CRA_c  gi|119618534 (+7) 29 kDa 3 4 3 
ribosomal protein S10, isoform CRA_a  gi|119624187 (+2) 20 kDa 3 4 2 
MYL6 protein  gi|113812151 (+6) 16 kDa 3 6 4 
Similar to RIKEN cDNA 3930401K13 gene, partial  gi|13277568 (+6) 57 kDa 3 6 0 
replication protein A 70 kDa DNA-binding subunit  gi|4506583 68 kDa 3 28 7 
myosin regulatory light chain 12B  gi|15809016 (+3) 20 kDa 4 6 4 
signal recognition particle 14 kDa protein [Pongo abelii] gi|197099116 15 kDa 4 6 1 
tropomyosin (227 AA)  gi|825723 (+2) 27 kDa 4 7 1 
Chain B, Structure Of The Hsddb1-Hsddb2 Complex gi|221046722 (+3) 49 kDa 4 7 0 
DAZ-associated protein 1 isoform b  gi|25470886 (+4) 43 kDa 4 9 5 
keratin, type I cytoskeletal 13 isoform a  gi|131412225 (+2) 50 kDa 4 12 4 
heterogeneous nuclear ribonucleoprotein A0  gi|5803036 31 kDa 4 13 5 
poly(rC)-binding protein 2 isoform b  gi|14141166 (+5) 38 kDa 4 17 5 
RecQ protein-like (DNA helicase Q1-like)  gi|12654453 (+5) 73 kDa 6 7 0 
unnamed protein product  gi|194379372 (+2) 52 kDa 6 7 5 
Heterogeneous nuclear ribonucleoprotein U-like 1  gi|12803479 (+5) 96 kDa 6 9 4 
ceruloplasmin (ferroxidase), isoform CRA_b  gi|119599289 (+6) 123 kDa 6 9 2 
hnRNP-E1  gi|460771 (+1) 38 kDa 6 19 7 
heterogeneous nuclear ribonucleoprotein D-like isoform a  gi|14110407 (+7) 46 kDa 7 25 7 
musashi homolog 2 (Drosophila), isoform CRA_a  gi|119614912 (+10) 37 kDa 9 10 1 
gamma-interferon-inducible protein 16 isoform 2  gi|112789562 (+3) 82 kDa 9 12 0 
YTH domain family protein 2 isoform 1  gi|116812575 (+3) 62 kDa 10 13 2 
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KIAA1398 protein  gi|14133249 (+2) 170 kDa 12 13 12 
damage-specific DNA binding protein 1, 127kDa, isoform CRA_d  gi|119594342 (+14) 128 kDa 12 16 0 
Annexin A2  gi|16306978 (+6) 39 kDa 12 17 1 
nucleolysin TIA-1 isoform p40 isoform 2  gi|188219591 (+3) 43 kDa 13 16 6 
nucleolysin TIAR isoform 1  gi|4507499 (+1) 42 kDa 16 22 6 
unnamed protein product  gi|194387362 (+3) 35 kDa 16 32 10 
heterogeneous nuclear ribonucleoprotein D (AU-rich element RNA binding protein 
1, 37kDa), isoform CRA_f  
gi|119626284 30 kDa 18 31 13 
Chain A, Human Mitochondrial Single-Stranded Dna Binding Protein gi|2624694 15 kDa 21 23 4 
keratin 10 (epidermolytic hyperkeratosis; keratosis palmaris et plantaris), isoform 
CRA_b  gi|119581085 (+4) 63 kDa 21 25 14 
epidermal cytokeratin 2  gi|181402 (+1) 66 kDa 22 26 12 
helicase-like transcription factor  gi|21071052 (+3) 114 kDa 34 36 3 
keratin 1  gi|11935049 (+4) 66 kDa 42 44 21 
vimentin  gi|62414289 54 kDa 42 51 41 
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 Association analysis  Appendix H
 
 
 
Figure H.1 Plot of the normalised PegQ7 (mean=0, SD=1) distribution (y-axis) for each genotype of 
rs11855415 (x-axis) in individuals from the Unaffected subgroup. 
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Figure H.2 Plot of normalised PegQ7 (mean=0, SD=1) distribution (y-axis) for each genotype of 
rs11855415 (x-axis) in individuals of the RD subgroup.With a minor allele frequency of 0.15 for this 
subgroup (N=183), there are a minimal number of A/A genotyped individuals available. 
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Figure H.3 Plot of normalised PegQ7 (mean=0, SD=1) distribution (y-axis) for each genotype of 
rs11855415 (x-axis) in individuals of the Affected subgroup. 
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 Genetic variant genotyping  Appendix I
 
For the genotyping of both the rs11855415 SNP and the rs10523972 VNTR, gDNA was 
extracted from all relevant cell lines using the QIAamp DNA mini kit according to the 
manufacturer’s instructions. rs11855415 SNP genotyping was performed using  the 
TaqMan assay (Life Technologies) which consisted of 5 μl GTX Express, 0.25 μl 20 X 
TaqMan Gene Expression Assay (rs11855415), 2.75 μl H20 and 40 ng of gDNA in a 10 
μl total reaction volume. Conditions used were 20 s at 95 °C followed by 40 cycles of 
15 s at 95 °C and 60 s at 60 °C. For the VNTR genotyping, VNTR alleles were 
determined visually by 2.0% agarose gel electrophoresis of the PCR product (1 µl 6 X 
Orange-G dye added to 5 μl PCR product) following a PCR with the following 
conditions: 60 s at 95 °C followed by 40 cycles of 10 s at 95 °C, 20 s at 60 °C, 20 s at 
72 °C. A primer pair flanking the VNTR was used: 5'-ACAGGGCTCGGTTCATTAAG 
and 5'-TCGGAATGTGGCTGTAACTG. PCR product size was dependent on VNTR 
allele - VNTR 10 allele corresponds to 516 bp, a 9 allele is 483 bp, 8 allele is 450 bp 
and a 6 allele corresponds to 384 bp. PCR product clean-up was performed (2 μl of 
ExoSAP-IT for every 5 μl PCR product, 37 °C 15min then 80 °C 15min) before 
confirming all sequences by Sanger sequencing (DNA Sequencing and Services, 
Dundee).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                      HEPG2      RPE-1    HEK293 SH-SY5Y  hNSC      HeLa    1321N1      K562 
9 
6 
 
Figure I.1 Genotyping of cell lines for the VNTR identified in the secondary promoter of PCSK6. 
Prior to use as a potential model for functional analysis, various cell lines cell lines were 
genotyped and the resulting product sequenced. See Table I.1 for a list of resulting genotypes. 
The grey triangle indicates 500 bp on the Gene O’Ruler 100 bp ladder. Arrows indicate 9 and 6 
copies of the 33 bp tandem repeat, the K562 genotype 9/6 has been highlighted. In this figure a 
VNTR 10 allele corresponds to 516 bp, a 9 allele is 483 bp, 8 allele is 450 bp and a 6 allele 
corresponds to 384 bp. 
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Table I.1 Genotyping of cell lines for the rs11855415 SNP and the VNTR identified in the secondary 
promoter of PCSK6 
 
  Tissue rs11855415 VNTR 
CHP212 Brain TT 9/9 
LAN5 Brain TT 9/6 
LMR32 Brain AT 9/9 
KELLY Brain TT 9/6 
M17 Brain * TT 9/9 
MRC5V2 Lung ** AT 9/9 
NT2 Testis *** AT 9/9 
SKNF1 Brain * AT - 
SKNMC Brain † TT 6/6 
SKNAS Brain * TT 9/9 
293T Kidney TT 9/9 
SH-SY5Y Brain * TT 9/9 
K562 Bone marrow TT 9/6 
RPE-1 Retina TT 9/9 
HeLa Cervix AT 9/8 
hNSC Brain AT 9/8 
HEPG2 Liver AT 9/9 
1321N1 Brain AA 10/10 †† 
HEK293 Kidney TT 9/9 
 
Rows in grey indicate cell lines previously genotyped by our collaborator Dr William Brandler and a dash (–) 
indicates an ambiguous VNTR genotype where genotyping was unsuccessful  
* derived from metastatic site: bone marrow ** foetal from human *** derived from metastatic site: lung          
† derived from metastatic site: supra-orbital area †† At this resolution a 10/9 VNTR cannot be discounted.  
Note: none of the cell lines employed in this project are known to possess rearrangements on chromosome 15 
according to the European Collection of Cell Cultures (ECACC). 
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